Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.8102932295876952,-2.034599977273249,0.0,0.078120905040622,0.064,6/11,13.14%,ITPR1;TRPC3;ITPR3;TRPC6;ITPR2;TRPC4
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.7900873727529473,-2.009073579472701,0.0,0.054042543897964535,0.086,5/11,9.85%,ITPR1;RYR2;ITPR3;RASA3;MCOLN1
prerank,solute:sodium symporter activity (GO:0015370),0.8090488739966182,1.972819976278338,0.0,0.0049129753122990555,0.005,6/27,6.27%,SLC4A10;SLC4A4;SLC5A6;SLC5A2;SLC4A8;SLC28A2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7273806859603892,-1.9359796328925891,0.0,0.07990448734748552,0.18,6/14,9.04%,SLC7A11;SLC1A3;SLC25A13;SLC1A1;SLC1A2;SLC38A7
prerank,calcium-release channel activity (GO:0015278),-0.6513255335348043,-1.8742446142338585,0.004016064257028112,0.11958919367519875,0.32,6/17,10.00%,ITPR1;RYR2;ITPR3;RASA3;MCOLN1;ITPR2
prerank,platelet-derived growth factor binding (GO:0048407),0.8838766854752534,1.8588492615171177,0.0,0.041760290154541975,0.072,4/11,1.18%,COL6A1;COL3A1;COL1A2;COL1A1
prerank,metalloendopeptidase activity (GO:0004222),0.6569485439283895,1.8303524979161698,0.0,0.052077538310369986,0.128,13/76,6.54%,ADAMTSL3;ADAMTS3;ADAMTS17;ADAMTS2;TRABD2B;ADAM9;ADAMTSL1;ECE1;ADAMTS10;MMP14;SPG7;MMP28;ADAM10
prerank,chloride transmembrane transporter activity (GO:0015108),0.8209899200281612,1.8137498794763616,0.0,0.054534025966519524,0.177,4/16,3.64%,SLC26A7;SLC26A2;SLC26A6;SLC4A8
prerank,retinoid binding (GO:0005501),-0.6014670630547777,-1.8011021995216643,0.004329004329004329,0.19326897877173055,0.526,5/22,2.47%,ALDH1A2;NR2F2;PTGDS;RBP4;CYP26B1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.7297708832252128,-1.7965007208756962,0.017985611510791366,0.16605151276899335,0.537,3/10,1.99%,SLC6A13;SLC6A1;SLC6A12
prerank,intracellular chloride channel activity (GO:0061778),-0.6315233433503884,-1.784481915545851,0.015037593984962405,0.13764796453219183,0.566,8/16,16.01%,ANO4;ANO1;ANO3;TTYH2;ANO10;ANO6;ANO2;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.6315233433503884,-1.784481915545851,0.015037593984962405,0.13764796453219183,0.566,8/16,16.01%,ANO4;ANO1;ANO3;TTYH2;ANO10;ANO6;ANO2;TTYH3
prerank,cAMP binding (GO:0030552),-0.7113866658107895,-1.7648823536197373,0.013029315960912053,0.14637265464993254,0.632,5/11,9.74%,RAPGEF4;PDE4D;RAPGEF2;PDE2A;PDE4B
prerank,sulfate transmembrane transporter activity (GO:0015116),0.7944731375981572,1.7463000882763349,0.0026954177897574125,0.16684464160567594,0.528,3/14,3.08%,SLC26A7;SLC26A2;SLC26A6
prerank,metallopeptidase activity (GO:0008237),0.6061068058455512,1.7438696926256325,0.0,0.14476900586907884,0.539,17/113,6.54%,ADAMTSL3;ADAMTS3;ADAMTS17;ADAMTS2;BMP1;TRABD2B;ADAM9;ADAMTSL1;ECE1;ADAM30;PAPPA;PSMD7;ADAMTS10;MMP14;SPG7;MMP28;ADAM10
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5867176174172043,-1.7273221444898739,0.012195121951219513,0.17518345418013453,0.733,7/19,10.18%,ITPR1;RYR2;ITPR3;GRIN2B;RASA3;MCOLN1;GRIN2A
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.7866231514889673,1.7121913862309197,0.0,0.2128020163841534,0.745,5/15,5.77%,SLC26A7;SLC26A2;SLC26A6;SLC4A8;SLC4A11
prerank,anion:anion antiporter activity (GO:0015301),0.7602269434515817,1.7097931914967024,0.003926701570680628,0.19222015909370055,0.754,7/17,15.65%,SLC26A7;SLC26A2;SLC26A6;SLC4A2;SLC26A4;SLC4A3;SLC26A11
prerank,MAP kinase phosphatase activity (GO:0033549),-0.665979364311488,-1.7090406698488823,0.016722408026755852,0.18416298037596193,0.795,4/12,12.01%,DUSP16;DUSP10;DUSP3;DUSP6
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6230409131976995,-1.6824615056639654,0.0149812734082397,0.20297166652106813,0.844,6/15,10.82%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH1L1;ALDH2;ALDH9A1
prerank,chemorepellent activity (GO:0045499),-0.5078693768847437,-1.6603965985485543,0.014218009478672985,0.22053309231172427,0.894,14/25,20.72%,SEMA6A;DPP4;SEMA3D;SEMA7A;EPHA7;NRG3;SEMA5A;SEMA4D;SEMA3G;SEMA4A;SEMA5B;SEMA4G;SEMA6D;SEMA3B
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.675675491291679,1.6585935849183744,0.0035842293906810036,0.34936713331904395,0.941,9/32,9.35%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC38A3;SFXN3;SLC7A10;SLC43A1;SLC6A7
prerank,symporter activity (GO:0015293),0.8105207983839161,1.645719697345745,0.007194244604316547,0.3713226741035626,0.958,3/10,6.27%,SLC4A4;SLC5A6;SLC28A2
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7974521719355802,1.6425768945327384,0.0071633237822349575,0.3500718227072727,0.959,3/11,2.08%,SLC23A1;SLC23A2;SLC5A2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.7394915976101417,1.6218752478336618,0.020242914979757085,0.41956809167033937,0.987,4/15,14.20%,PLA2G4F;PLA2G4A;PLA2G5;PLA2G12A
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6294383534108338,-1.616187618205837,0.03985507246376811,0.27525770944352235,0.957,6/13,10.82%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH1L1;ALDH2;ALDH9A1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6121643229108662,1.6139310908950264,0.0043907793633369925,0.42856261570362536,0.992,10/55,6.01%,SLC38A2;SLC38A1;SLC23A1;SLC23A2;SLC16A9;SLC16A1;SLC38A6;ABCC1;SLC38A3;SLC25A32
prerank,R-SMAD binding (GO:0070412),0.697487251697312,1.6088181631597547,0.019157088122605363,0.42391958408980424,0.992,5/18,6.35%,PMEPA1;DDX5;SMAD6;LDLRAD4;SMAD4
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5555300817515689,-1.6018532579547589,0.022026431718061675,0.2820200343612591,0.973,7/18,10.82%,ALDH1A2;ALDH1A1;FAR2;ALDH6A1;HSD17B12;ALDH2;ALDH9A1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6169759999555503,-1.5837889705054473,0.007067137809187279,0.2961638420546868,0.984,8/12,14.97%,PDE8B;PDE7B;PDE4D;PDE2A;PDE4B;PDE8A;PDE4C;PDE1B
prerank,chemoattractant activity (GO:0042056),0.649478094427713,1.583575100942188,0.014814814814814815,0.5317149414657525,0.997,6/26,10.16%,PGF;VEGFA;FGF2;CCL15;HMGB1;BMP4
prerank,organic anion transmembrane transporter activity (GO:0008514),0.550827674145787,1.5643130598574482,0.0,0.6110513044671951,1.0,19/134,6.01%,SLC38A2;SLC38A1;SLC26A7;SLC26A2;SLC23A1;SLC23A2;SLC5A6;SLCO3A1;SLCO2A1;SLC16A1;SLC26A6;SLC38A6;SLC4A8;SLC1A5;ABCC1;SLC38A3;SFXN3;SLC4A11;SLC25A32
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5949205642477441,1.5536930732767706,0.010112359550561797,0.6401895830473452,1.0,8/47,7.63%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC38A3;SLC7A10;SLC43A1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.6686593306902163,1.552751091330395,0.03201024327784891,0.6107374199333537,1.0,9/20,18.43%,DLG2;MAGI3;AK3;AK6;DLG1;DTYMK;AK1;LRGUK;MPP1
prerank,diacylglycerol kinase activity (GO:0004143),-0.6226728497228194,-1.5502063511438577,0.05154639175257732,0.33967800451184227,0.993,7/11,14.25%,DGKB;DGKD;DGKG;DGKH;DGKE;DGKZ;DGKA
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.6358095659532343,1.5471722420519662,0.025925925925925925,0.6124670170900812,1.0,4/29,3.76%,SLC26A7;SLC26A2;SLC26A6;SLC1A5
prerank,gated channel activity (GO:0022836),0.7219494355977121,1.5400639710812396,0.0273224043715847,0.6236039563901191,1.0,3/14,7.57%,PIEZO2;TMEM266;TMC8
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6278469957897223,1.5381663344577314,0.025703794369645042,0.6044363341359924,1.0,5/27,5.77%,SLC26A7;SLC26A2;SLC39A14;SLC26A6;SLC4A11
prerank,outward rectifier potassium channel activity (GO:0015271),-0.583768017046816,-1.5299633348108657,0.04659498207885305,0.3640291488308436,0.997,4/11,5.30%,KCNK2;KCND3;KCND2;KCNT1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.6181365990255968,-1.5294343318831416,0.07668711656441718,0.32885690573949505,0.997,3/10,12.01%,DUSP16;DUSP10;DUSP6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.6181365990255968,-1.5294343318831416,0.07668711656441718,0.32885690573949505,0.997,3/10,12.01%,DUSP16;DUSP10;DUSP6
prerank,glutamate receptor activity (GO:0008066),-0.5118548731771639,-1.5291562208220884,0.0660377358490566,0.31355376954660613,0.997,9/19,7.76%,GRM7;GRM5;GRM3;GRIA1;GRID2;GRM8;GRM1;GRIK2;GRIA4
prerank,aspartic-type peptidase activity (GO:0070001),0.7564422887896619,1.527874314294392,0.03581661891117478,0.634622420113248,1.0,4/10,17.95%,BACE2;DDI2;BACE1;NAPSA
prerank,BMP binding (GO:0036122),-0.6006313503118212,-1.5219762564528052,0.051094890510948905,0.3111216118554286,0.998,3/11,9.22%,ENG;GREM2;BMPR2
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.6146003498809935,1.5217648667877217,0.023142509135200974,0.6417200188351662,1.0,4/31,7.19%,KCNK5;SLC12A7;SLC12A2;SLC12A4
prerank,ankyrin binding (GO:0030506),-0.509084753407488,-1.51949240197182,0.04780876494023904,0.3015960133849385,0.998,5/19,10.15%,SLC8A1;CACNA1D;CDH1;KCNQ2;FLNC
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.7179475521011554,1.517702876884676,0.04103967168262654,0.6392190295910429,1.0,5/12,12.13%,CRYZ;AKR1C1;CBR4;DHRS4;NDUFS7
prerank,mechanosensitive ion channel activity (GO:0008381),0.7276288629228486,1.5098500961733727,0.04184100418410042,0.6588103374780542,1.0,2/12,7.57%,PIEZO2;TMC8
prerank,endopeptidase activity (GO:0004175),0.5078268422124914,1.5094382364208343,0.0,0.6364948477672362,1.0,76/257,24.03%,ADAMTSL3;ADAMTS3;ADAMTS17;HTRA3;ADAMTS2;TRABD2B;PCSK5;F3;HTRA4;ADAM9;ADAMTSL1;ECE1;PRSS38;PRSS12;FAP;USP24;ADAMTS10;USP2;PSMA8;MMP14;PRSS53;SPG7;MMP28;ADAM10;BACE2;TASP1;CLPP;MBTPS1;DDI2;PDIA3;USP40;PSMA4;BACE1;RHBDL3;ADAMTS6;ADAMTS20;USP48;USP34;PSMA6;CASP1;USP11;MMP16;USP7;USP33;NLN;USP36;PSEN2;USP13;HGF;PRSS36;USP35;IDE;PCSK7;TPP2;NAPSA;USP10;CTSZ;USP1;USP46;RHBDD3;MMP2;UCHL1;PSMA3;CTSB;PSMB1;USP5;CTSK;SENP1;USP47;CTSO;AFG3L2;PSMA5;USP14;ADAMTS9;PHEX;PSMA7
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5644794579571893,1.494560703192233,0.015521064301552107,0.6989162286866917,1.0,9/53,9.35%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC38A3;SLC7A10;SLC43A1;SLC6A7
prerank,solute:anion antiporter activity (GO:0140323),0.6840596872047555,1.4895900978911625,0.0398936170212766,0.7030467671899948,1.0,7/14,15.65%,SLC26A7;SLC26A2;SLC26A6;SLC4A2;SLC26A4;SLC4A3;SLC26A11
prerank,O-acyltransferase activity (GO:0008374),0.6037358113886659,1.4794297222307493,0.03694874851013111,0.7390470173232208,1.0,8/30,10.34%,PLA2G4A;SOAT1;PIGW;LPCAT1;MBOAT2;LPCAT4;GPAT4;LPCAT3
prerank,histone methyltransferase activity (GO:0042054),0.5818857273246408,1.4769343043157424,0.04513888888888889,0.7292493021889231,1.0,19/32,30.63%,PRMT8;KMT5A;KMT2C;EHMT1;CARM1;SETDB1;MEN1;NTMT1;SUV39H1;FBL;SETD2;PRMT1;SMYD2;SETD7;EHMT2;PRMT5;NSD3;SUZ12;TTLL12
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.5775381432838169,1.4738236157347178,0.029748283752860413,0.7255038188594394,1.0,20/40,26.32%,PRMT8;PEMT;TPMT;LRTOMT;TARBP1;LCMT1;NNMT;HNMT;CARNMT1;THUMPD3;PCMT1;GNMT;ARMT1;ASMT;SUV39H1;FBL;METTL8;METTL9;DNMT1;DNMT3A
prerank,cation transmembrane transporter activity (GO:0008324),0.5580726902537815,1.4625789854801565,0.0359955005624297,0.7726574861461322,1.0,6/48,5.31%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC38A3;SFXN3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.549954664257614,1.458328481811869,0.030577576443941108,0.7751484018489777,1.0,12/48,13.65%,PIEZO2;SLC12A7;SLC12A2;SLC4A11;CALHM6;SLC12A4;CALHM5;TRPM7;TRPM4;TMEM165;TRPM6;ATP6V1B2
prerank,semaphorin receptor binding (GO:0030215),-0.46567370892515897,-1.452928367568122,0.04522613065326633,0.415708446172214,1.0,13/23,20.72%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;SEMA4D;SEMA3G;RIT2;SEMA4A;PLXNB1;SEMA5B;SEMA4G;SEMA6D;SEMA3B
prerank,acetylation-dependent protein binding (GO:0140033),0.625319649976876,1.4488537833575492,0.06649282920469361,0.7866936811499666,1.0,15/20,25.38%,BAZ2A;BRD4;BRD3;CARM1;PHIP;BRD2;BRD9;MLLT3;THAP7;ATAD2B;BRDT;KMT2A;SMARCA4;TAF1;ZMYND8
prerank,lysine-acetylated histone binding (GO:0070577),0.625319649976876,1.4488537833575492,0.06649282920469361,0.7866936811499666,1.0,15/20,25.38%,BAZ2A;BRD4;BRD3;CARM1;PHIP;BRD2;BRD9;MLLT3;THAP7;ATAD2B;BRDT;KMT2A;SMARCA4;TAF1;ZMYND8
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.6886112187401354,1.4413074113149373,0.07943262411347518,0.8115416386699323,1.0,2/12,0.80%,PGF;VEGFA
prerank,hyaluronic acid binding (GO:0005540),-0.5855232640364225,-1.4410852352487893,0.08157099697885196,0.4240787979383245,1.0,4/10,16.14%,CEMIP;LAYN;HYAL2;CD44
prerank,manganese ion binding (GO:0030145),0.5396657930277214,1.4402988636252432,0.03591470258136925,0.7956364343593498,1.0,18/48,24.07%,ME1;ADCY2;XPNPEP1;B4GALT1;PPM1M;WRN;HMGCL;ABL1;GALNT3;GALNT1;XYLT2;MPPED2;NEK4;MGAT5;B4GALT7;GALNT2;ARG2;PRIMPOL
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.7100714499355265,1.435956846846903,0.07734806629834254,0.802211295204031,1.0,4/10,7.68%,DSE;GALE;FUOM;GFUS
prerank,insulin-like growth factor I binding (GO:0031994),-0.5325081661183233,-1.4344853556154467,0.08582089552238806,0.4210214634670824,1.0,6/13,4.90%,IGF1R;INSR;IGFBP2;ITGA6;IGFBP3;ITGB4
prerank,RNA polymerase II complex binding (GO:0000993),0.5728969769318544,1.4336488582083413,0.06107784431137724,0.7949697950203698,1.0,18/32,25.88%,ELOF1;BRD4;CCAR2;SCAF1;ESRRB;ERCC5;AGO1;URI1;AGO2;PCF11;RPRD1A;ELP4;RTRAF;PAF1;HNRNPU;SMYD2;RECQL5;UVSSA
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.5855376146706938,1.4289779442233521,0.07239263803680981,0.8006675866453771,1.0,7/27,6.52%,SLC23A1;SLC9B2;SLC4A8;SLC9A8;SLC4A11;SLC9A4;SLC9A1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6628008162998583,1.4237842512079006,0.07649513212795549,0.8116235215918041,1.0,6/14,22.81%,CAPN5;CAPN10;CAPN2;CAPN15;CAPNS1;CAPN6
prerank,Wnt-activated receptor activity (GO:0042813),0.6515703841848124,1.4207408636079062,0.07544581618655692,0.8098220973106276,1.0,5/15,8.32%,PKD1;LRP5;FZD7;ROR1;FZD5
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6638315471274685,1.4186606360551008,0.07880434782608696,0.8035113995645196,1.0,3/14,6.92%,KCNJ2;KCNE5;KCNIP2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5681432806537519,-1.4181630791663424,0.11564625850340136,0.4401484781715409,1.0,4/10,7.45%,PRKAG2;PRKAR2B;PRKAR1B;PKIG
prerank,SUMO transferase activity (GO:0019789),0.6467210188828255,1.4173634780331192,0.08053691275167785,0.7920609471664678,1.0,5/16,14.50%,HDAC4;TOPORS;TRIM28;RANBP2;PIAS4
prerank,cation:chloride symporter activity (GO:0015377),0.6974243531578809,1.413911041514176,0.1,0.7932599116467217,1.0,3/10,7.19%,SLC12A7;SLC12A2;SLC12A4
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6774394240871463,1.413650567305436,0.0958904109589041,0.7773608589790749,1.0,9/12,27.44%,ARSJ;ARSB;SULF1;ARSA;ARSI;SULF2;GNS;ARSG;SGSH
prerank,tropomyosin binding (GO:0005523),-0.50231691059394,-1.4063419819001268,0.09505703422053231,0.4507622084388923,1.0,5/16,10.23%,NEBL;TMOD3;TMOD1;LMOD1;S100A6
prerank,RNA cap binding (GO:0000339),0.6353332535081301,1.4040986391260077,0.09523809523809523,0.8133378363816276,1.0,12/16,28.88%,CYFIP1;EIF4E3;EIF4A1;AGO2;SNUPN;NCBP3;EIF3D;NCBP1;NCBP2;CYFIP2;EIF4E;LARP1
prerank,ubiquitin-specific protease binding (GO:1990381),0.6133272102463956,1.4022381362903333,0.08997429305912596,0.8076521998810289,1.0,12/19,31.82%,VCP;SYVN1;CHMP3;CLTC;SUMO1;LCOR;DERL1;SELENOS;AMFR;PRKN;SPATA2;SART3
prerank,inward rectifier potassium channel activity (GO:0005242),0.5827417617770948,1.402125307861912,0.07797029702970297,0.791650772975274,1.0,3/24,4.21%,KCNJ2;KCNJ15;KCNN1
prerank,ATPase binding (GO:0051117),0.5089233458111915,1.4010509060074157,0.03027027027027027,0.7813202898655434,1.0,16/71,13.30%,ESR1;EGFR;ATP1B1;SLC2A13;PTPN3;RDX;TCIRG1;ATP6V0A1;ANK2;CLPP;SNTA1;SYVN1;TMEM106B;ABCA1;EZR;S100A1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5398209569685647,1.3978693883323943,0.05787037037037037,0.7827621999532787,1.0,5/42,3.34%,IRS1;NEDD4;PTPN3;VAV2;SHC1
prerank,I-SMAD binding (GO:0070411),0.6535542575197163,1.3947846102397499,0.10449735449735449,0.7836951465472733,1.0,7/13,12.22%,SMAD9;SMAD6;SMAD4;AXIN1;SMAD7;TGFB1I1;TGFBR1
prerank,MAP kinase kinase kinase activity (GO:0004709),0.6789420739676203,1.3937823476180995,0.10909090909090909,0.7737658023928807,1.0,2/11,3.85%,EGFR;MAP3K5
prerank,serine-type peptidase activity (GO:0008236),0.491862481081314,1.3923786266819804,0.037894736842105266,0.7667152879964185,1.0,10/96,7.92%,HTRA3;PCSK5;F3;HTRA1;PRSS38;PRSS12;FAP;PRSS53;CLPP;MBTPS1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.606878376679506,1.3899135509980756,0.10499359795134443,0.7655666112095969,1.0,6/19,9.68%,EFNA5;GAS6;ABI1;DGKQ;PAK2;ANGPT4
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5521896205643386,1.3867701025198726,0.09191176470588236,0.7675822071851232,1.0,14/30,25.15%,GAS6;NOL3;CARD16;CST3;CD27;SERPINB9;PRDX3;BIRC6;BIRC5;CAST;BIRC3;DPEP1;UBE2Z;XIAP
prerank,sodium:proton antiporter activity (GO:0015385),0.660021287379667,1.3852505127795496,0.11571428571428571,0.7622007138010624,1.0,4/11,6.52%,SLC9B2;SLC9A8;SLC9A4;SLC9A1
prerank,frizzled binding (GO:0005109),0.556576833128982,1.3850537451359908,0.0713436385255648,0.749923328187,1.0,5/34,6.70%,MYOC;LRP6;WNT9A;DVL1;FZD7
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5435063259381044,-1.3787272195824811,0.12232415902140673,0.49662311763660405,1.0,3/11,6.78%,LEF1;MBD2;GATA2
prerank,ion gated channel activity (GO:0022839),-0.44949813714455406,-1.3756062246662681,0.095,0.4863115517894062,1.0,7/24,8.64%,ANO4;ANO1;KCNT1;ANO3;TTYH2;ANO10;ANO6
prerank,cysteine-type endopeptidase activity (GO:0004197),0.49341744839080637,1.372908485400495,0.043010752688172046,0.8012812922055744,1.0,40/78,31.14%,CAPN5;USP24;USP2;GPAA1;CAPN10;CAPN2;PDIA3;USP40;USP48;USP34;CASP1;USP11;USP7;USP33;USP36;USP13;CAPN15;USP35;USP10;CTSZ;USP1;USP46;UCHL1;CTSB;CAPNS1;USP5;CTSK;USP47;CTSO;CAPN6;USP14;USP49;CAPN1;USP16;USP37;USP30;CASP2;CASP6;USP26;USP9X
prerank,metal ion:proton antiporter activity (GO:0051139),0.6354416131364804,1.3724714371690259,0.12482468443197756,0.7904649745801694,1.0,10/13,29.28%,SLC9B2;SLC9A8;SLC9A4;SLC9A1;LETM1;SLC11A1;SLC9A5;SLC9A7;SLC9A6;SLC9A9
prerank,histone acetyltransferase activity (GO:0004402),0.549224683385281,1.370240569465458,0.08685162846803378,0.78892718646056,1.0,17/30,28.97%,NAA60;NAA40;TADA2A;KAT14;KAT6B;KAT2A;ARRB1;CREBBP;ATF2;KAT7;KAT8;KAT2B;TAF1;SRCAP;TAF10;USP22;TADA3
prerank,protease binding (GO:0002020),0.4849451141466613,1.366134071038651,0.051255230125523014,0.7968370507325298,1.0,22/99,13.87%,COL3A1;F3;COL1A2;COL1A1;SLC2A13;TIMP2;TIMP3;COMP;FAP;NOL3;ANXA2;CARD16;CRADD;VCP;SYVN1;CST3;STIM1;ITGAV;ATP9A;SERPINB9;CHMP3;CLTC
prerank,transcription corepressor binding (GO:0001222),0.5569655587117727,1.3649420980706999,0.11713933415536375,0.7905679131105222,1.0,10/27,17.51%,ESR1;PHF1;PER3;EHMT1;RORA;USP11;PER1;HDAC6;LCOR;THAP7
prerank,myosin binding (GO:0017022),0.5058762331416645,1.3646285700235132,0.06347438752783964,0.7799348308274752,1.0,13/55,15.43%,MYOC;GSN;DMD;RAB8A;LLGL1;GIPC1;RHOA;RAB3D;KIRREL1;STXBP5;RAB11B;CXCR4;RAB3B
prerank,nuclear import signal receptor activity (GO:0061608),0.6170846170702466,1.3618210670297528,0.10298102981029811,0.781540995833419,1.0,9/15,19.41%,IPO5;IPO4;HIKESHI;KPNA2;TNPO2;KPNA3;TNPO1;IPO9;KPNA4
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4916106781084843,-1.3617030199755307,0.100418410041841,0.4858143782213681,1.0,5/16,6.65%,PTPRG;PTPRB;PTPRD;PTPRO;PTPRK
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4916106781084843,-1.3617030199755307,0.100418410041841,0.4858143782213681,1.0,5/16,6.65%,PTPRG;PTPRB;PTPRD;PTPRO;PTPRK
prerank,store-operated calcium channel activity (GO:0015279),-0.5665152147252692,-1.3605026624866643,0.11077844311377245,0.47342760178000853,1.0,5/10,13.14%,TRPC3;TRPC6;ORAI1;ORAI2;TRPC4
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5082842042078376,-1.3577238858247478,0.12056737588652482,0.4655149820913776,1.0,3/12,1.05%,TGFBR3;ENG;LTBP1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5077491778445278,-1.3575585518581583,0.1504424778761062,0.4525203109985149,1.0,3/13,2.30%,CDH5;BMP6;BMP7
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6511792210607352,1.3564408079708017,0.11950549450549451,0.7972716785583002,1.0,4/12,8.68%,GNAS;IRS1;SHC1;SOCS2
prerank,RNA polymerase core enzyme binding (GO:0043175),0.5395910487303937,1.3532827123374418,0.09495192307692307,0.8009323006883233,1.0,18/33,25.88%,ELOF1;CCAR2;ESRRB;ERCC5;SPTY2D1;AGO1;URI1;AGO2;PCF11;ERBB2;RPRD1A;ELP4;RTRAF;PAF1;HNRNPU;SMYD2;RECQL5;UVSSA
prerank,pre-mRNA binding (GO:0036002),0.5628981939013532,1.3517153600189684,0.1003627569528416,0.7974047930409149,1.0,15/28,24.73%,SRSF6;DDX5;CELF4;CELF3;HNRNPL;U2AF1;ZRSR2;PTBP1;RBM4;U2AF2;RBM22;TRA2B;HNRNPA1;HNRNPU;RBM24
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6748430086248614,1.3505050087931303,0.12158054711246201,0.7921140254241238,1.0,5/10,13.88%,GNAS;DLG4;NSF;SHANK1;SQSTM1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6505814361865268,1.3496458436170442,0.11404728789986092,0.785009232471464,1.0,6/12,23.74%,HM13;BACE2;DDI2;BACE1;NAPSA;SPPL2A
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.5342673461782437,1.3478128604810133,0.09199522102747909,0.7827822806035469,1.0,16/37,25.72%,VARS1;VARS2;WARS2;HARS2;YARS1;DARS2;YARS2;NARS2;EPRS1;SARS2;SARS1;DARS1;CARS2;TARS2;CARS1;QARS1
prerank,wide pore channel activity (GO:0022829),-0.43356925933387824,-1.346791111834025,0.0979381443298969,0.46307741960533083,1.0,4/23,5.02%,GJB6;GJB2;GJC1;GJD3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5374726020251551,1.346348984270295,0.109375,0.77893858861137,1.0,17/33,25.88%,ELOF1;CCAR2;ESRRB;ERCC5;AGO1;URI1;AGO2;PCF11;RPRD1A;ELP4;RTRAF;PAF1;TBP;HNRNPU;SMYD2;RECQL5;UVSSA
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.4324183959169007,-1.3436233782085822,0.09615384615384616,0.4575611691013106,1.0,7/22,11.86%,CPEB2;RBMS3;ELAVL4;ELAVL1;EXOSC8;ZC3H12A;ZFP36
prerank,BMP receptor binding (GO:0070700),-0.5077506083922062,-1.341361898414594,0.15481171548117154,0.4498006832403801,1.0,3/12,2.30%,CDH5;BMP6;BMP7
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.6314340830151517,1.3385666821049036,0.14609929078014183,0.8067240064858401,1.0,9/12,29.28%,SLC9B2;SLC9A8;SLC9A4;SLC9A1;LETM1;SLC9A5;SLC9A7;SLC9A6;SLC9A9
prerank,transcription coactivator binding (GO:0001223),0.5804701379709717,1.3371947060225635,0.13733333333333334,0.8023685383683651,1.0,7/20,12.31%,ESR1;CIT;SMAD4;RORA;TERT;CCNT2;MED25
prerank,NAD binding (GO:0051287),0.5553519343837843,1.3353208277051862,0.12738853503184713,0.8006708619622519,1.0,9/26,16.57%,ME1;SORD;SIRT5;CRYZ;NNT;BDH2;SIRT2;CRYL1;HSD17B8
prerank,protein kinase inhibitor activity (GO:0004860),0.5126397882698521,1.331585616232954,0.10569105691056911,0.808468874286012,1.0,19/42,26.26%,CIT;SPRED2;GMFB;PARVA;HEXIM1;GSKIP;CAMK2N1;CDKN1C;DUSP19;RPTOR;TAOK3;SMCR8;IBTK;MAPK8IP1;YWHAB;NCK1;QARS1;SOCS1;SH3BP5
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6113456905212467,1.3309781708235098,0.14188267394270124,0.800802214929909,1.0,8/15,22.26%,KMT2C;WDR5;KMT2D;SETD4;KMT2B;WDR82;SETD1A;KMT2A
prerank,histone demethylase activity (GO:0032452),0.5521964278515892,1.330914991432743,0.13038130381303814,0.7909008436719785,1.0,10/27,16.78%,JMJD1C;RIOX2;KDM2A;PHF8;KDM5B;KDM4A;FBXL19;HR;KDM5C;KDM6B
prerank,endonuclease activity (GO:0004519),0.5002935451887096,1.3307005346405205,0.10971428571428571,0.7818471598256167,1.0,16/49,19.93%,N4BP2;ERN2;SMG6;ERCC5;ZC3H12D;ERCC4;OGG1;AGO1;ZC3H12C;AGO2;YBEY;SND1;LACTB2;DIS3;KHNYN;NOB1
prerank,LRR domain binding (GO:0030275),-0.49896343298881574,-1.3283053297917533,0.15267175572519084,0.4677101603152096,1.0,3/14,2.92%,ROBO1;PAWR;LRRFIP2
prerank,miRNA binding (GO:0035198),0.5296121273698885,1.3271887305915946,0.12826603325415678,0.7883237361732257,1.0,13/30,23.51%,ZC3H7A;PUM1;MATR3;HNRNPA2B1;RBM10;AGO1;AGO2;RBM4;TUT7;ZC3H10;ZNF346;HNRNPA1;YBX1
prerank,gap junction channel activity (GO:0005243),-0.4385433781567474,-1.3256579675798426,0.1134020618556701,0.46096684720887565,1.0,4/22,5.02%,GJB6;GJB2;GJC1;GJD3
prerank,fibroblast growth factor binding (GO:0017134),0.5657789011631247,1.3246821814970409,0.1481958762886598,0.791037548493109,1.0,5/21,12.82%,THBS1;FGFR1;ITGAV;FGFR2;GLG1
prerank,nuclear export signal receptor activity (GO:0005049),0.6346740915710369,1.3220751627314582,0.1636615811373093,0.7937810332015277,1.0,3/11,11.43%,XPO1;XPO6;XPO4
prerank,transferrin receptor binding (GO:1990459),0.6574010399454133,1.3214058886507343,0.1493411420204978,0.7875558618089027,1.0,4/10,12.32%,SNX2;SNX1;CHUK;RGMA
prerank,mannose binding (GO:0005537),0.6249854372018938,1.3196753789906248,0.16165951359084407,0.7860643524075815,1.0,4/12,21.36%,COLEC11;LMAN2L;LMAN2;LMAN1
prerank,phosphotyrosine residue binding (GO:0001784),0.5218032637493818,1.3188358855263767,0.11255924170616113,0.7802613991864691,1.0,4/37,3.34%,IRS1;PTPN3;VAV2;SHC1
prerank,GTPase inhibitor activity (GO:0005095),0.608701522866057,1.3169944137024427,0.16204986149584488,0.7796663310138959,1.0,8/13,21.19%,SLIT2;IPO5;PDE6D;GPS1;ARL2;IQGAP1;RTKN;GPS2
prerank,calcium channel regulator activity (GO:0005246),-0.37217930507663166,-1.3119558329156011,0.09803921568627451,0.47713001808973277,1.0,11/37,15.07%,ITPR1;PRKG1;NRXN1;CACNG7;CACNG8;REM1;PACSIN3;CACNG4;SLC30A1;MCUB;INAFM1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.6119319824402325,1.3112689246239402,0.17433751743375175,0.7964780045945787,1.0,3/12,3.34%,IRS1;GAB2;SHC1
prerank,ribonuclease activity (GO:0004540),0.4858903058719438,1.3111335246064724,0.1080773606370876,0.7879742449748735,1.0,20/56,19.93%,RNASE7;ERN2;PPP1R8;RNASE3;SMG6;ZC3H12D;RNASE6;AGO1;DIS3L2;ZC3H12C;AGO2;YBEY;SND1;LACTB2;EXOSC4;RPP40;N4BP1;ELAC2;KHNYN;NOB1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.6122169353074332,1.3107021353272745,0.16827586206896553,0.7813507613528736,1.0,1/13,0.97%,EHHADH
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5438958613962169,1.3075266228476738,0.1570048309178744,0.7874516830552927,1.0,4/25,9.00%,FMO1;MICAL2;MTRR;AKR1C1
prerank,small GTPase binding (GO:0031267),0.45078635392710026,1.3068976905034577,0.04158215010141988,0.7815733890772364,1.0,61/169,21.07%,SGSM2;PLCE1;SRGAP2;YBX3;DOCK4;EXOC4;EHD1;ANKRD27;UNC13B;DOCK7;FGD6;GOLGA5;RAB34;ERC1;RABGEF1;RILP;RAB3GAP1;CDC42EP2;RIC1;GGA2;RAB8A;IFT20;PEX5;RAF1;PDE6D;GOLGA4;NDRG1;CYFIP1;PPP6R1;LZTR1;PAK2;RGP1;ARFIP2;RCC1;ABCA1;EVI5L;SOD1;RCC2;TRIP11;CDC42EP5;OCRL;LSM2;USP33;RANBP2;CCDC186;TMEM127;HPS4;AKAP13;IQGAP1;GGA1;DAPK3;RAB3GAP2;BIRC5;MYCBP2;MAPKAP1;RTKN;EVI5;MLPH;LRRK2;OPTN;ABI2
prerank,calcium channel inhibitor activity (GO:0019855),-0.5013008451295372,-1.3044492589472885,0.14527027027027026,0.48156722285314935,1.0,4/11,14.05%,ITPR1;PACSIN3;SLC30A1;MCUB
prerank,ligand-gated cation channel activity (GO:0099094),0.4736073523762747,1.3001188458691253,0.10695187165775401,0.8035384730887379,1.0,9/75,9.44%,KCNJ2;KCNJ15;GRIK4;GRIN3A;KCNN1;CHRNB2;CHRNA5;TRPM4;KCNK6
prerank,methyltransferase activity (GO:0008168),0.5000909473329754,1.3001144344212676,0.1215909090909091,0.7949299710682932,1.0,21/46,29.80%,PRMT8;LRTOMT;EEF1AKMT3;EHMT1;LCMT1;NNMT;EEF1AKMT2;CARNMT1;GCSH;NTMT1;ARMT1;ASMT;SUV39H1;PRMT1;BUD23;DNMT1;NSUN3;PRMT5;METTL27;PRMT3;MEPCE
prerank,UDP-glycosyltransferase activity (GO:0008194),0.47168387614745516,1.3000314141695717,0.10278372591006424,0.786849582251062,1.0,17/70,20.34%,EXT1;GXYLT2;CHPF2;POGLUT3;B3GNT7;POGLUT1;B4GALT1;OGT;MGAT4B;B3GNT9;HEXA;B4GAT1;B3GNT6;GXYLT1;EXT2;GCNT7;B4GALNT3
prerank,acylglycerol lipase activity (GO:0047372),0.6267608914866327,1.2996352432800022,0.17563739376770537,0.7803563123937407,1.0,1/11,0.43%,MGLL
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6385688657558792,1.2984980681084122,0.17458100558659218,0.7768437505268202,1.0,3/10,10.81%,EHHADH;ECHDC2;AUH
prerank,cyclic nucleotide binding (GO:0030551),-0.4280252202702608,-1.2959222359462914,0.12658227848101267,0.48773924720806305,1.0,6/21,9.74%,RAPGEF4;PDE4D;RAPGEF2;KCNH1;PDE2A;PDE4B
prerank,ferrous iron binding (GO:0008198),0.5548055250029638,1.2956871266947134,0.16624040920716113,0.7807578808153602,1.0,9/21,23.90%,FTO;FXN;ALKBH1;FECH;DNAJC24;TET2;PHYH;ISCU;ALKBH3
prerank,signal sequence binding (GO:0005048),0.511919451176842,1.2925545633281672,0.14945321992709598,0.7857552026005151,1.0,17/35,19.69%,KDELR3;SEC61A1;IPO5;IPO4;KCNIP2;PEX5;KDELR1;KDELR2;KPNA2;TNPO2;CAT;KPNA3;TOMM70;TNPO1;POM121;KPNA4;NFKBIA
prerank,alkali metal ion binding (GO:0031420),-0.49189675168453806,-1.2919174627413539,0.17793594306049823,0.4845830983902094,1.0,1/13,0.01%,ATP1A2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.6318543195706506,1.2910872756851026,0.15827338129496402,0.7843093638959515,1.0,7/11,29.59%,PRMT8;CARM1;PRMT1;FBXO11;PRMT9;PRMT5;PRMT3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.6170488773085033,1.2894623202039257,0.1678520625889047,0.7836883439660715,1.0,10/12,32.59%,CYFIP1;EIF4E3;AGO2;NCBP3;NCBP1;NCBP2;CYFIP2;EIF4E;LARP1;DCPS
prerank,3'-5' DNA helicase activity (GO:0043138),0.585923639441503,1.2890336045498119,0.16688396349413298,0.7779234295486278,1.0,4/16,12.53%,NAV2;MCM2;WRN;ERCC3
prerank,kinase inhibitor activity (GO:0019210),0.5127037941894703,1.2870349644231172,0.14963503649635038,0.7783501554571356,1.0,15/33,26.26%,LRP6;GMFB;PARVA;HEXIM1;GSKIP;CDKN1C;DUSP19;TAOK3;SMCR8;MAPK8IP1;YWHAB;NCK1;QARS1;SOCS1;SH3BP5
prerank,clathrin adaptor activity (GO:0035615),0.5859681294687343,1.2866024620621197,0.18925831202046037,0.772691769651042,1.0,6/15,16.85%,STON2;AP2A1;STON1;AP2A2;DAB2;HIP1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.6075310506886725,1.2850803863168065,0.16573033707865167,0.7714599484137592,1.0,4/12,12.97%,AOX1;XDH;FXN;ISCA2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.49331725952727895,1.2835018387256267,0.13257142857142856,0.7705884801738394,1.0,23/44,26.23%,KMT5A;KMT2C;EHMT1;KMT5C;NSD1;ASH1L;SETD5;WDR5;SETDB1;KMT2D;SETD4;KMT2B;MEN1;WDR82;SUV39H2;SETD1A;SUV39H1;SETD2;KMT2A;SETDB2;SMYD2;SETD7;EHMT2
prerank,cation channel activity (GO:0005261),0.45716308600669736,1.2830814030650226,0.0925531914893617,0.765256158361389,1.0,13/94,8.80%,PIEZO2;KCNK5;PKD1;SLC24A3;SEC61A1;TRPV3;ANXA2;SLC4A11;MCU;CALHM6;CALHM5;TRPM7;TRPM4
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4666369216809003,1.2810151425843943,0.11312700106723586,0.7660109078045341,1.0,18/75,16.57%,ME1;EHHADH;LDHC;SORD;KDSR;GFUS;AKR1C1;NSDHL;CBR4;DHRS4;DHRS9;BDH2;MDH1B;CRYL1;AKR1A1;PHGDH;PGD;HSD17B8
prerank,amino acid:sodium symporter activity (GO:0005283),0.6401494139048611,1.2807541841027072,0.18478260869565216,0.7599462997883621,1.0,2/11,0.11%,SLC38A2;SLC38A1
prerank,sodium channel activity (GO:0005272),0.5075582597804844,1.2804010592107846,0.13673232908458866,0.7546780811371376,1.0,5/37,6.76%,CACNA1G;GRIK4;HCN4;SLC4A11;SCN11A
prerank,protein kinase C binding (GO:0005080),0.49216941495111727,1.2798527237275703,0.13901869158878505,0.7501755994585217,1.0,11/43,13.88%,IRS1;ADAM9;HDAC9;DACT1;PRKCSH;DACT3;ITGAV;ABL1;NELL1;PICK1;SQSTM1
prerank,transforming growth factor beta binding (GO:0050431),0.5446629247419509,1.277355314546581,0.16856780735107732,0.7531015760249408,1.0,8/23,12.22%,THBS1;LTBP3;TGFB3;ACVR1;TGFBR2;TSKU;ITGAV;TGFBR1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5790610305703633,1.277009764400165,0.18241469816272965,0.7477372961915153,1.0,2/15,8.64%,CMKLR1;ACKR4
prerank,poly(A) binding (GO:0008143),-0.42044132087986713,-1.2761224183049273,0.16593886462882096,0.5086063306252002,1.0,5/21,5.21%,RBPMS;RBMS1;RBMS3;ELAVL4;DDX3X
prerank,methylation-dependent protein binding (GO:0140034),0.4727764539723693,1.2755469798563968,0.14972067039106146,0.7469896357576112,1.0,24/57,25.93%,MORC3;PHF1;ING3;SGF29;MBTD1;PYGO1;ING5;PHF8;CBX2;KDM4A;WDR5;ING4;L3MBTL2;CBX5;THAP7;CHD8;ZMYND11;CDYL;BPTF;MPHOSPH8;KAT8;ZMYND8;ZCWPW2;CHD1
prerank,glucuronosyltransferase activity (GO:0015020),0.5530023605700696,1.2728969514471737,0.18607764390896922,0.7506250544248909,1.0,4/19,18.20%,EXT1;B4GAT1;EXT2;B3GAT2
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.3419953496566875,-1.2718288255703258,0.07633587786259542,0.5061108663367276,1.0,10/49,7.51%,ATP1A2;PPP1CB;DUSP16;PTPRO;DUSP10;PXYLP1;SAMHD1;PLCXD3;DUSP3;ACP2
prerank,histone deacetylase binding (GO:0042826),0.4507886056380522,1.2716746551070919,0.11428571428571428,0.7488399692530676,1.0,35/88,25.29%,NCOR2;HDAC9;HDAC4;DACT1;MEF2B;ANKRA2;IKZF3;BEX4;MIER2;PKN2;MAPK8;KPNA2;SFPQ;HDAC1;KAT2A;YWHAE;MEF2D;NACC1;MEF2A;SIRT2;HDAC6;NIPBL;MTA3;LCOR;THAP7;AKAP8;MIER1;GLI3;KAT2B;CHD4;PHF6;TP53;NCOR1;YWHAB;HDAC2
prerank,CARD domain binding (GO:0050700),0.5955532272196813,1.2712430329803297,0.19079837618403248,0.7442734065778561,1.0,4/14,12.63%,CARD14;CARD16;MAVS;CASP1
prerank,potassium ion antiporter activity (GO:0022821),0.5733753933316208,1.2658828403009574,0.19973368841544606,0.7589077164032549,1.0,4/15,6.52%,SLC24A3;SLC9A8;SLC9A4;SLC9A1
prerank,receptor antagonist activity (GO:0048019),0.5659205945595627,1.26568630498261,0.20666666666666667,0.7532257319898492,1.0,2/17,3.94%,DKK3;LRPAP1
prerank,GTPase binding (GO:0051020),0.43284104058474615,1.2650654463079791,0.058174523570712136,0.7493814915008624,1.0,87/194,28.13%,SGSM2;PLCE1;SRGAP2;YBX3;DOCK4;EXOC4;EHD1;ANKRD27;UNC13B;DOCK7;FGD6;GOLGA5;RAB34;ERC1;RABGEF1;RILP;RAB3GAP1;CDC42EP2;LAMTOR1;RIC1;GGA2;RAB8A;IFT20;PEX5;RAF1;PDE6D;GOLGA4;NDRG1;CYFIP1;PPP6R1;LZTR1;PAK2;RGP1;ARFIP2;RCC1;ABCA1;EVI5L;SOD1;RCC2;TRIP11;CDC42EP5;OCRL;LSM2;USP33;RANBP2;CCDC186;TMEM127;HPS4;AKAP13;IQGAP1;SPTBN1;GGA1;EPRS1;DAPK3;RAB3GAP2;BIRC5;MYCBP2;MAPKAP1;RTKN;EVI5;MLPH;LRRK2;GNB1;OPTN;ABI2;ATG16L1;STOML2;TSC2;KCTD13;RABGAP1;YBX1;RAPGEF6;RAB11FIP4;TBC1D20;AFDN;NUTF2;ARHGDIB;AMBRA1;CYRIB;RABGGTB;MYO5A;WAS;GCC2;XPO5;SPHK2;MTSS2;GGA3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5456920502539037,1.2644023261392052,0.2002652519893899,0.7458633470366811,1.0,9/18,25.15%,GAS6;NOL3;CD27;SERPINB9;PRDX3;BIRC5;BIRC3;DPEP1;XIAP
prerank,thiol-dependent deubiquitinase (GO:0004843),0.4522211883797975,1.2631378153939885,0.12658227848101267,0.7445147150119041,1.0,49/83,31.24%,USP24;USP2;USP50;OTUB1;USP40;UCHL3;USP48;USP45;USP34;OTUB2;USP11;TANK;USP7;USP33;USP36;USP13;USP19;USP35;PSMD14;OTULIN;OTUD5;YOD1;USP32;USP10;USP1;MPND;USP46;ZRANB1;UCHL5;UCHL1;OTUD6B;BRCC3;USP5;USP47;DESI2;USP14;USP4;CYLD;USP49;MYSM1;USP16;USP21;USP22;USP37;USP30;OTUD3;USP26;USP9X;COPS5
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.5714258248086966,1.2629865672773266,0.1829105473965287,0.7390161897223351,1.0,5/17,14.60%,AK5;AK3;DTYMK;CLP1;AK1
prerank,insulin-like growth factor binding (GO:0005520),-0.4555422939423064,-1.2612594969270396,0.14285714285714285,0.5187947599389601,1.0,6/15,4.90%,IGF1R;INSR;IGFBP2;ITGA6;IGFBP3;ITGB4
prerank,androgen receptor binding (GO:0050681),0.5252369821374236,1.261023038690036,0.18982630272952852,0.7405491454072111,1.0,5/25,11.87%,FOXP1;DDX5;NSD1;RNF14;TGFB1I1
prerank,serine-type endopeptidase activity (GO:0004252),0.4514665613558841,1.2609665856270251,0.13090128755364808,0.73479885118416,1.0,14/80,19.41%,PCSK5;F3;PRSS38;PRSS12;FAP;PRSS53;CLPP;MBTPS1;RHBDL3;HGF;PRSS36;PCSK7;RHBDD3;MMP2
prerank,ubiquitin binding (GO:0043130),0.4597154416281585,1.260165405815341,0.12459371614301191,0.732041182293059,1.0,29/73,21.88%,NEDD4;MVB12B;RAE1;TOM1L1;NBR1;OTUB1;FAF2;DDI2;SHARPIN;UCHL3;WDR48;OTUB2;USP33;SQSTM1;MARK4;UBAP1;SIRT2;UBE2L6;CXCR4;USP13;N4BP1;USPL1;CKS1B;NPLOC4;UCHL1;UBAP1L;NUP62;USP5;MVB12A
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.4044165555195379,-1.2562128616049242,0.175,0.5189778617396116,1.0,13/24,27.78%,ZDHHC14;GLUL;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;GOLGA7B;ZDHHC6;ZDHHC24;ZDHHC22
prerank,lysophospholipase activity (GO:0004622),0.543753256565028,1.2556198176892028,0.19101123595505617,0.7441987842106331,1.0,2/20,1.81%,MGLL;PLA2G4A
prerank,damaged DNA binding (GO:0003684),0.484784864245849,1.2555861252370393,0.1564310544611819,0.7384550057990289,1.0,25/44,33.35%,MPG;HMGB1;ERCC5;RBBP8;ERCC4;RAD1;OGG1;TDG;SDE2;ERCC3;ERCC2;DCLRE1B;CREBBP;FANCG;CRY2;POLD1;SMC6;XPA;PNKP;DDB1;XRCC1;ERCC1;CUL4B;POLQ;RPA3
prerank,MHC class II protein complex binding (GO:0023026),0.5940462408992794,1.253719708037555,0.2253922967189729,0.739732875029803,1.0,2/11,13.34%,ATP1B1;YWHAE
prerank,deubiquitinase activity (GO:0101005),0.44569013451831246,1.2502008272779983,0.1366982124079916,0.7471378642368833,1.0,45/88,27.74%,USP24;USP2;USP50;OTUB1;MINDY4;USP40;UCHL3;USP48;USP45;USP34;OTUB2;USP11;TANK;USP7;USP33;USP36;USP13;USP19;USP35;PSMD14;OTULIN;OTUD5;YOD1;USP32;USP10;USP1;MPND;USP46;ZRANB1;UCHL5;UCHL1;OTUD6B;BRCC3;USP5;USP47;DESI2;USP14;USP4;CYLD;USP49;MYSM1;USP16;USP21;USP22;USP37
prerank,flavin adenine dinucleotide binding (GO:0050660),0.46513111304953964,1.249355390639932,0.1689342403628118,0.7447843820738647,1.0,15/53,18.96%,MICAL2;ACOXL;AOX1;XDH;ACOX3;NOX4;QSOX1;MTRR;ETFDH;ETFA;AIFM1;GSR;AGPS;DAO;MTHFR
prerank,cell adhesion mediator activity (GO:0098631),-0.39954550085268925,-1.2464261058516204,0.17857142857142858,0.5296147462217176,1.0,10/24,9.99%,BSG;LRRC4C;ESAM;BCAM;NTNG1;CNTN6;CNTN4;DSCAML1;ROBO4;NEXN
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3397764659429945,-1.2461887800819367,0.09219858156028368,0.519664540927754,1.0,14/42,9.99%,STXBP6;BSG;LRRC4C;ESAM;NTNG1;TMOD3;CNTN6;CNTN4;DSCAML1;BAIAP2;ROBO4;CD200;PDLIM5;NEXN
prerank,sequence-specific DNA binding (GO:0043565),0.41418157278301004,1.242700364208636,0.006,0.7640089150536751,1.0,117/590,16.46%,TBX15;FOXP2;ESR1;SIX1;FOXP1;KLF12;HOXA5;NFIX;ZNF423;FOXD1;NFIB;TCF7L2;RARB;ELF4;VSX1;HOXB6;PRRX2;GLI2;JDP2;PRDM5;GLIS2;LHX9;CUX1;NFAT5;HDAC4;ELF1;RXRA;MEOX2;ONECUT2;ZNF250;HES5;KLF5;SIX4;TCF7L1;ATF4;NR2F1;TCFL5;GMEB1;FOXC2;PKNOX2;SAFB;BHLHE40;RXRB;LBX2;NFE2L2;SMAD4;MEF2B;E2F3;RFX7;PBX1;RUNX2;MEIS3;RORA;TBX21;SMG6;SOX9;FOXJ3;HOXA6;HOXA9;MAEL;RARA;IKZF3;ESRRB;TFE3;FOXK1;ZNF76;SLTM;ZIC1;FOXL1;RFX2;MBNL2;NFATC1;UBP1;SMG1;FOXA1;ZIC4;PRDM4;SREBF1;ZBTB2;KDM2A;CSRNP1;ABL1;TERT;RFX5;POU6F1;TELO2;CHTOP;GLIS1;HSF4;KDM5B;NEUROD2;NR1D2;SRF;HEY1;TEN1;FBXL19;LONP1;ZNF740;HOXB4;MEF2D;MEF2A;NFATC3;HOXA4;ERF;ZNF148;MAFG;MBD1;CPSF4;EN2;FOXO3;KMT2B;GRHL1;CREB1;NKX6-2;NFE2;PRDM2;NFKB2
prerank,lipoprotein particle receptor binding (GO:0070325),0.5112228902550254,1.2420103379745173,0.19551681195516812,0.7607891149134854,1.0,10/27,21.65%,LRP1;APBB3;LRPAP1;AP2A1;ANKRA2;CLTC;APBB1;DNAJA1;CLU;HSPG2
prerank,methylated histone binding (GO:0035064),0.45516168972451165,1.241535213375797,0.17549668874172186,0.7568863274732722,1.0,25/62,25.93%,MORC3;PHF1;ING3;SGF29;MBTD1;PYGO1;ING5;PHF8;CBX2;KDM4A;WDR5;ING4;L3MBTL2;CBX5;THAP7;CHD8;ZMYND11;CDYL;BPTF;MPHOSPH8;KAT8;TAF1;ZMYND8;ZCWPW2;CHD1
prerank,vitamin D receptor binding (GO:0042809),0.5589528325314944,1.2331310826152162,0.22420907840440166,0.7837148886983558,1.0,5/14,17.29%,RXRA;THRAP3;MED13;MED14;MED12
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.6107341694378455,1.2331290527690624,0.22317596566523606,0.7779168717084604,1.0,8/11,29.43%,UBR5;STUB1;UBE4A;UBOX5;AMFR;UBE4B;ANAPC11;RBX1
prerank,poly-pyrimidine tract binding (GO:0008187),0.5263596879874416,1.2325637784540933,0.2126865671641791,0.7742704592909421,1.0,10/23,14.34%,HNRNPH1;PABPC1;SSB;DIS3L2;DAZAP1;KHDRBS1;PATL1;PTBP1;HNRNPC;U2AF2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5055718317335238,1.2319875858045493,0.21532846715328466,0.7707920347992222,1.0,5/27,4.06%,SLC23A1;SLC12A2;SLC9B2;SLC4A8;CNNM2
prerank,double-stranded DNA binding (GO:0003690),0.4109954045600632,1.2299928878792346,0.012,0.7728466178950204,1.0,118/531,20.09%,TBX15;ESR1;EGFR;SIX1;FOXP1;KLF12;HOXA5;NFIX;NFIB;RARB;ELF4;VSX1;HOXB6;PRRX2;GLI2;JDP2;GLIS2;LHX9;CUX1;NFAT5;ELF1;RXRA;MEOX2;ONECUT2;ZNF250;HES5;KLF5;SIX4;TCF7L1;ATF4;NR2F1;TCFL5;GMEB1;FOXC2;PRKDC;PKNOX2;SAFB;BHLHE40;RXRB;LBX2;HMGB1;MEF2B;E2F3;RFX7;PBX1;RUNX2;MEIS3;TBX21;SOX9;FOXJ3;HOXA6;HOXA9;RARA;ESRRB;TFE3;ERCC5;FOXK1;ZNF76;ZIC1;RBBP8;PSIP1;RFX2;MBNL2;NFATC1;UBP1;FOXA1;ZIC4;PRDM4;SREBF1;ZBTB2;ABL1;RFX5;POU6F1;TDG;WDR48;GLIS1;HSF4;KDM5B;NEUROD2;NR1D2;TDP1;SRF;HEY1;RAD50;ZNF740;HOXB4;MEF2D;NFATC3;HOXA4;MAFG;MBD1;CPSF4;EN2;FOXO3;GRHL1;CREB1;NKX6-2;NFE2;NFKB2;HOXA2;E2F1;POLG2;KLF3;NR3C1;MEN1;HDGFL2;KLF10;ATF2;ZMYND11;HOXB2;RAD51;ZBTB32;IRF3;XRCC6;TEAD2;NFATC4;MAX;ATF6
prerank,regulatory RNA binding (GO:0061980),0.47911117759785765,1.2290719187419237,0.1910902696365768,0.7707928087805245,1.0,13/38,23.51%,ZC3H7A;PUM1;MATR3;HNRNPA2B1;RBM10;AGO1;AGO2;RBM4;TUT7;ZC3H10;ZNF346;HNRNPA1;YBX1
prerank,potassium:proton antiporter activity (GO:0015386),0.5992584231728408,1.2275980198042666,0.23088235294117648,0.7708247708912407,1.0,7/10,29.28%,SLC9A8;SLC9A4;SLC9A1;SLC9A5;SLC9A7;SLC9A6;SLC9A9
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5054024271467151,1.2274222048852783,0.20515970515970516,0.7658805854926111,1.0,4/28,8.65%,GRIK4;GABRA3;CHRNB2;CHRNA5
prerank,adrenergic receptor binding (GO:0031690),0.5537250535069568,1.2273145239836916,0.21680216802168023,0.7609091609385085,1.0,3/16,7.71%,GNAS;NEDD4;DLG4
prerank,phospholipid transfer activity (GO:0120014),0.5265871174872992,1.226687676346685,0.20483460559796438,0.7582679225708219,1.0,5/21,4.82%,TNFAIP8L3;PITPNC1;PRELID3B;PITPNA;PITPNM1
prerank,nuclear localization sequence binding (GO:0008139),0.5326042662909725,1.2220597793520915,0.2374839537869063,0.770033820857828,1.0,9/18,19.69%,IPO5;IPO4;KPNA2;TNPO2;KPNA3;TNPO1;POM121;KPNA4;NFKBIA
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.4360875390905397,-1.2217172803102556,0.199288256227758,0.5622690764084091,1.0,5/15,9.05%,HS3ST3A1;NDST3;NDST4;NDST1;HS6ST3
prerank,histone methyltransferase binding (GO:1990226),0.5940085422140696,1.2195533270406462,0.22331460674157302,0.7742171440416099,1.0,5/11,20.56%,CBX1;PHF1;PRDM4;LCOR;NOP56
prerank,mRNA methyltransferase activity (GO:0008174),0.584024625007881,1.2193294352551685,0.2334293948126801,0.7697690099929165,1.0,6/12,26.14%,TRMT61B;METTL16;TRMT61A;METTL8;METTL14;RNMT
prerank,phospholipase A2 activity (GO:0004623),0.5040589281515203,1.2171709216263042,0.21428571428571427,0.7721860326903558,1.0,6/26,16.77%,PLA2G4F;PLA2G4A;PLA2G5;PLA2G12A;PNPLA3;PLA2G15
prerank,N-acyltransferase activity (GO:0016410),-0.36119201885802965,-1.211641959710149,0.1794871794871795,0.5744232617212438,1.0,4/32,3.29%,CERS4;NMT2;TGM2;PLAAT3
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4037890922378134,1.2112570834797454,0.006,0.7893690712582548,1.0,117/731,12.41%,TBX15;FOXP2;PLAGL1;ESR1;SIX1;FOXP1;KLF12;ZBTB7C;PRRX1;ZFHX3;HOXA5;HIVEP3;PBX3;NFIX;ZNF423;HOXA3;FOXD1;NFIB;TCF7L2;SKIL;RARB;ELF4;HOXB6;MKX;SMAD9;NFIA;ZIM3;ZFHX4;MUC1;PRRX2;GLI2;JDP2;PRDM5;DMTF1;GLIS2;TWIST1;HOXC6;STAT5A;NFAT5;HDAC4;HOXB3;ELF1;SIX5;RXRA;MEOX2;ONECUT2;ZNF250;STAT3;HES5;KLF5;ZBTB25;SIX4;TCF7L1;ATF4;ZFP14;NR2F1;TCFL5;GMEB1;FOXC2;PKNOX2;SAFB;BHLHE40;RXRB;NFE2L2;SMAD4;MEF2B;E2F3;ZNF471;RFX7;PBX1;HEYL;RUNX2;MEIS3;NRIP1;THRAP3;SKI;RORA;ZNF691;TBX21;SOX9;FOXJ3;NSD1;HOXA6;HOXA9;RARA;IKZF3;ESRRB;TFE3;FOXK1;ZNF76;ZIC1;FOXL1;RFX2;NFATC1;RUNX1;UBP1;FOXA1;ZIC4;PRDM4;SREBF1;ZBTB2;ZNF260;EHF;RFX5;POU6F1;GLIS1;HSF4;NFE2L1;NRF1;MAZ;FOXP4;NEUROD2;NR1D2;FOXO6;HDAC1;SRF;HEY1
prerank,translation initiation factor activity (GO:0003743),0.48147024277941913,1.2111616341990132,0.218335343787696,0.7843944275455184,1.0,22/36,36.61%,EIF4A2;EIF4G2;EIF4G3;EIF4E3;EIF4A1;AGO2;EIF4G1;EIF2S2;EIF3D;EIF3A;EIF2S1;EIF2A;EIF4E;EIF3M;EIF3K;EIF3I;COPS5;EIF2D;EIF5B;EIF2B5;EIF1B;EIF3E
prerank,endoribonuclease activity (GO:0004521),0.48887168335552866,1.2098051505650786,0.2304785894206549,0.7843270307566704,1.0,12/32,20.80%,ERN2;SMG6;ZC3H12D;AGO1;ZC3H12C;AGO2;YBEY;SND1;LACTB2;KHNYN;NOB1;ENDOV
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4029397592283494,1.2094781138039425,0.02,0.7802455521137828,1.0,101/597,13.35%,TBX15;BNC2;ESR1;SIX1;FOXP1;KLF12;HOXA5;NFIX;NFIB;TCF7L2;RARB;ELF4;VSX1;HOXB6;SMAD6;PRRX2;GLI2;JDP2;PRDM5;DMTF1;GLIS2;LHX9;CUX1;NFAT5;HDAC4;ELF1;RXRA;MEOX2;ONECUT2;ZNF250;STAT3;HES5;KLF5;SIX4;TCF7L1;ATF4;MCMDC2;NR2F1;CHD3;TCFL5;GMEB1;FOXC2;PKNOX2;BHLHE40;RXRB;LBX2;NFE2L2;SMAD4;PER3;HMGB1;MEF2B;E2F3;RFX7;PBX1;RUNX2;MEIS3;MCM2;TBX21;SOX9;FOXJ3;HOXA6;HOXA9;CENPC;RARA;CARM1;ESRRB;TFE3;FOXK1;CDC6;ZNF76;ZIC1;HNRNPL;RFX2;MBNL2;NFATC1;RUNX1;UBP1;FOXA1;ZIC4;PRDM4;SREBF1;ZBTB2;ABL1;RFX5;POU6F1;GLIS1;HSF4;KDM5B;NEUROD2;NR1D2;SFPQ;SRF;HEY1;ZW10;HSPD1;ZNF740;ARID4B;KMT2D;HOXB4;CDC45;MEF2D
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4031334257185838,1.2090890664530891,0.006,0.7765474636384689,1.0,147/732,17.50%,TBX15;FOXP2;PLAGL1;ESR1;SIX1;FOXP1;KLF12;ZBTB7C;PRRX1;ZFHX3;HOXA5;HIVEP3;PBX3;NFIX;ZNF423;HOXA3;FOXD1;NFIB;TCF7L2;SKIL;RARB;ELF4;HOXB6;MKX;SMAD9;NFIA;ZIM3;ZFHX4;MUC1;PRRX2;GLI2;JDP2;PRDM5;DMTF1;GLIS2;HOXC6;STAT5A;NFAT5;HDAC4;HOXB3;ELF1;SIX5;RXRA;MEOX2;ONECUT2;ZNF250;STAT3;HES5;KLF5;ZBTB25;SIX4;TCF7L1;ATF4;ZFP14;NR2F1;TCFL5;GMEB1;FOXC2;PKNOX2;SAFB;BHLHE40;RXRB;NFE2L2;SMAD4;MEF2B;E2F3;ZNF471;RFX7;PBX1;HEYL;RUNX2;MEIS3;NRIP1;THRAP3;SKI;RORA;ZNF691;TBX21;SOX9;FOXJ3;NSD1;HOXA6;HOXA9;RARA;IKZF3;ESRRB;TFE3;FOXK1;ZNF76;ZIC1;FOXL1;RFX2;NFATC1;RUNX1;UBP1;FOXA1;ZIC4;PRDM4;SREBF1;ZBTB2;ZNF260;EHF;RFX5;POU6F1;GLIS1;HSF4;NFE2L1;NRF1;MAZ;FOXP4;NEUROD2;NR1D2;FOXO6;HDAC1;SRF;HEY1;ZNF112;ZNF740;HOXB4;MEF2D;MYPOP;NACC1;MEF2A;NFATC3;HOXA4;ZKSCAN1;ZNF148;MAFG;EN2;VDR;FOXO3;PER1;FOXN3;GRHL1;CREB1;HDAC6;NKX6-2;NFE2;NFKB2;KDM6B;HOXA2;E2F1;NFYA;CC2D1B;KLF3;E4F1;NR3C1
prerank,myosin II binding (GO:0045159),0.586620647090822,1.2089782869895052,0.25449101796407186,0.7719022767466149,1.0,3/10,12.90%,GSN;LLGL1;STXBP5
prerank,cytokine activity (GO:0005125),0.4237045890824162,1.2076516118787846,0.12744090441932168,0.7717709971754145,1.0,21/131,15.41%,GDF10;WNT9A;VEGFA;FGF2;IL33;INHBC;TGFB3;CCL13;SLURP1;CCL15;TGFB2;HMGB1;FAM3C;CXCL16;BMP4;CTF1;INHBA;BMP5;NDP;CLCF1;IL6
prerank,tRNA binding (GO:0000049),0.46813784834310745,1.206351883753504,0.2179930795847751,0.7714385531986896,1.0,18/43,25.20%,SSB;ELP5;TRNAU1AP;TERT;DALRD3;DARS2;ALKBH1;ELP1;YARS2;XPOT;ALKBH8;SARS2;SARS1;EIF2AK4;EIF2A;NSUN6;PUS1;CARS1
prerank,E-box binding (GO:0070888),-0.35365242759296517,-1.2032008667552176,0.18571428571428572,0.5829285418771664,1.0,4/34,4.80%,TCF4;ZEB1;AHR;MITF
prerank,nuclease activity (GO:0004518),0.4510825447675647,1.2015120803136057,0.19931662870159453,0.784123457215525,1.0,15/52,18.22%,N4BP2;RNASE7;ERN2;RNASE3;ERCC5;RNASE6;OGG1;WRN;REXO1;DIS3L2;SND1;AEN;N4BP1;DIS3;DFFB
prerank,iron ion binding (GO:0005506),0.4589998107536839,1.201072513254589,0.20795454545454545,0.7807374920807266,1.0,16/48,23.90%,AOX1;FTO;FXN;SCD5;ABCE1;PHF8;AGMO;ISCA2;ALKBH1;FECH;ALKBH8;DNAJC24;TET2;PHYH;ISCU;ALKBH3
prerank,SH3 domain binding (GO:0017124),0.4444032256876408,1.1983061015780803,0.21498371335504887,0.786281275518869,1.0,16/62,12.55%,ADAM9;DPYSL3;MAPK15;AFAP1L1;CD3E;SOCS7;DNM2;ABI1;CBL;ZNF106;SYNJ1;WIPF1;ABL1;SHANK1;KHDRBS1;REPS1
prerank,cGMP binding (GO:0030553),0.5686969841414063,1.1982673549890415,0.26770538243626063,0.7814906063430365,1.0,1/11,0.88%,PDE11A
prerank,low-density lipoprotein particle binding (GO:0030169),0.5417401922255516,1.1974803906453835,0.27712418300653596,0.779277720379455,1.0,1/16,0.08%,THBS1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5930522212379783,1.1971273897952595,0.2587904360056259,0.7757252348999493,1.0,2/10,1.22%,SLCO3A1;SLCO2A1
prerank,GTP binding (GO:0005525),0.41205529265834206,1.1962539608151603,0.13953488372093023,0.7740059007438056,1.0,28/172,11.16%,RHOJ;RHOBTB1;RHOQ;RND3;MRAS;TUBG2;GNL3;ATL2;TSR1;RAB2A;GNL1;DNM2;RAB21;ATL3;RAB8A;RABL6;GNL2;RHOT2;ARF4;GBP6;NOA1;RHOA;RHOT1;RRAD;PIP4K2B;ARFIP2;RAB38;ARF1
prerank,RNA binding (GO:0003723),0.39434725901660056,1.1933381106668244,0.002,0.7795475195835301,1.0,455/1321,25.86%,SRSF6;RPSA;STRBP;C1D;LRP1;RRBP1;COL14A1;P4HB;DDX5;HOXB6;HELB;FNDC3B;SERPINH1;YBX3;DDX17;HNRNPH1;PPP1CC;RCC1L;ERI3;GNL3;TCF20;RDX;AHNAK;ANXA7;KHDC4;PNISR;LUC7L2;SRSF1;SAMD4A;PABPC1;NOL3;ARC;SIDT2;SRSF5;ARCN1;CLK3;TSR1;HDLBP;RBFOX2;MBNL1;EIF4A2;IPO5;RBM39;GCN1;ZRANB2;BAZ2A;ANXA2;DUSP11;STAT3;ZCCHC24;RAE1;KCTD12;ZC3H7A;TRIM28;CELF4;DYNC1H1;RBM42;RRS1;SPATS2L;EIF4G2;SRSF2;VCP;CHD3;SREK1;CASC3;TENT4B;ATXN2L;KMT2C;GOLGB1;CCAR2;SNRNP70;RTCA;PRKDC;NFX1;PUM1;SAFB;FAM98A;DAP3;RRP7A;TENT5A;SSB;HMGB1;MRPS35;MRPS28;GNL2;PRKRA;CKAP4;FUS;PRPF40B;MTHFSD;MATR3;EIF4G3;ABCF1;HNRNPA2B1;CS;HNRNPDL;PPP1R8;THRAP3;RBM47;LAS1L;SMG6;FBRSL1;ELP5;TES;EWSR1;SRSF11;ACO1;PURG;HUWE1;GDI2;CHERP;PA2G4;ILF3;GSPT1;RBBP6;TRNAU1AP;HARS2;LUC7L;CELF3;RAVER2;SLTM;RBM45;NOA1;EMG1;UBAP2L;LUC7L3;HNRNPH2;SRFBP1;ZC3H12D;HNRNPL;PSIP1;MBNL2;RBM28;SF3B2;SF3B1;PRRC2C;PDIA3;RBM25;ALG13;PCBP4;MYEF2;R3HDM2;PKN2;ZNF106;SF3A1;TBRG4;ZCCHC9;RBM10;PNN;SMG1;NXF1;BZW1;ZC3H11A;GTF2F1;LARP1B;YARS1;RBM26;WDR3;U2AF1;ZC3H15;SRRM1;RBM6;FAM98B;TERT;AGO1;DAZAP1;KPNA2;NVL;TRMT1;FUBP1;CHTOP;ARF1;MRPL39;RBM5;MAZ;NUFIP2;DGCR8;METTL16;PABPN1;EIF4A1;USO1;TAF15;FAM120A;ZC3H12C;ESF1;MRPS14;DALRD3;DDX50;KHDRBS1;CRNKL1;PATL1;SFPQ;PRRC2A;SRF;DARS2;MSI2;RCC2;CCDC59;NOSIP;HSPD1;PSMA6;DHX29;RRP12;AGO2;EIF4G1;LONP1;SNUPN;EZR;DIDO1;ALKBH1;CSNK1E;HNRNPM;SUGP2;PCBP2;YWHAE;NOLC1;LSM2;PTBP1;ADD1;RBM4;MANF;HMGN2;CLTC;TIAL1;RALY;USP36;HNRNPC;FAM133B;ZCCHC7;SND1;ELP1;UTP14A;SUPV3L1;FNDC3A;SRPK1;ARHGEF1;DCAF13;ETF1;LACTB2;U2AF2;HNRNPK;G3BP2;PRR3;HEXIM1;HEATR6;XRN1;EIF2S2;CPSF4;FLNB;YTHDC1;SARNP;DDX19A;IREB2;RTCB;CMSS1;NCBP3;FYTTD1;THOC2;SRSF3;MRTO4;DDX56;NOC4L;LRRC59;PPAN;RPP40;UBAP2;PARP1;BYSL;PCF11;ISY1;N4BP1;AATF;RC3H2;YARS2;TUT7;XPOT;ZC3H10;TSN;SLC4A1AP;EIF3D;EIF3A;ELAC2;SPTBN1;RPS27A;UBC;MRPL45;SUMO1;NCBP1;ADAT1;SSRP1;EPRS1;ACIN1;RPP14;SPATS2;BOP1;SNRPA;TUFM;SECISBP2;CPSF7;NCBP2;KHNYN;CPSF6;SYNCRIP;TOP3B;TRMT6;SRSF10;SRSF7;RBM22;COA6;TNPO1;TFB2M;USP10;ALKBH8;ZCCHC17;AQR;SAFB2;U2SURP;SEC23IP;SARS2;SARS1;DRG2;NOC2L;DNAJC21;POLR1G;CAST;FASTKD3;AFF2;CLUH;ZNF346;PEBP1;GANAB;RAMAC;CCT6A;MTREX;CAVIN1;XRCC6;TRA2B;PTCD3;CCT4;UCHL5;RTRAF;LARP7;RCAN3;EIF2AK4;AKAP8;TRIP6;CALR;CSTF2;HNRNPH3;ZCCHC8;RPL7A;DARS1;UNK;ATXN2;NOP56;TRA2A;MRPL12;PARP12;CSTF2T;DHX8;EIF2S1;EIF2A;ENDOV;PSMD4;CIRBP;SAP18;FBL;CHD2;MRPS26;SHFL;PYM1;WDR36;SCAF4;ABT1;PPP1R10;DDX49;SNRPB;POLR2B;SBDS;FXR2;FAM50A;SRSF4;HNRNPA3;MRPS24;HNRNPA1;TASOR;DHX16;RSRC2;TOP1;SUMO2;SRP72;SLC3A2;MRPS21;DNAJC2;UPF1;MCAT;SMC1A;PRDX1;NGDN;UNC50;DCP1A;NSUN6;BCLAF1;EIF4B;DHX32;ZC3H14;PUS1;R3HDM1;PRMT1;NIFK;YBX1;TCP1;PABPC4;FKBP4;RPS9;SF3B6;WDR46;RBM19;BUD23;WDR75;ZFR;KRI1;STAU1;CDK13;PPIG;RPP21;TBL3;SF1;HNRNPU;DUS3L;SNRNP35;MRPL37;METAP2;RBM3;GTPBP4;PHF6;MTO1;RPS27L;SUGP1;UTP11;UPF3B;CARS1;HDAC2;MAK16;RTF1;C1QBP;DDX39B;SLC25A11;METTL14;TOE1;DDX20;TUBB4B;PUS10;ANKHD1;NOP58
prerank,transcription coregulator binding (GO:0001221),0.4494702401972577,1.192053364337788,0.21788990825688073,0.7795154304959374,1.0,17/50,20.00%,ESR1;CIT;PHF1;SMAD4;PER3;EHMT1;RORA;TERT;CCNT2;MED25;USP11;PER1;HDAC6;LCOR;THAP7;TEAD2;CHD6
prerank,ion channel activity (GO:0005216),0.430386131605832,1.189502927858932,0.2092274678111588,0.7838369242497587,1.0,11/80,8.80%,PIEZO2;GRIK4;GRIN3A;TRPV3;CHRNB2;CALHM6;TMC8;CALHM5;TRPM7;CHRNA5;TRPM4
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4096779925112017,1.1887448680797268,0.1494949494949495,0.7818733843392557,1.0,30/173,14.65%,FOXP2;PLAGL1;FOXP1;KLF12;ZFHX3;SKIL;DEAF1;JDP2;PRDM5;HES5;ZBTB25;NR2F1;TCFL5;ZNF25;NFX1;BHLHE40;HEYL;SKI;TBX21;FOXK1;ZFP90;ZBTB2;POU6F1;FOXP4;HEY1;MYPOP;NACC1;NFATC3;ERF;ZNF148
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.5413821202175573,1.1881653861124226,0.2696774193548387,0.7745539531044808,1.0,8/16,25.47%,ATP6V1C2;TCIRG1;ATP6V0A1;ATP6V0D1;ATP6V1B2;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.5413821202175573,1.1881653861124226,0.2696774193548387,0.7745539531044808,1.0,8/16,25.47%,ATP6V1C2;TCIRG1;ATP6V0A1;ATP6V0D1;ATP6V1B2;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,voltage-gated sodium channel activity (GO:0005248),0.5113635019107134,1.1880307312630087,0.23717948717948717,0.7705231399555412,1.0,3/22,6.76%,CACNA1G;HCN4;SCN11A
prerank,phospholipase inhibitor activity (GO:0004859),0.5811328424737892,1.187156646498376,0.2732474964234621,0.7689442160553143,1.0,3/10,9.20%,ANXA2;ANXA4;ANXA1
prerank,histone deacetylase activity (GO:0004407),0.5185647837735424,1.1864724287195527,0.2526041666666667,0.7670102580541551,1.0,9/19,26.24%,HDAC9;HDAC4;MIER2;HDAC1;SIRT2;HDAC6;MIER1;HDAC2;SUDS3
prerank,RNA polymerase binding (GO:0070063),0.5370814282026589,1.1862967269462859,0.27331606217616583,0.7631050340018554,1.0,7/18,20.47%,NEDD4;PKN2;ANP32B;CCNT2;PABPN1;STOM;PHRF1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5142912300208484,1.183549426381628,0.2643229166666667,0.7684631754667629,1.0,15/20,34.79%,USP50;OTUB1;SENP5;USP7;OTUD5;YOD1;SENP1;USP47;DESI2;SENP3;USP21;USP9X;COPS5;COPS2;USP25
prerank,glutamate receptor binding (GO:0035254),0.5304676421020449,1.1830013201896836,0.27211796246648795,0.7659272040893628,1.0,7/17,20.34%,GNAS;DLG4;NSF;SHANK1;SQSTM1;HIP1;HOMER2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.40077341734541605,1.1825082200310975,0.12024048096192384,0.763161933111286,1.0,58/254,20.09%,PLAGL1;ESR1;SIX1;PRRX1;HOXA5;NFIB;ELF4;NFIA;GLIS2;NFAT5;HOXB3;ELF1;MEOX2;ONECUT2;STAT3;KLF5;ATF4;GMEB1;FOXC2;RXRB;SMAD4;MEF2B;E2F3;MEIS3;MDM4;SOX9;FOXJ3;ESRRB;ZNF76;NFATC1;RUNX1;UBP1;FOXA1;PRDM4;EHF;RFX5;NRF1;SRF;ZNF112;MEF2A;NFATC3;TFDP1;FOXO3;GRHL1;CREB1;PRDM2;NFKB2;E4F1;NR3C1;RFXANK;KLF10;ATF2;HOXB2;TCF3;IRF3;FOSL2;VEZF1;ATF6
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.40212555662962945,1.1817080403412898,0.14242424242424243,0.7615781685242486,1.0,39/181,16.77%,ID2;PRRX1;ZFPM2;TCF7L2;MDFIC;LDB2;LDB1;NCOR2;HDAC4;RXRA;BAZ2A;STAT3;ANXA4;ATF4;BCAS3;DACT1;TACC2;BHLHE40;NFE2L2;NRIP1;JUP;CDK5RAP3;MIER2;RBBP8;NFATC1;WWP2;ATN1;RNF25;COMMD7;TAF6;HDAC1;PSMA6;BBS5;MEF2A;PIAS4;CREBBP;CREB1;MTA3;RBL2
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.5093323994344933,1.1813217955408697,0.2685069008782936,0.7585078743736374,1.0,5/20,10.01%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.43492995612796215,-1.1808073580728362,0.28085106382978725,0.6270282687684626,1.0,5/15,9.04%,SLC1A3;SLC25A13;SLC1A1;SLC1A2;SLC38A7
prerank,poly(U) RNA binding (GO:0008266),0.5151442759193653,1.1806878708806643,0.2633587786259542,0.7563553094269296,1.0,8/20,14.01%,HNRNPH1;PABPC1;SSB;DIS3L2;DAZAP1;KHDRBS1;PATL1;HNRNPC
prerank,calcium ion binding (GO:0005509),0.3960455049454397,1.1791760530118567,0.092,0.7571965381041558,1.0,59/323,16.30%,THBS1;SLIT3;SLIT2;SMOC2;SLIT1;CDH11;LRP1;GSN;PLA2G4F;ACER3;PLA2G4A;COLEC11;SYT8;DMP1;CALML4;COMP;ANXA7;CRACR2A;SPARC;NOL3;ANXA2;ANXA4;C2CD5;PITPNM1;CALM2;DSG3;THBS3;S100A10;TKT;ARSA;KCNIP2;PLA2G5;S100B;TRPM4;PGS1;ANXA1;CALU;STIM1;RCN1;HSPA5;AOC3;MICU2;CHP1;DCHS1;S100A1;LRP2;LETM1;NUCB1;SRR;GALNT3;MICU1;SCIN;IQGAP1;CALB2;NCS1;PKD2L1;TCHH;PLSCR3;CALM3
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3909986945223077,1.1752538575391487,0.018,0.766244006290535,1.0,144/831,14.99%,TBX15;FOXP2;PLAGL1;ESR1;SIX1;FOXP1;KLF12;ZBTB7C;PRRX1;ZFHX3;HOXA5;HIVEP3;PBX3;NFIX;ZNF423;HOXA3;FOXD1;NFIB;TCF7L2;SKIL;RARB;ELF4;TWIST2;HOXB6;MKX;SMAD9;NFIA;DEAF1;ZIM3;ZFHX4;MUC1;PRRX2;GLI2;JDP2;PRDM5;DMTF1;GLIS2;TWIST1;HOXC6;LHX9;CUX1;STAT5A;NFAT5;HDAC4;HOXB3;ELF1;SIX5;RXRA;MEOX2;ONECUT2;ZNF250;STAT3;HES5;KLF5;ZBTB25;SIX4;TCF7L1;ATF4;ZFP14;NR2F1;TCFL5;GMEB1;ZNF25;FOXC2;NFXL1;PKNOX2;NFX1;SAFB;BHLHE40;RXRB;NFE2L2;SMAD4;MEF2B;E2F3;ZNF471;RFX7;PBX1;HEYL;RUNX2;MEIS3;NRIP1;THRAP3;SKI;RORA;ZNF691;TBX21;SOX9;FOXJ3;NSD1;HOXA6;HOXA9;PURG;RARA;IKZF3;ESRRB;TFE3;FOXK1;ZNF76;ZIC1;FOXL1;RFX2;NFATC1;RUNX1;UBP1;FOXA1;ZIC4;ZFP90;FOXM1;PRDM4;SREBF1;ZBTB2;ZNF260;EHF;RFX5;POU6F1;GLIS1;HSF4;NFE2L1;NRF1;MAZ;FOXP4;NEUROD2;NR1D2;FOXO6;HDAC1;SRF;HEY1;ZNF112;ZNF740;HOXB4;MEF2D;MYPOP;NACC1;NPAS1;ZBTB9;MEF2A;NFATC3;HOXA4;ZKSCAN1;ZNF148;TFDP1;MAFG;EN2;VDR
prerank,retinoic acid binding (GO:0001972),-0.4615697701972166,-1.1731674496632287,0.2671232876712329,0.6346374993050978,1.0,2/12,2.47%,NR2F2;CYP26B1
prerank,kinase binding (GO:0019900),0.39227149892646435,1.1731167561547746,0.07207207207207207,0.7691004988059051,1.0,109/434,20.19%,ESR1;EGFR;PKD1;PRKCD;SLC12A7;RHOBTB1;CIT;SLC12A2;TCF7L2;TTC28;GSN;SRCIN1;CNTLN;TIAM1;GHR;DLG2;RND3;PPP1CC;SPRED2;SHC1;STRADA;STAT3;CARD16;NISCH;CD3E;CSPG4;ATF4;TAX1BP1;NBEA;CALM2;AP2A1;MAVS;DVL1;TOM1L1;ILK;PRAM1;ADAM10;ANKRA2;IRAK3;ANK2;SLC12A4;LLGL1;SKI;DLG4;TRIM27;FZD5;LAPTM4B;RBBP6;CDK5RAP3;CDC6;DLG1;RHOA;DGKQ;TSKS;DCTN2;PAK2;NSF;CDC25B;FOXM1;MAP3K12;IRAK1;TELO2;AXIN1;CHEK2;RCC2;CHP1;CASP1;PTPN2;AP2A2;MAPRE3;UBQLN1;SNAP91;CLTC;SQSTM1;WNK1;PRDX3;ACSL3;GSKIP;STUB1;RHOB;CAMK2N1;FOXO3;IQGAP1;STX1A;PER1;PIP5K1A;PARP1;CALM3;CDC25A;TPRKB;SUFU;NR3C1;UFL1;PRKAG1;TRIM6;CKS1B;VRK2;CNOT9;ATF2;RB1CC1;LRRC14;PTPN23;PEBP1;PRKAB1;MAPKAP1;CRK;MAP2K3;WWC2;TRIP6
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5869890810986486,1.1722875100887316,0.28763040238450077,0.7675687100001993,1.0,4/10,12.23%,RIOX2;KDM2A;PHF8;KDM4A
prerank,omega peptidase activity (GO:0008242),0.41819086595781974,1.1688539301919598,0.22328042328042327,0.775229918677309,1.0,50/89,31.24%,USP24;USP2;USP50;OTUB1;USP40;UCHL3;USP48;USP45;USP34;OTUB2;USP11;TANK;USP7;USP33;USP36;USP13;USP19;USP35;PSMD14;OTULIN;OTUD5;YOD1;USP32;USP10;USP1;MPND;USP46;ZRANB1;UCHL5;UCHL1;OTUD6B;BRCC3;USP5;USP47;DESI2;USP14;USP4;CYLD;USP49;MYSM1;USP16;USP21;USP22;USP37;USP30;OTUD3;ASRGL1;USP26;USP9X;COPS5
prerank,NADP binding (GO:0050661),0.4677623821631359,1.1686635750886822,0.2631578947368421,0.7715720924154529,1.0,8/32,16.49%,ME1;GMDS;CRYZ;MTRR;CBR4;NNT;CAT;PGD
prerank,secondary active transmembrane transporter activity (GO:0015291),0.44242996065016377,1.1672689428261185,0.2632768361581921,0.7719266810684277,1.0,6/51,6.27%,SLC4A4;SLC5A6;SLCO3A1;SLCO2A1;MCU;SLC28A2
prerank,protein serine/threonine kinase activity (GO:0004674),0.39548070398287966,1.166988556224655,0.09519038076152304,0.7687010222235998,1.0,128/334,25.69%,EGFR;PRKCD;CIT;ULK2;MARK1;CLK1;PRKCE;ACVR1B;MAPK15;CAMKK1;CSNK1D;CLK3;CAMK2D;MAP3K5;CSNK2A1;CSNK2A2;LIMK2;PRKCA;FASTK;ERN2;DYRK4;ACVR1;BRD4;NRBP2;ILK;PRKDC;NEK7;TGFBR2;TLK1;STK39;IRAK3;BCR;CDK10;RAF1;RPS6KA4;PAK4;KALRN;AKT2;CDK12;PKN2;PAK2;MAPK8;ALPK1;SMG1;CHUK;CSNK1G1;MAP4K5;RIPK3;RIOK1;ATM;MAP3K12;IRAK1;BMPR1A;CHEK2;PDPK1;MAPK12;NRBP1;GRK6;TGFBR1;UHMK1;CSNK1E;CLK4;MAP3K10;DMPK;SQSTM1;WNK1;MARK4;SRPK1;BRD2;LATS2;TRIO;TLK2;CDC42BPB;CAMK4;TP53RK;STK16;ARAF;MKNK2;SIK2;VRK2;DAPK3;MAST2;IKBKE;CLK2;BCKDK;AKT1;MAP3K14;CDKL2;CDK20;HIPK2;CDK2;CDK5;STK35;EIF2AK4;MAPK9;LRRK2;SGK3;NEK4;VRK3;MAST4;MOK;PRKACA;EIF2AK3;FAM20A;HIPK4;PRKCI;CSNK1G3;TOP1;STK38;CDKL3;CAMK1;PDIK1L;TAOK3;RPS6KB1;NEK8;TAOK1;CDK13;PLK4;TAF1;RPS6KA2;ROCK1;TBK1;NEK6;LMTK2;PINK1;TAOK2;STK24;STK3
prerank,tRNA methyltransferase activity (GO:0008175),0.5271438250770656,1.1668564996411248,0.29605263157894735,0.7650527192464495,1.0,5/16,18.42%,TARBP1;TYW3;THUMPD3;TRMT44;ALKBH8
prerank,voltage-gated potassium channel activity (GO:0005249),0.42094027876835727,1.1664658005011466,0.22175290390707497,0.7623683308012654,1.0,9/80,9.44%,KCNJ2;KCNJ15;KCNB1;HCN4;KCNN1;KCNE5;KCNIP2;KCND1;KCNK6
prerank,cysteine-type peptidase activity (GO:0008234),0.42387350008748714,1.166189762490267,0.2425249169435216,0.759265241835017,1.0,38/73,31.14%,USP24;USP2;USP50;CAPN2;PDIA3;USP40;USP48;USP34;CASP1;USP11;USP7;USP33;USP36;USP13;USP35;OTULIN;USP10;CTSZ;USP1;USP46;UCHL1;CTSB;USP5;CTSK;USP47;CTSO;USP14;USP49;USP16;USP21;USP37;ATG4A;USP30;CASP2;BLMH;CASP6;USP26;USP9X
prerank,GTPase activity (GO:0003924),0.3965461486152656,1.1644202443691025,0.16851664984863773,0.7609681603455205,1.0,46/192,22.04%,GNAS;RHOJ;RHOBTB1;RHOQ;RND3;MRAS;ATL2;GNG8;TSR1;RAB2A;RAB43;RAB24;GNL1;DNM2;RAB21;ATL3;RAB8A;GNL2;RHOT2;TBC1D24;GSPT1;GBP6;RHOA;RHOT1;RAB38;RAB11B;ARL2;RAB23;GNAO1;RHOB;RAB3B;GPN3;GNA11;RASL12;NKIRAS1;EFL1;RAB5B;DRG2;ENTPD7;RHEB;LRRK2;GNB1;ATL1;RAB1A;RAB4A;MFN1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.45473179167710603,1.163646106778783,0.26707317073170733,0.7594482382228647,1.0,15/35,27.27%,FOXP1;BAZ2A;AGO1;HDAC1;AGO2;NR3C1;KLF10;TBP;TAF1C;FOS;SMARCA4;TAF1;TP53;H3-3A;UBTF
prerank,nuclear receptor binding (GO:0016922),0.4052867119368358,1.162657394644508,0.222684703433923,0.7588090369845891,1.0,29/111,20.20%,ESR1;FOXP1;TCF7L2;DDX5;NCOR2;JMJD1C;RXRA;BAZ2A;BCAS3;TACC2;NRIP1;THRAP3;JUP;MED13;NSD1;RNF14;TGFB1I1;MED25;DNAAF4;DCAF13;MMS19;MED14;LCOR;MED12;HMGA1;BRD8;CCDC62;TRIP6;CALR
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.39703190510217845,-1.1625191972723286,0.2636363636363636,0.6494086878658164,1.0,3/18,1.05%,TGFBR3;ENG;LTBP1
prerank,lipoprotein particle binding (GO:0071813),0.4998537634086485,1.1623026489519717,0.2831858407079646,0.7560432609862404,1.0,1/20,0.08%,THBS1
prerank,N-methyltransferase activity (GO:0008170),0.5110612777468418,1.1608849742163847,0.2787958115183246,0.7567298860921162,1.0,10/20,29.01%,PEMT;NNMT;TRMT1;HNMT;GNMT;TFB2M;PRMT1;RNMT;TRMT1L;METTL15
prerank,DNA-binding transcription factor binding (GO:0140297),0.39560106842205717,1.1595352355206086,0.18218623481781376,0.7573893130930607,1.0,60/189,25.38%,ID2;PRRX1;ZFPM2;TCF7L2;LDB2;LDB1;PRDM5;TWIST1;TLE2;HDAC9;HDAC4;STAT3;ATF4;TLE6;DACT1;BHLHE40;NFE2L2;HMGB1;SKI;DGKQ;MIER2;RBBP8;NFATC1;WWP2;TLE3;ATN1;HDAC1;SRF;MEF2D;BBS5;MAP3K10;MEF2A;PIAS4;PSMC5;CREBBP;CRTC2;CREB1;MTA3;RBL2;CBX5;DAPK3;ATF2;HCFC1;NOC2L;HIPK2;TCF3;MAD2L2;MIER1;TBP;TXLNG;FOS;CRTC1;TAF1;CHD4;BBS7;NEK6;TP53;NCOR1;HDAC2;ZMYND8
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.502513197202676,1.15915183012348,0.29912390488110135,0.7548335375737186,1.0,2/19,5.11%,GRIK4;GABRA3
prerank,mRNA binding (GO:0003729),0.39027244658918075,1.1548894859910217,0.16349047141424272,0.7646584702815421,1.0,93/249,24.97%,SRSF6;DDX5;YBX3;GNL3;LUC7L2;SRSF1;SAMD4A;PABPC1;ARC;SRSF5;HDLBP;RBFOX2;CELF4;EIF4G2;SNRNP70;PUM1;SSB;CRYZ;EIF4G3;HNRNPA2B1;PPP1R8;RBM47;ACO1;LUC7L;CELF3;LUC7L3;ZC3H12D;HNRNPL;SF3B1;RBM25;PCBP4;MYEF2;ZC3H11A;DAZAP1;AUH;FUBP1;RBM5;EIF4A1;ZC3H12C;KHDRBS1;MARF1;AGO2;EIF4G1;HNRNPM;PCBP2;PTBP1;RBM4;HNRNPC;ETF1;HNRNPK;G3BP2;EIF2S2;YTHDC1;IREB2;NCBP3;FYTTD1;THOC2;PCF11;N4BP1;RC3H2;SLC4A1AP;EIF3D;EIF3A;NCBP1;SHMT2;SECISBP2;NCBP2;KHNYN;CPSF6;SYNCRIP;AQR;SHMT1;CLUH;TRA2B;CALR;CSTF2;UNK;CSTF2T;EIF2A;CIRBP;SHFL;FXR2;SRSF4;DCP1A;RNF20;PABPC4;SF3B6;SF1;HNRNPU;SNRNP35;RBM24;TP53;UPF3B
prerank,phospholipase activity (GO:0004620),0.42255990653128006,1.154384179314955,0.26384364820846906,0.7623448904290467,1.0,14/67,18.91%,MGLL;PLCE1;PLA2G4F;PLA2G4A;SMPD4;PDIA3;SMPDL3A;ABHD6;PLA2G12A;PNPLA3;GDPD3;PLA2G15;PNPLA7;SEC23IP
prerank,sodium channel regulator activity (GO:0017080),0.4560400082845747,1.1511017774295078,0.29732868757259,0.7693620585787713,1.0,5/37,3.50%,FGF13;FXYD5;NEDD4;PTPN3;CAMK2D
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.3781011401785078,-1.1461072370177534,0.22844827586206898,0.6804084882425335,1.0,8/22,21.72%,DUSP16;DUSP10;DUSP3;MTMR3;DUSP6;DUSP15;DUSP4;CDKN3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.3731480680863907,-1.145392078812548,0.2871287128712871,0.6482251536064763,1.0,10/22,29.00%,HTR2C;HTR4;CHRM3;HTR2B;CHRM2;CHRM1;HRH1;HTR1B;HTR1F;HTR1A
prerank,serotonin receptor activity (GO:0099589),-0.3731480680863907,-1.145392078812548,0.2871287128712871,0.6482251536064763,1.0,10/22,29.00%,HTR2C;HTR4;CHRM3;HTR2B;CHRM2;CHRM1;HRH1;HTR1B;HTR1F;HTR1A
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.3731480680863907,-1.145392078812548,0.2871287128712871,0.6482251536064763,1.0,10/22,29.00%,HTR2C;HTR4;CHRM3;HTR2B;CHRM2;CHRM1;HRH1;HTR1B;HTR1F;HTR1A
prerank,solute:proton symporter activity (GO:0015295),0.5164310456331911,1.1428218563183048,0.3155080213903743,0.7920207500957307,1.0,5/16,17.19%,SLC2A13;SLC2A9;SLC25A3;SLC17A5;SLC2A10
prerank,phosphatidate phosphatase activity (GO:0008195),0.5339267585032612,1.1396798272928623,0.3333333333333333,0.798439149037306,1.0,3/13,6.23%,PLPP3;PLPP5;PLPP1
prerank,FAD binding (GO:0071949),0.4708405437247262,1.1394665274993903,0.31545338441890164,0.7951966724535526,1.0,7/24,18.96%,MICAL2;QSOX1;MTRR;AIFM1;AGPS;DAO;MTHFR
prerank,copper ion binding (GO:0005507),-0.3184841547308404,-1.1384197112742216,0.2328767123287671,0.6545279241321729,1.0,11/42,18.03%,PAM;MOXD1;SOD3;LACC1;SUMF1;LOXL3;CUTA;SNCA;S100A13;ATP13A2;MT3
prerank,alpha-actinin binding (GO:0051393),0.4775059664685357,1.1371382818026643,0.3048469387755102,0.7987432976449785,1.0,4/24,8.14%,CACNA1C;PDLIM7;PALLD;RARA
prerank,neurexin family protein binding (GO:0042043),0.569923085457208,1.1363506811683146,0.31857142857142856,0.7974722260353975,1.0,4/10,17.41%,CEL;SYTL5;NLGN1;SYTL4
prerank,growth factor activity (GO:0008083),0.4167688455667967,1.1355978112504703,0.2843243243243243,0.7961272784848158,1.0,5/74,2.13%,PGF;VEGFA;FGF2;OSGIN2;FGF17
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5168097310776707,1.1346445635357305,0.3157894736842105,0.7952437572981779,1.0,2/17,2.54%,GRIK4;GRIN3A
prerank,guanyl ribonucleotide binding (GO:0032561),0.3884956944429323,1.1342804465766536,0.20362903225806453,0.7925649748489242,1.0,29/196,11.16%,RHOJ;RHOBTB1;PDE11A;RHOQ;RND3;MRAS;TUBG2;GNL3;ATL2;TSR1;RAB2A;GNL1;DNM2;RAB21;ATL3;RAB8A;RABL6;GNL2;RHOT2;ARF4;GBP6;NOA1;RHOA;RHOT1;RRAD;PIP4K2B;ARFIP2;RAB38;ARF1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.40724731409326914,-1.1338482809785013,0.2743682310469314,0.6558462281989647,1.0,7/16,16.20%,SLC13A3;SLC25A13;SLC1A1;SLC38A7;SLC25A14;SLC13A5;SLC25A30
prerank,protein kinase C activity (GO:0004697),0.5271999360941066,1.1330931067416572,0.31564625850340133,0.7925385021094116,1.0,4/14,10.01%,PRKCD;PRKCE;PRKCA;SMG1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.5281657416985186,1.1303461503733383,0.34305555555555556,0.797618015892915,1.0,4/14,22.03%,AK5;DTYMK;AK1;NME3
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.47516868037873805,1.1274620052426827,0.31113801452784506,0.8036036742724891,1.0,4/26,3.08%,SLC5A6;SLC16A9;SLC16A1;SLC26A6
prerank,NF-kappaB binding (GO:0051059),0.46636481620231174,1.1250248894467645,0.32323232323232326,0.8080563755356703,1.0,6/24,12.62%,ANXA4;CDK5RAP3;RNF25;COMMD7;HDAC1;PSMA6
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.39998765683565074,1.1223261210032234,0.27700534759358286,0.8129444630672805,1.0,15/91,8.34%,KCNJ2;GSN;PLEKHA4;MARK1;VILL;ANXA2;SNX18;PFN2;SLC9A1;FZD7;GBF1;WIPI2;FCHO2;SH3PXD2B;LAPTM4B
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.4834734520020908,1.1166894245458925,0.34207240948813983,0.8269898321695206,1.0,9/22,25.47%,ATP6V1C2;TCIRG1;ATP6V0A1;ATP6V0D1;ATP6V1B2;ATP6V1E1;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.5284653822440755,1.1153407900700545,0.3858695652173913,0.8274598317339718,1.0,6/14,22.10%,RSAD1;ACO1;ETFDH;ISCA2;IREB2;ISCU
prerank,lipase activator activity (GO:0060229),-0.45948867480818756,-1.1152670838553473,0.3104575163398693,0.6925904895023443,1.0,1/10,0.73%,ARHGAP6
prerank,DNA replication origin binding (GO:0003688),0.4745129833525641,1.1145344245374447,0.3417402269861286,0.826229911450509,1.0,8/23,20.52%,MCMDC2;MCM2;CDC6;HSPD1;CDC45;MCM4;ORC2;KAT7
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.472651140157646,1.1142402676270622,0.35242839352428396,0.8232372493439332,1.0,9/22,21.65%,APBB3;LRPAP1;AP2A1;ANKRA2;CLTC;APBB1;DNAJA1;CLU;HSPG2
prerank,Hsp70 protein binding (GO:0030544),0.4519781885589615,1.1134114504211972,0.33616504854368934,0.8221060449539904,1.0,15/31,31.04%,SPN;DNAJB14;HIKESHI;PPEF2;STUB1;DNAJC18;DNAJA1;DNAJC2;RNF207;DNAJB12;PPID;ERN1;DNAJB1;PRKN;GPR37
prerank,voltage-gated calcium channel activity (GO:0005245),0.4346574239792708,1.1118251737186982,0.31971995332555425,0.8232974721045145,1.0,6/37,10.09%,CACNA1G;CACNA1C;CACHD1;CATSPER3;ITGAV;CACNA2D2
prerank,poly-purine tract binding (GO:0070717),-0.34735895189610966,-1.1115483797039427,0.31693989071038253,0.6919686244212457,1.0,9/27,13.94%,RBPMS;RBMS1;RBMS3;ELAVL4;DDX3X;ATXN1;MCRS1;PABPC4L;KHDRBS2
prerank,carboxylic acid binding (GO:0031406),0.4402525041463818,1.111042843772238,0.33448275862068966,0.8220103141470297,1.0,15/38,20.84%,GCLC;GRIN3A;SESN3;EPDR1;CASTOR2;AKR1C1;SESN2;SRR;SHMT2;GNMT;CAD;SHMT1;UBR2;GLRB;PHYH
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.40347997275176756,1.1107934659169751,0.3008658008658009,0.8191091094312706,1.0,11/72,7.87%,KCNJ2;GSN;PLEKHA4;MARK1;VILL;ANXA2;SNX18;PFN2;SLC9A1;FZD7;FCHO2
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4900235795526922,1.1069655334923416,0.3673740053050398,0.8277674250840736,1.0,7/18,12.22%,SMAD6;INHBC;TGFB3;TGFB2;TGFBR2;SMAD7;TGFBR1
prerank,acid-thiol ligase activity (GO:0016878),-0.42647334332726483,-1.1059626946111683,0.3115942028985507,0.6946092694760468,1.0,3/13,5.73%,ACSS3;ACSL1;ACSS2
prerank,filamin binding (GO:0031005),-0.44583016547889537,-1.1049414776251778,0.34265734265734266,0.6866467593732378,1.0,6/11,13.14%,NEBL;SYNPO2;RFLNA;CEACAM1;RFLNB;FBLIM1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.43033026566138827,-1.1045877132541633,0.3357142857142857,0.6775323391777027,1.0,8/12,36.87%,SLC2A1;SLC5A3;SLC2A4;SLC2A3;MFSD4A;PPBP;SLC2A5;SLC2A6
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5323250656180838,1.1043681976924165,0.3645251396648045,0.832359818292814,1.0,2/11,8.65%,CHRNB2;CHRNA5
prerank,Toll-like receptor binding (GO:0035325),-0.44445894147152004,-1.1039198583327614,0.3141025641025641,0.6691895898745626,1.0,6/11,31.51%,TOLLIP;UNC93B1;MYD88;TLR6;CD36;TLR2
prerank,lysine N-methyltransferase activity (GO:0016278),0.4889299791515692,1.1036324922405742,0.3686274509803922,0.8309713911849028,1.0,9/20,26.23%,EEF1AKMT3;KMT5A;EHMT1;EEF1AKMT2;SETD4;SETD2;SMYD2;SETD7;EHMT2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4203626299113552,1.1036294106094782,0.3235294117647059,0.827279243814657,1.0,6/49,4.52%,PLA2G4F;PLA2G4A;SYT8;ANXA2;ANXA4;C2CD5
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5133217269364658,1.1035610029960825,0.35157318741450067,0.8237902320096399,1.0,6/14,22.85%,MINDY4;USP7;USP13;OTUD5;YOD1;DESI2
prerank,protein phosphatase binding (GO:0019903),0.386203333619048,1.1030832710445526,0.3161688980432544,0.8215451230631903,1.0,41/117,24.86%,EGFR;PPP1R9B;GRIN3A;ANAPC5;PPP1R3C;MAP3K5;STAT3;VCP;ADCY8;SLC9A1;STRN4;JUP;DLG4;PPP6R1;PPP6R3;PPP1R3F;GTF2F1;SHOC2;ANAPC4;SOD1;TRAF3;ARPP19;IQGAP1;ERBB2;KCNN4;IKBKE;CDC27;JAK1;AKAP11;VRK3;MAP2K7;ATP2B4;EIF2AK3;PPP1R3B;AP3B1;BOD1L1;PXN;SNX3;TBK1;BAD;TP53
prerank,hydro-lyase activity (GO:0016836),0.4299660323002438,1.097423268048952,0.3652073732718894,0.8360022678110711,1.0,14/41,25.19%,EHHADH;ECHDC2;GMDS;ACO1;AUH;IREB2;ENO2;L3HYPDH;CDYL;UROS;ECHDC1;HADHA;PCBD2;ENO4
prerank,metal ion binding (GO:0046872),0.36505091466580375,1.0959664195699468,0.212,0.8368994866853426,1.0,82/477,15.97%,THBS1;SLIT3;SLIT2;SMOC2;SLIT1;CDH11;LRP1;EYA2;GSN;PLA2G4F;GCLC;ACER3;PLA2G4A;MARK1;COLEC11;SYT8;DMP1;CALML4;COMP;ANXA7;CRACR2A;SPARC;NOL3;MAP3K5;ANXA2;ANXA4;C2CD5;PITPNM1;ERN2;ADCY2;CALM2;DSG3;THBS3;S100A10;TKT;ARSA;IRAK3;KCNIP2;TRIM27;PLA2G5;S100B;DCTPP1;TRPM4;PGS1;ANXA1;CALU;STIM1;WRN;PPA2;HMGCL;ABL1;SNN;RCN1;DIS3L2;TDG;MAPK12;HSPA5;CLYBL;AOC3;MICU2;CHP1;DCHS1;MTHFD2;S100A1;LRP2;LETM1;TRIM26;NUCB1;PI4K2A;SRR;SRPK1;GALNT3;MICU1;SCIN;HACL1;IQGAP1;CALB2;NCS1;CDC42BPB;PKD2L1;TCHH;PLSCR3
prerank,ribosome binding (GO:0043022),0.40957067626685356,1.0942112554112993,0.35193621867881547,0.8387671738412397,1.0,20/46,29.06%,RPSA;SEC61A1;NAA16;NCLN;ETF1;EIF6;EFL1;EIF2S1;EIF2A;SHFL;PYM1;SBDS;SRP72;C1QBP;NAA15;SEC61B;YTHDF1;CCDC47;IGHMBP2;ERI1
prerank,protein homodimerization activity (GO:0042803),0.3638946352099414,1.0917648077029771,0.163,0.842959759779381,1.0,145/589,20.67%,PRPS2;SLIT2;FOXP2;LRP6;EXT1;MGLL;PRMT8;VEGFA;ABCD3;SRGAP2;GHR;NPR3;ECE1;NTRK1;LDB1;FAP;PEX7;AOX1;PSMD7;GALE;CAMK2D;GOLGA5;MAP3K5;SNX2;STAT3;TGFB2;MID1;XDH;PEX11A;TMEM266;NECTIN3;HM13;STARD3NL;ADCY8;ACVR1;CPQ;S100A10;BHLHE40;SMAD4;TKT;ADAM10;NAA60;KLHL7;PRKRA;IRAK3;FGFR1;JUP;XPNPEP1;MUC13;TRIM27;IKZF3;EEA1;NFS1;S100B;ST3GAL2;NOG;TIMM9;ERCC5;SNX1;FGFR2;PIP4K2B;WRN;SLC39A13;MYOM3;CHUK;TERT;ATIC;BCL2L2;MAP3K12;CCDC66;IRAK1;TDG;BMPR1A;SNX9;AXIN1;NRF1;CHEK2;DGCR8;NRBP1;SFPQ;MID2;SRF;DARS2;TENM1;CIDEA;ERP29;STK25;ALDH3A2;S100A1;PAFAH1B2;SRM;UBA5;ADD1;MAP3K10;SRR;NDP;GUCY2D;SUPV3L1;CARNMT1;HPS4;DCLRE1B;STUB1;CAT;CRYL1;GRHL1;WDR54;GSTZ1;NECTIN1;IDE;YARS2;FECH;HIP1;ACP3;EPRS1;SHMT2;DNTTIP1;HMOX1;TRIM6;EXT2;DAPK3;COQ9;CNOT9;GLB1;KIF20B;GDNF;AKT1;SHMT1;ACSL6;AOC1;SARS1;PAFAH1B3;TCF3;PHETA2;IRF3;MLXIPL;CHMP4B;CHMP4A;APPL2;DPY30;ASMT;KYAT1;APPL1;MTMR1;LRRK2;PDCD6IP
prerank,NADPH binding (GO:0070402),0.5073606581860096,1.0916017351210423,0.3803009575923393,0.839884827197791,1.0,3/13,10.76%,CRYZ;MTRR;CBR4
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4224466643269228,1.0906359249315454,0.35754824063564133,0.8392971256353919,1.0,14/46,26.09%,EXT1;B3GNT7;OGT;MGAT4B;B3GNT9;HEXA;B4GAT1;B3GNT6;EXT2;GCNT7;B3GNT2;MGAT5;PIGQ;RFNG
prerank,acetyltransferase activity (GO:0016407),0.4388902430092724,1.0894897249074413,0.3746958637469586,0.8392711320187848,1.0,12/31,26.91%,SAT2;KAT6B;NAA16;ACAT1;PAFAH1B2;CREBBP;PAFAH1B3;ELP3;KAT8;KAT2B;NAA15;ESCO1
prerank,telomeric DNA binding (GO:0042162),0.43483718844903874,1.0854053501858816,0.3586698337292161,0.8488277619909232,1.0,11/32,23.20%,HNRNPA2B1;SMG6;WRN;SMG1;TERT;TELO2;TEN1;RAD50;XRCC6;UPF1;UPF3A
prerank,cytochrome-c oxidase activity (GO:0004129),-0.39395668398300654,-1.0817028283313062,0.375,0.7155422026909145,1.0,6/15,24.08%,COX8A;COX4I1;COX10;COX5B;NDUFA4L2;NDUFA4
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5264786238829628,1.0804574120336152,0.3977110157367668,0.8606696496030959,1.0,5/10,27.18%,NAA60;NAA40;ATF2;KAT8;USP22
prerank,calcium channel activity (GO:0005262),0.3867861345416593,1.0798669659466416,0.3336875664187035,0.8588338835122776,1.0,13/84,10.09%,CACNA1C;PKD1;SLC24A3;SEC61A1;TRPV3;ANXA2;CACHD1;MCU;TRPM7;TRPM4;CATSPER3;ITGAV;CACNA2D2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.36722388062737055,1.0795202073957546,0.31786074672048437,0.8564704869531027,1.0,26/188,10.07%,BNC2;SIX1;TCF7L2;VSX1;SMAD6;PRDM5;DMTF1;GLIS2;HDAC4;RXRA;STAT3;ATF4;CHD3;FOXC2;NFE2L2;SMAD4;PER3;HMGB1;PBX1;TBX21;CARM1;TFE3;FOXK1;HNRNPL;RUNX1;FOXA1
prerank,potassium channel regulator activity (GO:0015459),-0.2946562219448111,-1.0790112756610253,0.33043478260869563,0.7122455665239801,1.0,9/49,8.60%,NEDD4L;DPP10;KCNIP3;KCNIP4;ABCC9;KCNIP1;WNK2;SLC5A3;DPP6
prerank,magnesium ion binding (GO:0000287),0.37128399388338634,1.0784397667639372,0.3452868852459016,0.8562490259200733,1.0,32/135,21.16%,EYA2;GCLC;MARK1;MAP3K5;ERN2;ADCY2;TKT;IRAK3;DCTPP1;WRN;PPA2;HMGCL;ABL1;DIS3L2;TDG;MAPK12;CLYBL;MTHFD2;PI4K2A;SRR;SRPK1;HACL1;CDC42BPB;PLSCR3;XYLT2;PPA1;SIK2;MAST2;RHEB;LRRK2;ENDOV;MAP2K7
prerank,chemokine receptor activity (GO:0004950),0.44911604278979933,1.0780985109083694,0.39081885856079407,0.8537394371559811,1.0,2/24,8.64%,CMKLR1;ACKR4
prerank,carbohydrate kinase activity (GO:0019200),-0.4269502478569899,-1.0760542167620177,0.3254237288135593,0.7091473010334216,1.0,5/11,22.58%,HK2;GALK2;FGGY;KHK;XYLB
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4006347376975498,1.0756029329875152,0.3902439024390244,0.8579283139102226,1.0,21/54,26.68%,ACER3;HDAC9;HDAC4;SIRT5;PM20D2;NTAN1;MIER2;HDAC1;PIGL;NGLY1;SIRT2;HDAC6;NTAQ1;ASAH1;DARS1;HINT3;MIER1;VNN1;HDAC2;SUDS3;FAAH
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5055754272829565,1.0754874853387886,0.3914835164835165,0.8547272352860992,1.0,3/14,2.72%,TIMP2;TIMP3;RARRES1
prerank,phosphatase binding (GO:0019902),0.37782761306135176,1.0729025607802345,0.35517970401691334,0.8590804269225077,1.0,39/105,24.86%,EGFR;ANAPC5;PPP1R3C;MAP3K5;STAT3;VCP;SFI1;JUP;DLG4;TRPC4AP;PPP6R1;DLG1;PPP6R3;PPP1R3F;GTF2F1;SHOC2;ANAPC4;TRAF3;WNK1;IQGAP1;ERBB2;KCNN4;CNST;MAST2;IKBKE;CDC27;RCAN3;JAK1;VRK3;MAP2K7;EIF2AK3;CRY2;TSC2;AP3B1;PXN;SNX3;TBK1;BAD;TP53
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.4096172778419404,-1.0727979554930642,0.3938356164383562,0.7076511434339905,1.0,5/12,23.05%,STAT1;BABAM2;TRAP1;TRAF1;TRAF2
prerank,chemokine activity (GO:0008009),0.43110016926478967,1.072717959824018,0.38658536585365855,0.8561152642759411,1.0,3/31,7.33%,CCL13;CCL15;CXCL16
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5052545955495626,1.0726487282068131,0.40198863636363635,0.8528482168967264,1.0,5/12,27.37%,OPN1MW;OPN1MW3;OPN3;RRH;GPR52
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.429142292202604,1.0708400641354021,0.3888888888888889,0.8548055666428439,1.0,15/34,31.09%,EEF1AKMT3;KMT5A;EHMT1;EEF1AKMT2;SETDB1;SETD4;MEN1;SUV39H1;SETD2;SMYD2;SETD7;EHMT2;NSD3;TTLL12;EEF2KMT
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.516511797798806,1.0707963351885277,0.4041958041958042,0.8515064959766057,1.0,4/12,13.57%,JMJD1C;PHF8;KDM4A;HR
prerank,receptor tyrosine kinase binding (GO:0030971),0.39480816277424075,1.0703262804891809,0.3851276359600444,0.8493957487904109,1.0,11/56,13.88%,IRS1;GAS6;DOCK4;GAB2;SHC1;PITPNM1;CBL;ANGPT4;SH2B1;PTPN2;SQSTM1
prerank,disordered domain specific binding (GO:0097718),0.45117811617433096,1.070275468165847,0.3847167325428195,0.8461292490069754,1.0,7/23,19.91%,HSPA2;CALM2;BCL2L2;CLTC;CALM3;DFFB;TEAD2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4316365229988484,1.0693657306609774,0.3934624697336562,0.8454776703502086,1.0,6/30,11.64%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13;TMEM165
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.4205732544504269,-1.0690532654371105,0.35379061371841153,0.7072514662572356,1.0,6/11,23.78%,PPP1R1A;PPP1R2;PPP1R14C;PPP1R11;PPP1R14A;PPP1R14B
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.5297990587637332,1.0674811670756565,0.4020319303338171,0.8477555072285762,1.0,3/10,12.61%,PIK3C2B;ATM;PIK3CB
prerank,single-stranded RNA binding (GO:0003727),0.405262179757519,1.067445455695774,0.3929824561403509,0.8444758632816953,1.0,16/43,24.26%,STRBP;SRA1;ILF3;AGO1;AGO2;LONP1;PTBP1;LACTB2;U2AF2;AQR;ENDOV;HNRNPA1;EIF4B;PUS1;ZFR;HNRNPU
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.360602911565718,1.067102612034155,0.32364729458917835,0.8422594319320688,1.0,94/269,26.53%,EGFR;SMAD6;PRR7;ACVR1B;GLMN;FHIT;MID1;UBE2B;SNCAIP;TRIM28;HM13;VCP;USP2;CASC3;TNFRSF1B;ANKRA2;OTUB1;SKI;SLF2;FAF2;FZD5;LAPTM4B;PA2G4;CDK5RAP3;ITCH;CUL4A;LTBR;UBE2C;SNX9;AXIN1;CHEK2;HSPA5;SMAD7;CUL1;KDM4A;HSPD1;TANK;TRAF3;PCBP2;YWHAE;MC4R;SLC22A18;USP7;SQSTM1;PIAS4;ARRB1;UBE2L6;STUB1;CXCR4;USP13;PER1;PSMD1;CKB;HDAC6;RPS27A;UBC;SUMO1;APBB1;YOD1;IKBKE;NPLOC4;BLZF1;DNAJA1;NFKBIA;UCHL1;CALR;PSMA3;JAK1;SCAMP3;CLU;SMAD5;ABI2;PRKACA;PRKAR2A;MUL1;UBOX5;SLF1;SUMO2;DERL1;RNF20;TCP1;DET1;NEK6;TP53;CAMLG;UBE2W;PINK1;DAXX;AMBRA1;RIPK1;SMC6;SHPRH;JKAMP;RALA
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3935266009611426,1.0648027641315216,0.38706140350877194,0.845921138179087,1.0,15/60,11.32%,EGFR;DDR2;NTRK3;NTRK1;ACVR1B;EPHB2;EPHB3;ACVR1;EPHB6;TGFBR2;FGFR1;ROR1;FGFR2;MUSK;DDR1
prerank,ubiquitin protein ligase binding (GO:0031625),0.35996225262675435,1.0641850203141436,0.349,0.8443663743818034,1.0,90/254,26.53%,EGFR;SMAD6;ACVR1B;GLMN;FHIT;MID1;UBE2B;SNCAIP;TRIM28;HM13;VCP;USP2;CASC3;TNFRSF1B;ANKRA2;OTUB1;SKI;SLF2;FAF2;FZD5;LAPTM4B;PA2G4;CUL4A;LTBR;SNX9;AXIN1;CHEK2;HSPA5;SMAD7;CUL1;KDM4A;HSPD1;TANK;TRAF3;PCBP2;YWHAE;MC4R;SLC22A18;USP7;SQSTM1;PIAS4;ARRB1;UBE2L6;STUB1;CXCR4;USP13;PER1;PSMD1;CKB;HDAC6;RPS27A;UBC;SUMO1;APBB1;YOD1;IKBKE;NPLOC4;BLZF1;DNAJA1;NFKBIA;UCHL1;CALR;PSMA3;JAK1;SCAMP3;CLU;SMAD5;ABI2;PRKACA;PRKAR2A;MUL1;UBOX5;SLF1;SUMO2;DERL1;RNF20;TCP1;DET1;NEK6;TP53;CAMLG;UBE2W;PINK1;DAXX;AMBRA1;RIPK1;SMC6;SHPRH;JKAMP;RALA
prerank,transition metal ion binding (GO:0046914),0.35557796852332285,1.0626411185507596,0.317,0.8458178297654054,1.0,112/397,24.07%,ADAMTS3;ME1;ZFPM2;TIMP2;ACER3;ECE1;SEC24D;GLI2;ADAM30;PAPPA;AOX1;SEC23A;HDAC4;RXRA;SORD;TRIM28;ADCY2;CHD3;ADA;GLO1;SIRT5;SCD5;SKI;MDM4;XPNPEP1;B4GALT1;TES;NSD1;EEA1;S100B;TIMM9;PPM1M;SMPDL3A;SLC30A5;WRN;HMGCL;KDM2A;ABL1;ABCE1;TAB2;PHF8;RNF2;KDM5B;AGMO;SOD1;KDM4A;AOC3;CHORDC1;FBXL19;MMP16;ISCA2;SEC24C;SEC24B;UBA5;QPCTL;USP33;RNF11;LACTB2;GALNT3;PIAS4;LNPEP;MBD1;SIRT2;KMT2B;PLSCR3;GALNT1;IDE;PRDM2;ZFPL1;KDM5C;XYLT2;PLA2G15;SEC24A;EPRS1;DPF3;SHMT2;MPPED2;COA6;CAD;NPEPPS;SUV39H2;ALKBH8;ZMYND11;SHMT1;TK1;AOC1;ZBTB32;RNF7;MYCBP2;LVRN;DNAJC24;TET2;CALR;IKZF4;ZDHHC20;NEK4;ZKSCAN5;TRIM8;ISCU;LOXL2;KMT2A;MGAT5;GPC1;RASSF1;B4GALT7;DPEP1;GALNT2;CZIB;CYLD;ARG2;PHEX;PRIMPOL
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.39241927788469255,1.0620215934125798,0.3995609220636663,0.8442564247989655,1.0,15/60,11.54%,EGFR;DDR2;CRIM1;NTRK3;NTRK1;IGF2R;EPHB2;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;DDR1;NRP1
prerank,myosin V binding (GO:0031489),0.4864448213011784,1.0585510631773751,0.40583554376657827,0.8513861233411505,1.0,4/15,15.43%,RAB8A;RAB3D;RAB11B;RAB3B
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.4261737789510724,1.0579986570235889,0.4082624544349939,0.8496971760081248,1.0,10/32,23.90%,FTO;RIOX2;KDM2A;PHF8;KDM4A;ALKBH1;HSPBAP1;TET2;PHYH;ALKBH3
prerank,syntaxin binding (GO:0019905),0.38855926524709894,1.0574977026935484,0.3878453038674033,0.847892281426228,1.0,16/61,18.01%,SYT8;UNC13B;PRRT2;VPS52;SCFD1;NSF;ABL1;ABCA1;TMED9;PTPN2;STXBP5;SNAP23;SCFD2;STX16;NAPA;VPS11
prerank,DNA secondary structure binding (GO:0000217),0.42153286033953197,1.0572272929754911,0.3918757467144564,0.845405895681528,1.0,9/31,22.26%,HMGB1;ERCC5;RBBP8;WRN;ABL1;MEN1;HMGA1;XRCC3;KMT2A
prerank,pyrophosphatase activity (GO:0016462),0.39991838987398787,1.0564845171126709,0.3935340022296544,0.8443277488239433,1.0,9/50,12.68%,ALPL;ENTPD2;PLPP5;ENTPD6;PLPP1;DCTPP1;PPA2;DOLPP1;DHX29
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.5055419271278757,1.0546226907690832,0.4167852062588905,0.8465356492117978,1.0,3/11,11.63%,NAA60;NAA40;NAA16
prerank,ligand-gated anion channel activity (GO:0099095),-0.3638151965794958,-1.0538351979592402,0.36153846153846153,0.7359012393191654,1.0,7/17,14.56%,GLRA2;GABRB1;GABRB2;GABRB3;GABRA5;GLRA1;CFTR
prerank,nucleotidase activity (GO:0008252),0.4809254226955886,1.0537608525129318,0.41460055096418735,0.8458387519416403,1.0,6/15,22.46%,NT5DC3;NT5C3B;BPNT1;ACP3;NT5C;NT5DC1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5200559835108086,1.0519602816566997,0.4099290780141844,0.8478753242749804,1.0,6/10,29.54%,NSD1;ASH1L;SETD5;SETD2;SMYD2;NSD3
prerank,signaling receptor complex adaptor activity (GO:0030159),0.41958187131236857,1.05144432514166,0.41586538461538464,0.8462071598844932,1.0,18/38,25.59%,IRS1;GAB2;SHC1;CD3E;AXIN1;SH2B1;SHANK1;MMS19;G3BP2;SPAG9;TRAT1;LRRK2;MAPK8IP3;NUP62;DLG5;PTPN11;NCK1;TRADD
prerank,cholesterol transfer activity (GO:0120020),-0.3745933481925457,-1.0499350072160925,0.3799126637554585,0.7359203284703415,1.0,4/16,6.89%,PLTP;GRAMD1B;ABCG1;STARD4
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.41537375991125747,1.049180132631812,0.41843971631205673,0.8494164918325044,1.0,11/35,26.65%,FTO;MTFMT;PTRH2;ALKBH1;TYW3;DUS1L;ELAC2;TARS2;DUS3L;PUS10;DTWD1
prerank,cholesterol binding (GO:0015485),-0.2878129438487151,-1.048699940648108,0.37142857142857144,0.7293208861894406,1.0,10/47,6.89%,OSBPL8;APOD;SIDT1;PROM1;PTCH1;GRAMD1B;ABCG1;NR1H3;OSBPL10;STARD4
prerank,nuclear receptor coactivator activity (GO:0030374),0.3929631059237138,1.0486459971249509,0.43194600674915634,0.8476593674779707,1.0,18/52,19.14%,FGF2;ZMIZ1;DCAF6;CCAR2;THRAP3;MED13;SRA1;CARM1;ENY2;SFR1;ZMIZ2;SLC30A9;MED14;MED12;HMGA1;CNOT9;BRD8;CCDC62
prerank,lipid phosphatase activity (GO:0042577),0.4828998580659116,1.047713191481006,0.44291609353507566,0.8472242606085382,1.0,2/14,6.23%,PLPP3;PLPP1
prerank,3'-5' exonuclease activity (GO:0008408),0.4070464545522379,1.0476462095716665,0.43137254901960786,0.8442354499101727,1.0,10/45,17.21%,REV3L;ERI3;REXO2;RAD1;WRN;DIS3L2;RAD50;EXOSC4;CNOT8;DIS3
prerank,"DNA binding, bending (GO:0008301)",0.49445439853895207,1.0471907234282805,0.4231311706629055,0.8423496331190194,1.0,3/14,9.14%,FOXD1;HMGB1;FOXL1
prerank,ADP binding (GO:0043531),0.4408089808601695,1.0469471207557872,0.4215189873417722,0.8399447394252858,1.0,2/25,1.59%,ME1;GCLC
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.4906613534222003,1.0466530796887725,0.4153846153846154,0.8377020280473091,1.0,4/13,21.12%,TARBP1;TRMT1;THUMPD3;METTL1
prerank,gamma-tubulin binding (GO:0043015),0.4475012783291954,1.0464115941813774,0.4155844155844156,0.8353317768167958,1.0,6/21,14.10%,TUBGCP3;BLOC1S2;NDRG1;RAB11FIP5;GIT1;MARK4
prerank,chloride channel activity (GO:0005254),0.38375239454291016,1.0452477707143624,0.4125560538116592,0.8356289644681032,1.0,4/59,5.11%,SLC26A7;CLIC3;CLIC4;GABRA3
prerank,phosphatidylinositol kinase activity (GO:0052742),0.47244522360528746,1.0437566471704474,0.45026881720430106,0.836785101336684,1.0,5/15,16.21%,PIK3C2B;ATM;PIK3CB;PI4K2A;PI4KB
prerank,chemokine receptor binding (GO:0042379),0.41049156357806793,1.0430106090961893,0.4304556354916067,0.8359783506580634,1.0,4/35,9.77%,CCL13;CCL15;CXCL16;ITCH
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.40670740002683303,1.042933231643044,0.4349315068493151,0.8331696674740455,1.0,15/38,29.16%,PLEKHA4;PLA2G4A;WIPI2;SH3PXD2B;ZFYVE19;BBS5;HIP1;SNX13;RUFY4;DENND1A;SNX3;ATG2B;PARD3;PLEKHF1;ZFYVE1
prerank,CoA-ligase activity (GO:0016405),-0.3926815118347017,-1.0411429040933338,0.3840304182509506,0.7390145889752773,1.0,3/14,5.73%,ACSS3;ACSL1;ACSS2
prerank,metalloaminopeptidase activity (GO:0070006),0.4641801495205019,1.0404084698606035,0.4508990318118949,0.8372840976833804,1.0,7/16,21.52%,MMP14;XPNPEP1;MMP16;LNPEP;NPEPPS;LVRN;RNPEPL1
prerank,sialyltransferase activity (GO:0008373),0.45546294787636055,1.0403159140170668,0.43766233766233764,0.8345859581768864,1.0,4/20,8.47%,ST3GAL4;ST8SIA2;ST6GALNAC5;ST3GAL2
prerank,heme binding (GO:0020037),0.38434862241785617,1.0392292996575683,0.42888165038002174,0.8347180148276899,1.0,14/65,15.56%,PTGIS;CYP19A1;CYP1B1;FLVCR1;HMOX2;NOX4;HEBP1;PTGES2;RSAD1;DGCR8;CYP2U1;SUOX;ABCB6;CAT
prerank,DNA polymerase binding (GO:0070182),0.4561626008387322,1.038487809291252,0.4213917525773196,0.8338175815969016,1.0,9/18,30.61%,HMGB1;SMG6;LONP1;POLG2;CDT1;RAD51;SMARCA4;RTEL1;HSP90AA1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.47038592904479837,1.038481461581821,0.42047026279391425,0.8308782035604313,1.0,4/15,8.68%,SOCS4;SOCS7;SOCS6;SOCS2
prerank,receptor ligand activity (GO:0048018),0.3550152240530457,1.037322089067312,0.4166666666666667,0.8311434842813765,1.0,22/245,7.38%,PGF;GDF10;WNT9A;VEGFA;GAS6;FGF2;OSGIN2;IL33;FGF17;INHBC;TGFB3;INSL6;SLURP1;LRPAP1;CCL15;TGFB2;SEMA3E;JAG1;HMGB1;SEMA4B;FAM3C;EDN3
prerank,zinc ion binding (GO:0008270),0.3481119094392407,1.033941068546968,0.406,0.8373301459371434,1.0,76/293,21.42%,ADAMTS3;ZFPM2;TIMP2;ACER3;ECE1;SEC24D;GLI2;ADAM30;PAPPA;SEC23A;HDAC4;RXRA;SORD;TRIM28;CHD3;ADA;GLO1;SIRT5;SKI;MDM4;TES;NSD1;EEA1;S100B;TIMM9;SMPDL3A;SLC30A5;KDM2A;TAB2;PHF8;RNF2;KDM5B;SOD1;KDM4A;CHORDC1;FBXL19;MMP16;SEC24C;SEC24B;UBA5;QPCTL;USP33;RNF11;LACTB2;PIAS4;LNPEP;MBD1;SIRT2;KMT2B;IDE;PRDM2;ZFPL1;KDM5C;PLA2G15;SEC24A;EPRS1;DPF3;SHMT2;CAD;NPEPPS;SUV39H2;ALKBH8;ZMYND11;SHMT1;TK1;AOC1;ZBTB32;MYCBP2;LVRN;DNAJC24;TET2;CALR;IKZF4;ZDHHC20;ZKSCAN5;TRIM8
prerank,high voltage-gated calcium channel activity (GO:0008331),0.510324389860095,1.0329839434548367,0.4375896700143472,0.837005503521029,1.0,1/10,0.47%,CACNA1C
prerank,actin monomer binding (GO:0003785),0.4383967608711987,1.0328765273958427,0.43198992443324935,0.8343640695583128,1.0,6/22,13.69%,PRKCE;LIMA1;COBL;PFN2;ABL1;PFN4
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5017339437690332,1.0323183633412778,0.454014598540146,0.8329050927006896,1.0,1/11,3.02%,HCN4
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.37908154306446723,-1.031768250000777,0.39591836734693875,0.7534263260108459,1.0,5/16,26.37%,SLC44A1;SLC22A2;SLC22A4;SLC44A2;SLC29A4
prerank,Hsp90 protein binding (GO:0051879),0.41199332286630574,1.0276117352908107,0.4431279620853081,0.8429198566888313,1.0,15/33,28.16%,SLC12A2;CSNK2A1;TELO2;CHORDC1;PPEF2;STUB1;PTGES3L;USP19;HDAC6;NR3C1;TSC2;UNC45A;PPID;ERN1;HSF1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.3989776202561698,-1.0268715634104209,0.3920265780730897,0.7566227069609748,1.0,4/11,17.90%,KCND3;KCNJ3;KCNJ8;KCNQ1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3475656000408744,1.0267544664097596,0.42857142857142855,0.8423525671783499,1.0,63/248,24.33%,GNAS;RHOJ;RHOBTB1;RHOQ;RND3;MRAS;ATL2;GNG8;TSR1;RAB2A;RAB43;CHD1L;RAB24;VCP;CHD3;GNL1;MYO1E;DNM2;RAB21;ATL3;RAB8A;GNL2;RHOT2;TBC1D24;GSPT1;GBP6;RHOA;RHOT1;RAB38;DHX29;RAB11B;ARL2;ABCB6;VWA8;RAB23;GNAO1;RHOB;RAB3B;GPN3;GNA11;RASL12;KLC1;NKIRAS1;EFL1;RAB5B;KIF20B;DRG2;ENTPD7;RHEB;LRRK2;CLU;GNB1;ATL1;RAB1A;RAB4A;MFN1;ABCD1;RAB18;RAB1B;DYNC2H1;ABCB10;NRAS;KRAS
prerank,nucleosomal DNA binding (GO:0031492),0.432376252044574,1.0265203410042743,0.4368421052631579,0.8400611780029253,1.0,12/21,31.51%,SMARCC2;RCC1;HDAC1;HNRNPC;SMARCA4;CHD4;HDAC2;H3-3A;SMARCD2;SMARCC1;MBD3;GATAD2B
prerank,anion transmembrane transporter activity (GO:0008509),-0.38918050797545545,-1.026390128075634,0.4078014184397163,0.748663132261728,1.0,3/12,4.07%,SLCO2B1;SLC22A6;SLC39A8
prerank,protein kinase binding (GO:0019901),0.34231264841120845,1.0258494030027903,0.42,0.8389335864205839,1.0,106/479,19.58%,ESR1;IRS1;PKD1;PRKCD;SLC12A7;RHOBTB1;CIT;ADAM9;SLC12A2;TCF7L2;SRCIN1;CNTLN;GHR;RND3;PRR7;PPP1CC;SPRED2;SHC1;HDAC9;STAT3;NISCH;CD3E;CSPG4;ATF4;NBEA;CALM2;AP2A1;MAVS;ACVR1;DACT1;DVL1;TOM1L1;PRKCSH;ILK;PRAM1;NOX4;ADAM10;ANKRA2;IRAK3;NBR1;ANK2;SLC12A4;LLGL1;SKI;TRIM27;SOX9;RARA;FZD5;DACT3;RBBP6;CDK5RAP3;DLG1;RHOA;TSKS;DCTN2;PAK2;NSF;ITGAV;CDC25B;FOXM1;ABL1;MAP3K12;IRAK1;TELO2;AXIN1;CHEK2;NELL1;KHDRBS1;RCC2;PTPN2;EZR;AP2A2;PPEF2;MAPRE3;PICK1;SNAP91;CLTC;SQSTM1;WNK1;PRDX3;ACSL3;GSKIP;RHOB;CAMK2N1;FOXO3;IQGAP1;PARP1;SPAG9;CALM3;CDC25A;TPRKB;SUFU;NR3C1;UFL1;PRKAG1;TRIM6;CKS1B;VRK2;ATF2;RB1CC1;TCF3;PTPN23;PEBP1;PRKAB1;MAPKAP1;CRK
prerank,pseudouridine synthase activity (GO:0009982),0.4862564801846757,1.0253829903991687,0.4429347826086957,0.8373392457949475,1.0,8/13,33.67%,RPUSD1;PUS3;TRUB1;PUS1;PUS10;DKC1;PUS7L;PUS7
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3440737255794027,1.0247577197439672,0.434,0.8361951052868314,1.0,126/431,25.20%,PRPS2;RHOJ;RHOBTB1;ABCD3;N4BP2;MARK1;RHOQ;RND3;MRAS;TUBG2;GNL3;ACVR1B;ATL2;HSPA2;TSR1;SMC4;RAB2A;MAP3K5;TNK1;ERN2;GNL1;ACVR1;DNM2;RAB21;ATL3;RAB8A;RABL6;TLK1;GNL2;IRAK3;ABCF1;RHOT2;ARF4;RPS6KA4;AK6;GBP6;AKT2;NOA1;RHOA;RHOT1;RRAD;PIP4K2B;PEX1;HSPA14;ABL1;MAP4K5;ARFIP2;ABCE1;RAB38;NVL;TDG;ABCA1;ARF1;BMPR1A;ABCB8;HSPA5;TGFBR1;DARS2;PSMA6;EIF4G1;LONP1;UHMK1;LIG4;RAB11B;DMPK;ARL2;WNK1;PI4K2A;SRR;MARK4;SRPK1;ABCB6;CLP1;TBCK;RHOB;HACL1;LATS2;TLK2;CDC42BPB;RASL12;IDE;YARS2;HASPIN;PGK1;MKNK2;PRKAG1;SIK2;DAPK3;MAST2;PEX6;CAD;CHD8;BCKDK;AKT1;RAD51;SARS2;DRG2;MTREX;ABCF3;RHEB;LRRK2;ATL1;ANXA6;RAB4A;PANK3;CARS2;PRKCI;TUBB6;TOP1;STK38;PYGL;ABCD1;PPIP5K1;RAB1B;TAOK1;HNRNPU;NRAS;KRAS;ARF5;NEK6;GTPBP4;SYN3;ABCF2;LMTK2;PINK1;CARS1
prerank,TBP-class protein binding (GO:0017025),0.4390696871876547,1.024437004713158,0.4338896020539153,0.8342098393880741,1.0,1/21,0.27%,ESR1
prerank,N-acetyltransferase activity (GO:0008080),0.4401253990775328,1.023022422691976,0.44148936170212766,0.8350958856770728,1.0,3/19,9.74%,NAT1;ATAT1;SAT2
prerank,DNA binding (GO:0003677),0.33950928091522337,1.021576085870715,0.428,0.8361419240625073,1.0,152/694,20.20%,FOXP2;PLAGL1;EGFR;SIX1;KLF12;HOXA5;C1D;ZNF423;FOXD1;NFIB;TCF7L2;RARB;COLEC11;GLI2;PRDM5;CUX1;HDAC4;TOPORS;RXRA;MEOX2;STAT3;MPG;TCF7L1;ATF4;TRIM28;MCMDC2;NR2F1;CHD3;TCFL5;PHF1;FOXC2;PRKDC;SAFB;NFE2L2;SMAD4;HMGB1;E2F3;EZH1;PBX1;TSHZ2;MEIS3;THRAP3;RORA;MCM2;TBX21;SOX9;FOXJ3;CENPC;MAEL;HUWE1;MBD6;IKZF3;ILF3;ESRRB;ERCC5;HMGN1;ZNF76;SLTM;RBBP8;PSIP1;FOXL1;RFX2;ERCC4;RAD1;OGG1;WRN;FOXA1;ZIC4;SREBF1;CSRNP1;ABL1;EHF;RBM6;TERT;SPTY2D1;RFX5;POU6F1;TDG;FUBP1;WDR48;RBM5;AIFM1;SDE2;KDM5B;TDP1;TAF6;PMS2;KHDRBS1;SFPQ;CCDC25;RAD50;ERCC3;HSPD1;LONP1;KMT2D;CDC45;LIG4;PCBP2;ERCC2;MEF2A;TRIM26;RNF11;SUPV3L1;ERF;MSH4;DEDD;XRN1;ZNF148;DCLRE1B;MBD1;SNAPC4;VDR;FOXO3;CREBBP;GRHL1;NKX6-2;NFE2;PRDM2;RC3H2;ZFPL1;TSN;MCM4;E2F1;POLG2;NFYA;DNTTIP1;SMARCAD1;MEN1;HMGA1;HDGFL2;CDT1;RYBP;CHD8;SAFB2;ZMYND11;HOXB2;RAD51;CBFB;ZMYM3;ZBTB32;TCF3;GTF3C4;QRICH1;IRF3;MLXIPL;XRCC6;GTF3C1;APLP2;TWNK;MAX;ATF6;CALR
prerank,anion channel activity (GO:0005253),0.3729572956793993,1.0195503297285824,0.44334433443344334,0.8387921096487737,1.0,7/61,11.03%,SLC26A7;CLIC3;CLIC4;GABRA3;LRRC8D;CLCN4;VDAC2
prerank,exoribonuclease activity (GO:0004532),-0.3825080770770516,-1.0184216544483586,0.43223443223443225,0.7603741667178959,1.0,5/12,18.18%,EXOSC8;ZC3H12A;EXOSC1;EXOSC9;EXOSC10
prerank,transcription cis-regulatory region binding (GO:0000976),0.3405293640949016,1.0167856212919144,0.45545545545545546,0.8432907799134952,1.0,76/406,18.45%,PLAGL1;BNC2;SIX1;FOXP1;TCF7L2;TWIST2;VSX1;DEAF1;SMAD6;PRDM5;DMTF1;GLIS2;TWIST1;LHX9;CUX1;HDAC4;RXRA;STAT3;ATF4;CHD3;ZNF25;FOXC2;NFXL1;NFX1;RXRB;NFE2L2;SMAD4;PER3;HMGB1;E2F3;PBX1;RORA;TBX21;SOX9;PURG;RARA;CARM1;ESRRB;TFE3;FOXK1;HNRNPL;RUNX1;FOXA1;ZFP90;FOXM1;SREBF1;RFX5;AGO1;SFPQ;HDAC1;AGO2;LONP1;ARID4B;KMT2D;MEF2D;NPAS1;ZBTB9;MEF2A;TFDP1;FOXO3;PER1;FOXN3;GRHL1;NFE2;PRDM2;RBL2;E2F1;NFYA;E4F1;NR3C1;RFXANK;MEN1;HMGA1;KLF10;SUV39H2;ATF2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.46226129795842963,1.0158679230705074,0.46153846153846156,0.8430534185060703,1.0,6/17,11.47%,PITPNC1;PITPNA;PITPNM1;ATP8B2;ABCA1;PCTP
prerank,DNA polymerase activity (GO:0034061),0.43081821606049703,1.0156278465388637,0.4580152671755725,0.8408950285024818,1.0,8/22,26.19%,REV3L;POLE2;TERT;POLB;REV1;PRIMPOL;POLD1;POLG
prerank,G protein-coupled receptor binding (GO:0001664),0.35377976647789333,1.015438246057885,0.4618556701030928,0.8385551138353038,1.0,5/132,1.98%,MYOC;GNAS;LRP6;WNT9A;PROK2
prerank,dynactin binding (GO:0034452),-0.39410754625880823,-1.014997852061341,0.40468227424749165,0.7603280868136716,1.0,2/12,10.46%,BICDL1;SNX6
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.3895433745463046,-1.010451406178515,0.47686832740213525,0.762797323652959,1.0,5/13,7.77%,IL1R1;PDGFD;PDGFRB;PDGFRA;PDGFC
prerank,fibroblast growth factor receptor binding (GO:0005104),0.4373099939883658,1.008660740324824,0.46825396825396826,0.8534163480066923,1.0,2/21,2.13%,FGF2;FGF17
prerank,growth factor receptor binding (GO:0070851),0.3595777802770136,1.007056635643738,0.47127659574468084,0.8546242164044017,1.0,10/95,8.81%,PGF;VEGFA;FGF2;FGF17;GLMN;SHC1;SNX2;AGR2;ARF4;SNX1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4311031132206441,1.0053857112011844,0.4789808917197452,0.856276649183522,1.0,8/24,23.49%,CAMKK1;CAMK2D;PHKA1;EEF2K;CAMK4;MKNK2;CAMK1;PHKA2
prerank,potassium channel activity (GO:0005267),0.35719682592392454,1.0036645610719634,0.4937106918238994,0.8580406680177743,1.0,8/89,9.44%,KCNK5;GRIK4;KCNB1;HCN4;KCNN1;KCNE5;KCND1;KCNK6
prerank,retinoid X receptor binding (GO:0046965),0.4830331607592758,1.0025881233859641,0.45555555555555555,0.8581426544998279,1.0,5/11,17.91%,NRIP1;NSD1;MED25;VDR;HMGA1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.3782786973723374,1.0006942495690911,0.48914285714285716,0.8602411730535777,1.0,15/49,20.96%,VCP;FAAP20;SHARPIN;TAB2;UBQLN1;SQSTM1;ATRIP;HDAC6;UBL7;IKBKE;ZFAND2B;ZRANB1;PSMD4;BRCC3;OPTN
prerank,5'-nucleotidase activity (GO:0008253),0.46548457809712823,0.9960540815835939,0.475,0.8692712254185858,1.0,5/13,22.46%,NT5DC3;NT5C3B;ACP3;NT5C;NT5DC1
prerank,ligand-gated ion channel activity (GO:0015276),0.41034596879739843,0.994534535992232,0.4745762711864407,0.8704138695360014,1.0,4/30,8.65%,GRIK4;GRIN3A;CHRNB2;CHRNA5
prerank,ubiquitin-protein transferase activity (GO:0004842),0.33306631934805137,0.9923209568570176,0.547,0.8733875454211327,1.0,106/346,26.36%,WWP1;RNF144A;SH3RF3;NEDD4;FBXO10;FBXW8;TOPORS;COP1;UBE2B;TRIM28;UBR4;RNF182;DTX3;LRSAM1;UBE2R2;NFX1;ERCC8;UBE3C;RNF115;TRIM41;SYVN1;TRIM27;CBL;HUWE1;RBBP6;WWP2;SHARPIN;ITCH;FBXO25;CUL4A;UBR5;RNF114;RNF25;UBE2C;FBXO22;MYLIP;RNF2;RNF14;ANAPC4;FBXO3;CUL1;DTX2;RNF38;TRAF3;LTN1;RNF103-CHMP3;TRIM26;RNF11;FBXL14;RING1;UBE2L6;STUB1;FBXO17;RNF214;TRAF3IP2;RC3H2;RNF121;TRIM13;BIRC6;TRIM6;VPS11;GID4;HECTD1;UBR2;UHRF2;RNF7;MYCBP2;FBXW2;RNF141;TRAIP;NEURL1B;NEURL3;UBE2G2;SMURF2;RMND5B;SH3RF1;BIRC3;TRIM47;TRIM43;MUL1;RNF4;AREL1;KCTD13;TTC3;RNF20;RNF216;ZFP91;RNF146;FBXO11;UBE2Z;TAF1;RNF122;FBXO9;RNF138;KCMF1;AMFR;IRF2BPL;UBE2W;RNF111;XIAP;RNFT1;RCHY1;UBR3;SHPRH;RNF126;RNF166
prerank,mannosyltransferase activity (GO:0000030),-0.31998246057742585,-0.991388712597559,0.46613545816733065,0.8032745115168458,1.0,2/21,1.28%,TMTC2;TMTC4
prerank,ligand-gated channel activity (GO:0022834),0.4123009623415809,0.9909374545157457,0.4933008526187576,0.8742284127900072,1.0,4/29,8.65%,GRIK4;GRIN3A;CHRNB2;CHRNA5
prerank,potassium ion leak channel activity (GO:0022841),0.44524389016310095,0.990120980139607,0.47690217391304346,0.8736687309684731,1.0,1/15,0.40%,KCNK5
prerank,Notch binding (GO:0005112),0.4216943249980988,0.9900924694809302,0.49435382685069007,0.8709527998200085,1.0,3/22,6.22%,CCN3;NCOR2;JAG1
prerank,hormone receptor binding (GO:0051427),0.4626615963071452,0.9871435039015303,0.5067934782608695,0.8758739732555775,1.0,4/14,25.12%,SOCS2;VIP;JAK1;TYK2
prerank,protein phosphatase 1 binding (GO:0008157),0.430887465021342,0.9868188147465582,0.5095057034220533,0.8738607809130678,1.0,4/21,11.44%,PPP1R9B;PPP1R3C;PPP1R3F;SHOC2
prerank,sterol binding (GO:0032934),-0.26053493363864044,-0.9867813597441322,0.46788990825688076,0.8062883159728468,1.0,11/56,6.89%,OSBPL8;APOD;SIDT1;PROM1;PTCH1;GRAMD1B;ABCG1;NR1H3;OSBPL10;INSIG2;STARD4
prerank,ubiquitin protein ligase activity (GO:0061630),0.3344292431153173,0.9844298862266675,0.5341365461847389,0.8771277861037607,1.0,70/228,26.36%,WWP1;RNF144A;SH3RF3;NEDD4;TOPORS;COP1;UBR4;DTX3;LRSAM1;NFX1;UBE3C;RNF115;TRIM41;SYVN1;TRIM27;CBL;HUWE1;RBBP6;WWP2;ITCH;UBR5;RNF114;RNF25;MYLIP;RNF2;RNF14;DTX2;RNF38;LTN1;TRIM26;RNF11;RING1;STUB1;FBXO17;TRAF3IP2;RC3H2;RNF121;TRIM13;TRIM6;VPS11;UBE4A;GID4;HECTD1;UBR2;UHRF2;RNF7;MYCBP2;NEURL1B;NEURL3;SMURF2;SH3RF1;BIRC3;TRIM43;MUL1;UBOX5;AREL1;RNF216;RNF122;RNF138;KCMF1;AMFR;IRF2BPL;RNF111;XIAP;RNFT1;RCHY1;UBR3;SHPRH;RNF126;RNF166
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.437233160118806,0.9843418034609587,0.4967148488830486,0.8745715989685668,1.0,4/18,22.20%,AKR1C1;DHRS9;HSD17B8;HSD3B7
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.39791620311190345,-0.9823352896137459,0.46579804560260585,0.8084231981162933,1.0,6/10,16.84%,CXADR;CD200;PKP2;SIRPA;DSP;CD47
prerank,chemokine binding (GO:0019956),0.39862401663275465,0.9809269432238348,0.5196078431372549,0.880766696788858,1.0,7/30,21.67%,FGF2;HMGB1;ACKR4;ITGAV;CXCR4;PLP2;ACKR3
prerank,single-stranded DNA binding (GO:0003697),0.34860171793885797,0.9796089735202936,0.5205913410770855,0.8814062524382836,1.0,43/93,33.48%,MCMDC2;HMGB1;MCM2;ERCC5;RBBP8;ERCC4;FUBP1;WDR48;TDP1;PMS2;HSPD1;LONP1;CDC45;PCBP2;MCM4;RAD51;TWNK;CRY2;HNRNPA1;TOP1;NUP35;HNRNPU;RNF138;TOP3A;MCM7;RTF1;FBH1;SMC6;POLR2H;SWSAP1;RAD52;HMCES;IGHMBP2;DDX11;CTC1;TDP2;SSBP1;RAD23B;BLM;MSH2;ERCC1;RPA3;PURA
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3322934414027296,0.9789081508417372,0.5502008032128514,0.8805679182712106,1.0,70/232,26.36%,WWP1;RNF144A;SH3RF3;NEDD4;TOPORS;COP1;UBR4;DTX3;LRSAM1;NFX1;UBE3C;RNF115;TRIM41;SYVN1;TRIM27;CBL;HUWE1;RBBP6;WWP2;ITCH;UBR5;RNF114;RNF25;MYLIP;RNF2;RNF14;DTX2;RNF38;LTN1;TRIM26;RNF11;PIAS4;RING1;STUB1;FBXO17;TRAF3IP2;RC3H2;RNF121;TRIM13;UFL1;TRIM6;VPS11;GID4;HECTD1;UBR2;UHRF2;RNF7;MYCBP2;NEURL1B;NEURL3;SMURF2;SH3RF1;BIRC3;TRIM43;MUL1;AREL1;RNF216;RNF122;RNF138;KCMF1;AMFR;IRF2BPL;RNF111;XIAP;RNFT1;RCHY1;UBR3;SHPRH;RNF126;RNF166
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4492654740045594,0.9771959121336958,0.5099866844207723,0.8821469098909056,1.0,7/14,30.67%,RPP40;ELAC2;RPP14;TSEN34;RPP21;POP5;PRORP
prerank,phospholipase activator activity (GO:0016004),-0.3986640757855604,-0.975115805279991,0.46394984326018807,0.8185166720387513,1.0,1/10,0.73%,ARHGAP6
prerank,four-way junction DNA binding (GO:0000400),0.4346465391174712,0.9749384248363315,0.5179282868525896,0.8850953890416329,1.0,8/17,32.24%,HMGB1;WRN;ABL1;MEN1;XRCC3;YY1;BLM;MSH2
prerank,general transcription initiation factor binding (GO:0140296),0.4015197547164205,0.9745048460659467,0.5025,0.8833833820511368,1.0,8/25,26.38%,ESR1;TAF13;PSMC5;THAP7;YEATS2;TBP;TAF1;PSMC1
prerank,sterol transfer activity (GO:0120015),-0.33949941736883615,-0.974005189780073,0.4678111587982833,0.8121339354495422,1.0,4/17,6.89%,PLTP;GRAMD1B;ABCG1;STARD4
prerank,semaphorin receptor activity (GO:0017154),0.4757138845680249,0.9702677895645533,0.5502873563218391,0.8909923344919142,1.0,1/11,0.51%,PLXNA4
prerank,leucine zipper domain binding (GO:0043522),0.46822631401758635,0.9686673346810127,0.5261627906976745,0.8921116623696659,1.0,4/10,18.05%,ATF4;ERC1;AATF;DAPK3
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3765853095392451,0.968291940212097,0.5389150943396226,0.8902733239225596,1.0,11/35,21.18%,PDE11A;PLCE1;SMPD4;PDIA3;SMPDL3A;PLCXD2;ENPP6;GDPD3;MPPED2;PLCB2;APEX2
prerank,aminopeptidase activity (GO:0004177),0.3999730265277373,0.9675570856204068,0.5293367346938775,0.8893416827400015,1.0,10/26,24.66%,MMP14;XPNPEP1;MMP16;LNPEP;LAP3;NPEPPS;LVRN;METAP1D;RNPEPL1;METAP2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.39615466126598214,0.9667619005967238,0.5109756097560976,0.8885025980793227,1.0,11/27,22.32%,POLR3H;TERT;CRCP;MED21;POLR2F;POLR3K;TENT2;MED20;POLR2B;POLR1D;POLR1C
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3576749861559591,0.9642734289843582,0.5492341356673961,0.8919633610452049,1.0,7/55,8.41%,PKD1;SLC24A3;SEC61A1;TRPV3;ANXA2;MCU;TRPM7
prerank,endopeptidase regulator activity (GO:0061135),-0.2772946642978739,-0.9640900951859704,0.5266666666666666,0.8289689757288844,1.0,8/40,11.80%,ITIH2;TFPI;PROS1;SERPIND1;PSME3;PSME1;A2M;SPINT2
prerank,Tat protein binding (GO:0030957),0.46932246188697063,0.9599241693665822,0.5286713286713287,0.8995449367563898,1.0,4/10,25.29%,MDFIC;DNAJA1;SMARCA4;CTDP1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.4627821626994506,0.9590091562395519,0.5523415977961432,0.8989468338495618,1.0,5/12,22.30%,B3GNT7;B3GNT9;B4GAT1;B3GNT6;B3GNT2
prerank,leak channel activity (GO:0022840),0.4140777824352527,0.958171626776186,0.533508541392904,0.8981717969276843,1.0,1/18,0.40%,KCNK5
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.3839494000267275,0.9555303180992504,0.5379975874547648,0.9018245680312452,1.0,14/31,32.37%,UBE2B;UBE2R2;UBE2C;UBE2L6;BIRC6;UBE2G2;UBE2Z;TAF1;UBE2W;UBE2Q2;UBE2S;UBE2H;UBE2A;UBE2N
prerank,phosphatidylinositol binding (GO:0035091),0.34350661835525054,0.9549621956901446,0.5709745762711864,0.900433640590417,1.0,31/91,23.43%,TNFAIP8L3;PITPNC1;SNX2;PITPNA;PITPNM1;BCAS3;MYO1E;GPAA1;GAP43;FCHO2;EEA1;SNX24;SNX1;SNX9;SNAP91;MITD1;SCIN;HIP1;SNX13;DENND1B;C2CD2L;AIDA;ZFYVE16;APPL2;APPL1;SNX11;RUBCN;SNX4;MTM1;DENND1A;DPEP1
prerank,nucleotidyltransferase activity (GO:0016779),0.4041194537030999,0.9541287851274075,0.5255754475703325,0.8996523067098453,1.0,6/19,21.40%,PAPSS2;TENT4B;TERT;TUT7;REV1;TENT2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.33546274280175786,0.9514650539126371,0.5799793601651186,0.9030750477621707,1.0,25/100,19.57%,CYTH3;ARAP1;PLEKHA4;PLA2G4A;GAB2;GAP43;GBF1;WIPI2;SH3PXD2B;LAPTM4B;OGT;SNX24;DAPP1;ARFIP2;ZFYVE19;OSBP;BBS5;IQGAP1;HIP1;SNX13;GOLPH3;DENND1B;AKT1;ZFYVE16;MAPKAP1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.38182613702943224,-0.9505167169627375,0.5215827338129496,0.8553109499820428,1.0,3/10,10.36%,ADARB2;LACC1;GDA
prerank,death receptor activity (GO:0005035),-0.37000898215833067,-0.9505051287497559,0.4966442953020134,0.8459236884370107,1.0,5/11,17.63%,TNFRSF19;FAS;TNFRSF1A;TNFRSF11A;TNFRSF25
prerank,phosphatase inhibitor activity (GO:0019212),0.4173297166761121,0.9486072997566923,0.5482625482625483,0.9068944226774845,1.0,11/20,27.37%,PPP1R9B;URI1;CABIN1;ARPP19;STYX;SAG;MGAT5;BOD1L1;LMTK2;ANP32E;PPME1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3998788083075737,0.9461262713659043,0.5492227979274611,0.9098830278377851,1.0,7/22,20.96%,FAAP20;TAB2;SQSTM1;ATRIP;IKBKE;ZRANB1;OPTN
prerank,thyroid hormone receptor binding (GO:0046966),0.388436859661412,0.9454559906573198,0.5604534005037783,0.9087410146973451,1.0,9/28,25.34%,JMJD1C;THRAP3;MED13;NSD1;MED12;BRD8;TRIP6;NCOR1;MED24
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.32840236116650173,0.944116704941868,0.6068895643363729,0.9090969517878174,1.0,39/147,19.04%,PLCE1;ARHGEF28;CYTH3;TIAM1;FARP1;DOCK4;RCC1L;ANKRD27;VAV2;FGD6;RABGEF1;RAB3GAP1;DENND6A;EPS8L1;RASGEF1B;LAMTOR1;RIC1;BCR;DOCK5;MON1A;KALRN;RGP1;MADD;RCC1;IQSEC2;GAPVD1;FARP2;NUCB1;WDR41;PREB;HPS4;AKAP13;SOS1;EEF1B2;DIS3;NGEF;DENND1B;RAB3GAP2;MYCBP2
prerank,cadherin binding (GO:0045296),0.3182764369564167,0.9414845725174399,0.6576576576576577,0.912364008332735,1.0,81/315,20.77%,EGFR;CDH11;CTNND2;MPP7;FXYD5;FMNL2;CTTN;EHD1;RDX;AHNAK;PDXDC1;STX5;LIMA1;SCYL1;CSNK1D;HDLBP;GCN1;SNX2;ANXA2;ERC1;BAG3;ARGLU1;EIF4G2;ACVR1;ATXN2L;EPS8L1;ABI1;GIPC1;KLC2;JUP;TES;CBL;NDRG1;PAK4;DLG1;SNX1;ANXA1;PKN2;PAK2;BZW1;ZC3H15;CKAP5;ARFIP2;ATIC;SNX9;USO1;HSPA5;PARVA;DCHS1;DHX29;EEF1G;GAPVD1;EZR;YWHAE;MPRIP;RAB11B;ADD1;SND1;HNRNPK;FLNB;TBC1D10A;IQGAP1;LRRC59;UBAP2;PLIN3;SPTBN1;PCMT1;IST1;CNN3;HCFC1;CC2D1A;TNKS1BP1;CAST;CHMP4B;ABCF3;CALD1;CCT8;CAPZA1;RPL7A;NOP56;EIF2A
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4002075194514081,0.9407045246193092,0.5514138817480719,0.9114862092554828,1.0,5/24,14.60%,AK5;AK3;IP6K1;DTYMK;AK1
prerank,O-methyltransferase activity (GO:0008171),0.467283801460391,0.9405930453686391,0.5573997233748271,0.9091181506317305,1.0,1/10,2.45%,LRTOMT
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.46354786115469165,0.939848373057743,0.5687679083094556,0.9081634864784804,1.0,8/10,26.23%,EHMT1;ASH1L;SETD5;SETDB1;SUV39H2;SUV39H1;SETDB2;EHMT2
prerank,transaminase activity (GO:0008483),0.4611183043184487,0.9389772260145864,0.548621190130624,0.9075077110780996,1.0,3/11,20.94%,AGXT2;PSAT1;BCAT1
prerank,vinculin binding (GO:0017166),-0.3660350497248014,-0.9369357453383865,0.5083056478405316,0.8706595804482662,1.0,4/11,5.14%,UTRN;DAG1;CORO2B;SYNM
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3673304902465457,0.936921423386399,0.564650059311981,0.9095195244620775,1.0,6/35,13.86%,PKDCC;CLK1;TNK1;ABL1;SRMS;FRK
prerank,telomerase RNA binding (GO:0070034),0.4002796049757465,0.9360190787463903,0.5754119138149556,0.9089995417873891,1.0,8/22,27.34%,TENT4B;SMG6;TERT;HNRNPC;XRN1;SNRPB;HNRNPU;DKC1
prerank,kinase activity (GO:0016301),0.32946410301671586,0.9352296045064734,0.615866388308977,0.9081070154978794,1.0,32/109,20.63%,PAPSS2;MAPK15;PIK3C2B;NADK;SCYL3;CSNK2A1;SHPK;STK39;HYKK;TRRAP;FCSK;ETNK1;DGKQ;PKN2;DCAKD;PANK4;ABL1;IRAK1;IP6K1;PIK3CB;ADPGK;COQ8B;CHKB;CKB;PI4KB;PGK1;BCKDK;AKT1;RFK;CDK5;SEPHS2;LRRK2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.40110399659742657,0.9337205868118073,0.5548387096774193,0.9087089815883703,1.0,7/21,26.19%,REV3L;POLE2;POLB;REV1;PRIMPOL;POLD1;POLG
prerank,adenylate cyclase binding (GO:0008179),-0.37793442786336795,-0.9332757652160102,0.5407166123778502,0.8702730959231464,1.0,3/10,4.91%,ADCY5;CAP2;AKAP6
prerank,ATP binding (GO:0005524),0.31572143444350775,0.9316651101474688,0.685427135678392,0.9107729782229271,1.0,66/266,19.70%,PRPS2;ABCD3;N4BP2;MARK1;ACVR1B;HSPA2;SMC4;MAP3K5;TNK1;ERN2;ACVR1;TLK1;IRAK3;ABCF1;RPS6KA4;AK6;AKT2;PIP4K2B;PEX1;HSPA14;ABL1;MAP4K5;ABCE1;NVL;TDG;ABCA1;BMPR1A;ABCB8;HSPA5;TGFBR1;DARS2;EIF4G1;LONP1;UHMK1;LIG4;DMPK;WNK1;PI4K2A;SRR;MARK4;SRPK1;ABCB6;CLP1;TBCK;HACL1;LATS2;TLK2;CDC42BPB;IDE;YARS2;HASPIN;PGK1;MKNK2;PRKAG1;SIK2;DAPK3;MAST2;PEX6;CAD;CHD8;BCKDK;AKT1;RAD51;SARS2;MTREX;ABCF3
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.39867041698989025,0.9313962284292793,0.5666666666666667,0.9088360462042809,1.0,4/21,4.94%,PDE11A;PDE6C;PDE3A;PDE6A
prerank,antiporter activity (GO:0015297),0.4053857930485004,0.9305786593565972,0.5683269476372924,0.9080462450221641,1.0,7/20,25.50%,CLCN4;SLC35E1;TMEM241;SLC35C2;SLC35E2B;SLC35E2A;SLC25A11
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.4594945664521859,0.9294090667629522,0.5653409090909091,0.9080737168162585,1.0,4/10,27.47%,DPYSL3;CAD;DPEP1;OPLAH
prerank,phosphatidylglycerol binding (GO:1901611),0.4368994333737656,0.9287176337099016,0.5653409090909091,0.9069602238808071,1.0,5/13,21.92%,PITPNC1;PITPNA;GSDME;UQCC3;STOML2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.36804393821581566,0.9276528590114779,0.5774309723889556,0.906769170245483,1.0,15/34,32.37%,UBE2B;UBE2R2;UBE2C;UBE2L6;BIRC6;UBE2G2;UBE2Z;TAF1;UBE2W;UFC1;UBE2Q2;UBE2S;UBE2H;UBE2A;UBE2N
prerank,glutathione transferase activity (GO:0004364),0.399322677989086,0.9261781777787128,0.5773067331670823,0.9075259037272775,1.0,4/23,16.08%,GSTT1;GSTM5;PTGES;GSTZ1
prerank,sequence-specific mRNA binding (GO:1990825),0.47172862491150575,0.9255056768345266,0.5887573964497042,0.9065113781136583,1.0,6/10,34.83%,SSB;ETF1;SHFL;RBM24;DHFR;DHX9
prerank,amino acid binding (GO:0016597),0.37668415885710527,0.9252476985311159,0.5903614457831325,0.9044787549942562,1.0,10/31,19.72%,GCLC;GRIN3A;DDAH1;CASTOR2;SRR;SHMT2;GNMT;CAD;SHMT1;GLRB
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.43910543977538163,0.921795378940741,0.587431693989071,0.909568268973766,1.0,3/12,12.61%,PIK3C2B;ATM;PIK3CB
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.45063368030551354,0.9189649301814898,0.5780346820809249,0.9131856390199417,1.0,6/11,31.43%,AKR1C1;AKR1A1;AKR1B10;RDH14;RDH13;ALDH3A1
prerank,peptide hormone receptor binding (GO:0051428),0.451242573446395,0.918136133952717,0.6051502145922747,0.9124443074881305,1.0,2/11,15.39%,VIP;PSMC5
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.38691640818596534,0.917694603155573,0.600250626566416,0.9108384793902323,1.0,4/23,4.94%,PDE11A;PDE6C;PDE3A;PDE6A
prerank,hexosyltransferase activity (GO:0016758),0.3231565984045107,0.9156745516129302,0.6427083333333333,0.9127198312137021,1.0,32/101,29.90%,EXT1;CHPF2;POGLUT3;B3GNT7;POGLUT1;B4GALT1;B4GALT5;OGT;MGAT4B;FUT4;B3GNT9;HEXA;B4GAT1;B3GNT6;ALG1;EXT2;TMTC1;GCNT7;B4GALNT3;B3GNT2;B4GALT7;PIGV;DPY19L2;POMT1;ALG12;RFNG;PIGB;B3GAT3;DPY19L4;ALG9;B3GALNT2;HAS3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3968018197428065,0.9156417692360459,0.5800807537012113,0.910287943385502,1.0,4/18,8.68%,SOCS4;SOCS7;SOCS6;SOCS2
prerank,SUMO binding (GO:0032183),0.42312106974436836,0.9151863492640052,0.5791666666666667,0.9087765988770428,1.0,9/13,38.31%,TDG;USPL1;RNF4;SIMC1;RNF111;HERC2;USP25;CBX4;CASP8AP2
prerank,triglyceride lipase activity (GO:0004806),0.39260860209180004,0.9116822675880215,0.5808538163001293,0.9134992998299527,1.0,4/20,21.21%,CEL;PNPLA3;PLA2G15;DAGLB
prerank,protein kinase regulator activity (GO:0019887),0.32114512564035425,0.9113291691477624,0.6400414937759336,0.911687575718161,1.0,32/95,26.76%,FGF13;STRADA;CCNL2;KIDINS220;CCNL1;GMFB;MADD;CCNT2;PARVA;CCNE2;WNK1;CCNG2;HEXIM1;GSKIP;PRKAG1;ELP4;CDKN1C;DUSP19;PRKAR2A;ELP3;RPTOR;TAOK3;SMCR8;MAPK8IP1;YWHAB;CCNC;NCK1;QARS1;DAXX;SOCS1;SH3BP5;WNT11
prerank,tau protein binding (GO:0048156),-0.2557271241606053,-0.9104140043169989,0.6571428571428571,0.9199186258965927,1.0,4/40,2.51%,ROCK2;APOE;MAP2;PICALM
prerank,protein tyrosine kinase activity (GO:0004713),0.3200089128320239,0.909696715236669,0.6590198123044838,0.912796101786545,1.0,17/108,11.32%,EGFR;PKDCC;DDR2;NTRK3;CLK1;NTRK1;EPHB2;SCYL1;TNK1;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;ABL1;MUSK;DDR1
prerank,kinesin binding (GO:0019894),0.37607610473560726,0.908596411876719,0.6189889025893958,0.9125725156781223,1.0,12/27,28.99%,KLC2;PLEKHM2;IFT88;SPAG9;KIF1B;MAPK8IP3;ARHGEF10;MAPK8IP1;NEK6;FAM83D;TTBK2;KIFAP3
prerank,CCR chemokine receptor binding (GO:0048020),0.371722997947887,0.9083101824036994,0.6059850374064838,0.9107328397836962,1.0,3/28,12.23%,CCL13;CCL15;DEFB1
prerank,adenyl ribonucleotide binding (GO:0032559),0.3066263383719635,0.907602840111766,0.7464929859719439,0.9097188205766733,1.0,69/291,19.70%,PRPS2;ME1;ABCD3;N4BP2;GCLC;MARK1;ACVR1B;HSPA2;SMC4;MAP3K5;TNK1;ERN2;ACVR1;TLK1;IRAK3;ABCF1;RPS6KA4;AK6;AKT2;PIP4K2B;PEX1;HSPA14;ABL1;MAP4K5;ABCE1;NVL;TDG;ABCA1;BMPR1A;ABCB8;HSPA5;TGFBR1;DARS2;EIF4G1;LONP1;UHMK1;LIG4;DMPK;WNK1;PI4K2A;SRR;MARK4;SRPK1;ABCB6;CLP1;TBCK;HACL1;LATS2;TLK2;CDC42BPB;IDE;YARS2;HASPIN;PGK1;MPPED2;MKNK2;PRKAG1;SIK2;DAPK3;MAST2;PEX6;CAD;CHD8;BCKDK;AKT1;RAD51;SARS2;MTREX;ABCF3
prerank,transmitter-gated ion channel activity (GO:0022824),0.36810969498170343,0.9069565968662596,0.6007194244604317,0.9084646043202019,1.0,2/29,5.11%,GRIK4;GABRA3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3627511403089506,0.9067604139167792,0.6062717770034843,0.9063925762084037,1.0,6/34,9.04%,CYTH3;ARAP1;GAB2;GBF1;OGT;DAPP1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3617262888655117,0.9065837637004203,0.6193853427895981,0.904297474087011,1.0,7/33,17.21%,ERI3;REXO2;DIS3L2;XRN1;EXOSC4;CNOT8;DIS3
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.4017166688285687,0.906427532640758,0.6104417670682731,0.8997852956001662,1.0,3/17,5.95%,EPHB2;EPHB3;EPHB6
prerank,ephrin receptor activity (GO:0005003),0.4017166688285687,0.906427532640758,0.6104417670682731,0.8997852956001662,1.0,3/17,5.95%,EPHB2;EPHB3;EPHB6
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3286008806972631,0.9049012801550297,0.6478260869565218,0.9004349983910562,1.0,14/71,13.15%,EYA2;UBASH3B;PTPN3;PTPRS;PTPRF;DUSP11;PTP4A2;PTPRU;CDC14A;PTPN18;CDC25B;PTPDC1;PTPN2;DUSP18
prerank,snRNA binding (GO:0017069),0.3501437280835588,0.899818101219871,0.6274738067520372,0.908403936328421,1.0,15/42,29.80%,SNRNP70;CCNT2;LSM2;HEXIM1;SNRPA;NCBP2;RBM22;LARP7;SNRPB2;HNRNPU;SNRNP35;DDX39B;TOE1;CDK9;MEPCE
prerank,voltage-gated ion channel activity (GO:0005244),-0.33176861830960414,-0.8984913620631607,0.6037735849056604,0.9389040107037927,1.0,3/14,8.64%,CACNA1E;KCND2;ANO6
prerank,galactosyltransferase activity (GO:0008378),0.439739698534354,0.8977147518244981,0.6115007012622721,0.9101371025505057,1.0,4/11,22.98%,B4GALT1;B4GALT5;B3GNT6;B4GALT7
prerank,endopeptidase inhibitor activity (GO:0004866),0.32158660460034894,0.897152100796412,0.6777301927194861,0.9089650771873292,1.0,16/82,19.92%,SERPINH1;TIMP2;TIMP3;RARRES1;ANXA2;CARD16;SERPINF1;CST3;SERPINE2;SERPINB9;CRB2;SERPING1;RENBP;BIRC6;CAST;UCHL5
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.36781137740588304,0.8968278456869663,0.6211936662606578,0.9072524583792313,1.0,14/29,33.94%,ACER3;GAA;GALC;HEXD;GANAB;PARG;GUSB;ADPRS;HPSE;GANC;MGAM;CTBS;GBA2;HYAL3
prerank,ATPase activator activity (GO:0001671),0.3882435323633508,0.8957326378395443,0.6202046035805626,0.9069841151796904,1.0,8/20,28.80%,ATP1B1;DNAJA2;DNAJA1;DNAJC24;DNAJC1;DNAJB1;TOR1AIP2;TOR1AIP1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.4083973151041777,0.8955713913358007,0.6280653950953679,0.9049007834218661,1.0,9/14,33.80%,MTMR11;SYNJ1;MTMR10;MTMR1;MTM1;MTMR2;MTMR9;MTMR12;MTMR4
prerank,ATPase regulator activity (GO:0060590),0.3514700435333966,0.8947047199398246,0.625,0.9042228708634072,1.0,15/38,31.50%,ATP1B1;BAG3;DNAJA2;SIL1;GRPEL1;DNAJA1;DNAJC24;DNAJC1;KATNB1;BAG1;DNAJB1;TOR1AIP2;TOR1AIP1;HSPH1;GRPEL2
prerank,pyridoxal phosphate binding (GO:0030170),0.389015529496904,0.8942918553759114,0.6150845253576073,0.902573541451071,1.0,6/20,22.51%,PYGB;SRR;SHMT2;PSAT1;SHMT1;PYGL
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.35181466565917147,-0.8916867290767868,0.603448275862069,0.9463241824641101,1.0,1/11,4.17%,NUDT4
prerank,deoxyribonuclease activity (GO:0004536),0.41184787946198115,0.8904595668301829,0.6163265306122448,0.9074876341751563,1.0,8/14,35.77%,ERCC5;ERCC4;DFFB;DNASE1L2;ZRANB3;MBD4;MRE11;APLF
prerank,nucleoside-diphosphatase activity (GO:0017110),0.426160534199302,0.8894301031371701,0.6242690058479532,0.9070748879435201,1.0,6/12,28.01%,ENTPD2;ENTPD6;ENTPD7;ENTPD5;NUDT18;CANT1
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2789087856707999,-0.8876390598383914,0.6345177664974619,0.9464754192112641,1.0,3/26,3.54%,AEBP1;CPM;AGBL4
prerank,sulfotransferase activity (GO:0008146),0.35732019792616043,0.8874813491906759,0.6542617046818727,0.9084142001670978,1.0,3/33,2.92%,SULT1C2;SULT1C4;CHST11
prerank,phosphatase activator activity (GO:0019211),0.40658027229776084,0.8873386493863196,0.6157024793388429,0.9063365921881872,1.0,4/14,16.30%,CALM2;GTF2F1;PPP2R5C;CALM3
prerank,GABA receptor binding (GO:0050811),-0.33863192855967117,-0.8850887505424676,0.5912162162162162,0.9430090853498734,1.0,4/11,16.12%,TRAK2;TRAK1;GABARAP;GABARAPL1
prerank,cytokine receptor binding (GO:0005126),0.3169227568442979,0.8841947282808887,0.6810526315789474,0.9100871052738344,1.0,5/83,4.18%,PGF;VEGFA;INHBC;SPRED2;TGFB2
prerank,endopeptidase activator activity (GO:0061133),-0.3639640106238463,-0.8840411656590181,0.632258064516129,0.9358186124369403,1.0,7/10,30.52%,PSME3;PSME1;APH1B;NLRC4;PSME2;APH1A;PSENEN
prerank,protein kinase activator activity (GO:0030295),0.3249237155344704,0.8835585570977708,0.6684841875681571,0.908960745515732,1.0,19/60,26.87%,GAS6;FGF13;STRADA;CALM2;ABI1;PAK2;MADD;WNK1;IQGAP1;CALM3;DBF4;DUSP19;FAM20A;RPTOR;TAOK1;STK3;DAXX;WNT11;IGF2
prerank,1-phosphatidylinositol binding (GO:0005545),-0.31589684180747835,-0.8828957143425056,0.5836575875486382,0.9294889490696252,1.0,5/15,11.38%,EPB41;PICALM;ZFYVE9;SESTD1;SCARB1
prerank,estrogen receptor binding (GO:0030331),0.35283416304067583,0.8818765511078122,0.6291866028708134,0.9098780145976705,1.0,8/32,19.14%,ESR1;NRIP1;NSD1;DNAAF4;DCAF13;MMS19;LCOR;CCDC62
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.3297398211665654,-0.8793924491001474,0.5928853754940712,0.9282009554148392,1.0,6/13,21.74%,SLC38A5;SLC7A1;SLC38A7;SLC25A29;SLC3A1;SLC7A3
prerank,lipase activity (GO:0016298),0.33715518323399235,0.8768776787319706,0.6543352601156069,0.9169137080302456,1.0,2/43,2.79%,MGLL;CEL
prerank,phosphatidic acid binding (GO:0070300),0.38169323854289067,0.8755107079120861,0.6263297872340425,0.9171053509364745,1.0,3/19,4.82%,PITPNC1;MARK1;PITPNM1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.31185949093581383,0.8745403900024653,0.6977730646871686,0.9165174101962164,1.0,17/85,24.15%,MGLL;PLA2G4F;PLA2G4A;CEL;ABHD6;PTRH2;PAFAH1B2;PLA2G12A;PNPLA3;GDPD3;PLA2G15;PNPLA7;PAFAH1B3;DAGLB;ABHD12;PGAP1;TARS2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3593762708089275,0.8743865648006485,0.6427703523693803,0.9145156161751904,1.0,13/27,29.76%,POLR3H;CRCP;MED21;POLR2F;POLR3K;MED20;POLR2B;POLR1D;POLR1C;PRIMPOL;PRIM1;POLR2I;POLR2L
prerank,motor activity (GO:0003774),-0.2216125798545499,-0.8728033187916862,0.7411764705882353,0.9341145124075663,1.0,20/60,18.16%,STARD9;DYNC1I1;MYO6;KIF3C;MYL6;MYH9;KIF18A;KIFC3;KIF26A;KIFC2;KIF1A;KIF11;KIF5B;KIF1C;KIF15;KIF21B;DNAH3;KIF26B;GPR88;KIF27
prerank,CoA hydrolase activity (GO:0016289),0.39847657843013745,0.8714689946217293,0.6367239101717305,0.9174839080312716,1.0,5/16,26.33%,ACOT11;ACOT13;ABCD1;ACOT8;HIBCH
prerank,titin binding (GO:0031432),0.4087739722874598,0.8712164147087436,0.6308539944903582,0.9156699696126741,1.0,2/13,4.94%,CAMK2D;CALM2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.370414943535461,0.8708492305501362,0.6567741935483871,0.9140424340044384,1.0,4/23,8.24%,PLEKHA4;GBF1;WIPI2;SH3PXD2B
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.34147455843716,0.8694595173432768,0.6863905325443787,0.9142310109891697,1.0,6/38,16.63%,SERPINH1;ANXA2;SERPINF1;SERPINE2;SERPINB9;SERPING1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3487278478266665,0.8684944942926015,0.6718192627824019,0.9137129432558017,1.0,3/32,13.12%,KCNB1;KCNE5;KCNG3
prerank,SH2 domain binding (GO:0042169),0.34901161969673555,0.8679204155574923,0.6526946107784432,0.9123908450867497,1.0,5/31,13.88%,IRS1;SH3PXD2B;ABL1;KHDRBS1;SQSTM1
prerank,cytokine receptor activity (GO:0004896),0.31233310735109965,0.8651951685849001,0.7025586353944563,0.9149715536327072,1.0,14/83,17.52%,CMKLR1;F3;GHR;CNTFR;MPL;IL12RB2;IFNLR1;ACKR4;IL20RB;IL17RD;GFRA3;OSMR;PRLR;IL17RE
prerank,epidermal growth factor receptor binding (GO:0005154),0.36525528989625505,0.865075508682977,0.6539877300613497,0.9129353961630006,1.0,9/25,22.91%,SHC1;SNX2;AGR2;ARF4;SNX1;HIP1;CNOT9;ATXN2;SNX4
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4184760299072192,0.8634052830109582,0.6361149110807114,0.913451910151065,1.0,2/11,15.08%,SLC25A25;SLC35B3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.412023876045582,0.8624702327510942,0.6559139784946236,0.9128162919158671,1.0,2/12,6.44%,TENT4B;TENT5A
prerank,GTPase activator activity (GO:0005096),0.29109954990200626,0.861899059229766,0.8408408408408409,0.9115464381523669,1.0,73/313,17.21%,SGSM2;PLCE1;SRGAP2;ARHGEF28;CYTH3;ARFGAP3;ARFGAP1;ASAP3;TIAM1;FARP1;ARAP1;NPRL3;DOCK4;RCC1L;ANKRD27;VAV2;TBC1D8B;TBC1D2B;SIPA1L1;SEC23A;FGD6;ARHGAP17;RABGEF1;RAB3GAP1;DENND6A;EPS8L1;CDC42EP2;RASGEF1B;LAMTOR1;RIC1;BCR;ARFGAP2;DOCK5;LLGL1;MON1A;PGAM5;KALRN;ADAP1;RGP1;RGPD1;MADD;RCC1;ARHGAP20;NRP1;EVI5L;IQSEC2;ARHGAP8;GAPVD1;STXBP5;TBC1D9B;TBC1D25;OCRL;ARHGAP44;FARP2;NUCB1;RANBP2;WDR41;PREB;SIPA1L3;HPS4;AKAP13;TBCK;ARRB1;TBC1D10A;IQGAP1;SOS1;TBC1D17;NF1;TBCD;TAGAP;EEF1B2;FLCN;DIS3
prerank,glycine binding (GO:0016594),0.4161066387599452,0.858403299989346,0.6483050847457628,0.9152800757176195,1.0,4/11,19.72%,GRIN3A;SRR;GNMT;GLRB
prerank,ribonuclease P activity (GO:0004526),0.4162361053758772,0.8580986313595633,0.6689560439560439,0.913553945332745,1.0,5/11,30.67%,RPP40;RPP14;RPP21;POP5;PRORP
prerank,rRNA binding (GO:0019843),0.3306836524135754,0.8576881142714513,0.6963048498845266,0.9120207712419659,1.0,15/42,29.78%,RCC1L;RRS1;EMG1;PPAN;CAVIN1;PTCD3;CIRBP;GTF3A;SBDS;MRPS18A;RPS9;NOP53;MRPL11;ERI1;RPF2
prerank,AMP binding (GO:0016208),-0.3365883075917625,-0.8568097240760961,0.6597938144329897,0.9615240267301984,1.0,3/11,8.76%,PRKAG2;ACSS2;PRKAG3
prerank,GTPase regulator activity (GO:0030695),0.29057024413429267,0.8554368316756262,0.8125,0.913710606171114,1.0,47/212,16.42%,SLIT2;SGSM2;SRGAP2;ARFGAP3;ARFGAP1;ASAP3;ARAP1;NPRL3;TBC1D8B;TBC1D2B;GDI1;SIPA1L1;SEC23A;IPO5;ARHGAP17;RAB3GAP1;CDC42EP2;BCR;ARFGAP2;LLGL1;PDE6D;GPS1;PGAM5;ADAP1;RGPD1;ARHGAP20;NRP1;EVI5L;ARHGAP8;STXBP5;TBC1D9B;TBC1D25;OCRL;ARHGAP44;ARL2;RANBP2;PREB;SIPA1L3;TBCK;ARRB1;TBC1D10A;IQGAP1;SOS1;TBC1D17;NF1;TBCD;TAGAP
prerank,ribonuclease P RNA binding (GO:0033204),0.42245625019567545,0.8547510086521344,0.6728307254623044,0.9127401853252289,1.0,4/10,27.42%,RPP40;RPP14;RPP21;POP5
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.41547278768861484,0.8543599137271058,0.6624649859943977,0.9090357176027655,1.0,6/11,31.50%,BAG3;SIL1;GRPEL1;BAG1;HSPH1;GRPEL2
prerank,adenyl nucleotide binding (GO:0030554),0.41547278768861484,0.8543599137271058,0.6624649859943977,0.9090357176027655,1.0,6/11,31.50%,BAG3;SIL1;GRPEL1;BAG1;HSPH1;GRPEL2
prerank,actinin binding (GO:0042805),0.3633559226530017,0.852536697209143,0.6508344030808729,0.9097693782883922,1.0,4/21,15.82%,CACNA1C;RARA;CSRP3;PKD2L1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3375072850780072,0.8525340225553175,0.6733727810650888,0.9075824326675067,1.0,11/34,26.87%,STRADA;CALM2;CCNT2;IQGAP1;CALM3;CKS1B;DBF4;FAM20A;TAOK1;STK3;IGF2
prerank,double-stranded RNA binding (GO:0003725),0.3073083588190914,0.8511549232948469,0.7051705170517052,0.9075714552807753,1.0,12/70,14.22%,STRBP;SIDT2;MBNL1;PRKRA;ILF3;AGO1;DGCR8;EIF4A1;HSPD1;AGO2;CLTC;SUPV3L1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3075697344984555,0.8508154203002396,0.7257019438444925,0.9059738039409653,1.0,8/73,13.36%,FSHR;GALR1;NPR3;EDNRA;FPR3;GLP1R;F2R;MC4R
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.36587877731626445,0.8499882368732391,0.6486486486486487,0.9052092522781612,1.0,3/21,8.65%,DRD1;CHRNB2;CHRNA5
prerank,channel activity (GO:0015267),-0.2424864494091662,-0.8491735679652637,0.7682119205298014,0.9689893976251756,1.0,11/41,20.12%,BCL2;AQP11;TRPV2;CHRNB1;KCNK3;MCUB;TRPV4;TRPA1;TMEM120B;SLC14A1;PANX2
prerank,snoRNA binding (GO:0030515),0.34278532746407875,0.8491684705301042,0.683698296836983,0.9045161871871117,1.0,10/30,31.29%,TSR1;PRKDC;WDR3;BYSL;NOP56;TBL3;NOP58;DKC1;NOP10;NOP14
prerank,water transmembrane transporter activity (GO:0005372),0.4074213584682884,0.8483618877041068,0.6585714285714286,0.9036840433107227,1.0,1/11,5.77%,SLC4A11
prerank,calcium-activated potassium channel activity (GO:0015269),0.41019358384688454,0.8475145319088215,0.6671368124118476,0.9029629507628311,1.0,3/11,16.88%,KCNN1;PKD2L1;KCNN4
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.3125583007634958,0.8471149533536123,0.7400644468313641,0.9014763811922956,1.0,26/69,29.26%,PLA2G4A;SOAT1;LPCAT4;LPCAT3;KAT6B;NAA16;ZDHHC16;HHAT;GLYAT;CREBBP;ZDHHC13;LIPT1;PLA2G15;ZDHHC20;ELP3;MCAT;KAT8;ZDHHC9;KAT2B;NMT1;NAA15;CERS3;ESCO1;SOAT2;CERS6;SCP2
prerank,peptidase inhibitor activity (GO:0030414),0.33732558480213093,0.8453560818100544,0.6771844660194175,0.9022099800740955,1.0,8/33,24.04%,GPC3;TIMP2;CST3;RENBP;CAST;UCHL5;USP14;SIMC1
prerank,UDP-galactosyltransferase activity (GO:0035250),0.41689200667945997,0.8450270591426832,0.6638176638176638,0.9006304503319871,1.0,2/10,8.24%,B4GALT1;B4GALT5
prerank,voltage-gated cation channel activity (GO:0022843),0.29846913071954406,0.8448886125847093,0.7572614107883817,0.8987700160750355,1.0,10/97,10.09%,CACNA1C;KCNB1;GRIN3A;HCN4;CACHD1;KCNE5;KCND1;CATSPER3;ITGAV;CACNA2D2
prerank,metalloexopeptidase activity (GO:0008235),0.3168742712848953,0.8438613633741631,0.7131608548931384,0.8983818331722719,1.0,18/51,25.21%,CPZ;CPQ;MMP14;XPNPEP1;AGBL5;AGBL3;MMP16;CPXM2;LNPEP;LAP3;NPEPPS;LVRN;CPB2;METAP1D;RNPEPL1;DPEP1;METAP2;VASH1
prerank,GDP binding (GO:0019003),0.31030068923521625,0.8438473956394462,0.737885462555066,0.8963172469404136,1.0,22/63,32.69%,MRAS;RAB2A;RAB21;RAB8A;RAB11B;RAB3B;RASL12;RAB5B;RHEB;RAB4A;RAB18;NRAS;KRAS;RAB5A;RALA;DIRAS1;RAB5C;MIEF1;RAB27B;RAB12;RAP2C;ARL3
prerank,peptide N-acetyltransferase activity (GO:0034212),0.41081125679247366,0.8415182023917328,0.6666666666666666,0.8979613324995489,1.0,5/10,33.42%,NAA60;NAA16;NAA15;NAA25;NAA20
prerank,cAMP response element binding (GO:0035497),-0.35081458834711443,-0.8412691639074217,0.6332179930795848,0.9768119740252176,1.0,1/10,0.39%,CREB5
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3783954271096052,0.8386771944208569,0.6727272727272727,0.9004821067053208,1.0,4/17,25.09%,ACOT11;ACOT13;ABCD1;ACOT8
prerank,carboxy-lyase activity (GO:0016831),0.3589407714777125,0.8383980673804574,0.6853932584269663,0.8987986259963012,1.0,5/23,22.44%,GGCX;CSAD;AZIN1;ACOD1;ECHDC1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.3401341222366202,0.8376238948903953,0.6888331242158093,0.8979599646030297,1.0,2/29,3.33%,CIT;SPRED2
prerank,muscle alpha-actinin binding (GO:0051371),0.37982846533501946,0.8360244569077029,0.6832214765100671,0.8984277394421798,1.0,3/15,15.82%,PDLIM7;PALLD;PKD2L1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.3862848667657344,0.8341777781463351,0.6939058171745153,0.899332583157917,1.0,4/14,24.81%,DHRS9;AKR1A1;DHRS3;RDH10
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.3126336742201006,-0.8336909789082341,0.7075812274368231,0.9833360392687546,1.0,3/13,6.59%,RYR2;PRKAR2B;PRKAR1B
prerank,ephrin receptor binding (GO:0046875),0.3600010963927782,0.8324717964878419,0.6993548387096774,0.8999735001618973,1.0,7/21,19.58%,EFNA5;SHC1;CBL;ABL1;EFNA1;ANKS1B;CRK
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3398955333418656,-0.831903519455098,0.6678082191780822,0.9781365398761785,1.0,3/10,8.60%,DPP4;DPP10;DPP6
prerank,death domain binding (GO:0070513),-0.3286278720247975,-0.8306567231805315,0.69375,0.9722108978901152,1.0,3/11,8.46%,BCL2;BCL2L1;DAPL1
prerank,WW domain binding (GO:0050699),0.3444412242349805,0.827979201571421,0.7178841309823678,0.9047537013190728,1.0,5/26,18.42%,PMEPA1;SCNN1A;PRRG4;NFE2;KIF20B
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3412421400962925,-0.8263765603011536,0.6798679867986799,0.9722159886449154,1.0,2/10,8.64%,ANO1;ANO6
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.3676356412732209,0.8260801466275629,0.7227456258411844,0.9056131238935947,1.0,10/16,33.80%,MTMR11;SYNJ1;MTMR10;MTMR1;MTM1;SACM1L;MTMR2;MTMR9;MTMR12;MTMR4
prerank,phospholipase binding (GO:0043274),-0.3070766828000209,-0.8256474221063612,0.6539923954372624,0.9649731569208287,1.0,1/13,0.73%,ARHGAP6
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.39178227494973566,0.8223341331841246,0.7051460361613352,0.9093019955976547,1.0,4/13,17.61%,LPCAT1;GPAT4;PNPLA3;AGPAT5
prerank,CXCR chemokine receptor binding (GO:0045236),0.3974721976009252,0.8206797735362641,0.7006896551724138,0.9097934975359665,1.0,2/11,10.28%,ITCH;YARS1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.34733349567987326,0.8192393254620044,0.7122940430925222,0.9099634219792592,1.0,2/23,3.12%,PLCE1;EDNRA
prerank,protein phosphatase regulator activity (GO:0019888),0.30811387803307616,0.8190331158279449,0.7379077615298087,0.9082342288667642,1.0,24/53,29.64%,PPP1R9B;CALM2;PPP6R1;PPP6R3;RCAN1;CABIN1;SHOC2;DMPK;PPP2R2D;ARPP19;PPP2R5C;CALM3;PPP6R2;SAG;RCAN3;PPP1R7;MGAT5;BOD1L1;LMTK2;PPP2R1A;PPME1;B3GAT3;PPP2R1B;RCAN2
prerank,MAP-kinase scaffold activity (GO:0005078),0.39753086149926775,0.8168369421752762,0.7006896551724138,0.9094228532270857,1.0,7/11,24.26%,AKAP13;IQGAP1;SPAG9;DUSP19;SH3RF1;MAPK8IP3;MAPK8IP1
prerank,endodeoxyribonuclease activity (GO:0004520),0.35102030993296346,0.8163751995065414,0.6925064599483204,0.908055356660659,1.0,11/20,37.18%,ERCC5;RBBP8;ERCC4;RAD50;ENDOV;ZRANB3;MBD4;ERCC1;MRE11;APLF;EXOG
prerank,monocarboxylic acid binding (GO:0033293),0.35854415541445855,0.8149511323326194,0.7118193891102258,0.9082276649848123,1.0,3/18,9.00%,RXRA;RARA;AKR1C1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.32996664589613534,0.802127337208984,0.7390761548064919,0.9250216160360424,1.0,4/27,12.75%,RNF144A;DCUN1D5;RNF14;DCUN1D2
prerank,neuropeptide hormone activity (GO:0005184),0.3434306539408815,0.8012591038692553,0.7396226415094339,0.9242077657214481,1.0,7/22,33.52%,VIP;AGRP;PENK;NMB;SPX;HCRT;NPFF
prerank,actin binding (GO:0003779),0.2740160433776591,0.8008960697748607,0.8649193548387096,0.9226633582474973,1.0,29/170,15.21%,MICAL2;FXYD5;MAP1B;GSN;P4HB;PRKCE;RDX;PDLIM7;LIMA1;COBL;SLC6A2;TNNT3;ADCY8;SPATA32;EPS8L1;DMD;PFN2;GIPC1;ABL1;TLNRD1;BCL7B;PARVA;EZR;CAP1;PFN4;ADD1;FLNB;SCIN;CXCR4
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.37703356028413754,0.7997818882334301,0.7298444130127298,0.9222246850173864,1.0,2/13,8.23%,GDI1;GDI2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.2067633937512257,-0.7997403905282923,0.8703703703703703,1.0,1.0,17/57,24.48%,COX8A;NDUFC2;COX4I1;UQCR11;COX10;NDUFA13;NDUFB2;NDUFB7;COX5B;UQCRC1;NDUFS1;NDUFA8;NDUFA4L2;UQCRQ;NDUFS6;NDUFA4;CYB561D2
prerank,alpha-tubulin binding (GO:0043014),0.32540110743737055,0.7995017597120723,0.7628992628992629,0.9206171676626523,1.0,10/31,27.57%,TBCE;BEX4;SPAST;TRAPPC14;HDAC6;DIP2B;SETD2;TAOK1;DNAL1;EFHC1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2935457238238081,0.7991687999217889,0.8043715846994536,0.9190582821765765,1.0,15/74,16.21%,PAPSS2;PIK3C2B;NADK;SHPK;HYKK;FCSK;ETNK1;DGKQ;DCAKD;PANK4;PIK3CB;ADPGK;CLP1;CHKB;PI4KB
prerank,peptidoglycan binding (GO:0042834),0.3953221198947283,0.7953702054174017,0.7256011315417256,0.9222602396999451,1.0,1/10,4.32%,RNASE7
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.2583397714284892,-0.7933305786632115,0.775609756097561,1.0,1.0,5/21,10.64%,CDK6;CDK19;CDK14;CDK15;CDK8
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.2583397714284892,-0.7933305786632115,0.775609756097561,1.0,1.0,5/21,10.64%,CDK6;CDK19;CDK14;CDK15;CDK8
prerank,active ion transmembrane transporter activity (GO:0022853),0.31187779495442153,0.7922440958138683,0.7570422535211268,0.9246523881350238,1.0,3/37,5.77%,SLCO3A1;SLCO2A1;SLC4A11
prerank,U6 snRNA binding (GO:0017070),0.36878445895243944,0.7905138634241407,0.720108695652174,0.9250319106550463,1.0,5/14,25.41%,METTL16;LSM2;RBM22;LARP7;DDX39B
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3444111775474783,0.7898865348634578,0.7697368421052632,0.9239077326940397,1.0,8/21,24.18%,PRRC1;AKAP9;EZR;GSKIP;AKAP8;ARFGEF2;PRKACA;ACBD3
prerank,carboxypeptidase activity (GO:0004180),-0.2239744552331001,-0.7861952988180382,0.8493150684931506,1.0,1.0,3/35,3.54%,AEBP1;CPM;AGBL4
prerank,phosphatase activity (GO:0016791),0.28131096869604794,0.786071605800943,0.8140540540540541,0.9271378290444969,1.0,8/73,8.64%,ALPL;PLPP3;PPP1CC;PLPP5;DUSP11;PLPP1;PGAM5;NANP
prerank,palmitoyltransferase activity (GO:0016409),-0.2368155705545052,-0.7854194534879058,0.8351063829787234,0.9972396412958019,1.0,13/28,27.78%,ZDHHC14;GLUL;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;GOLGA7B;ZDHHC6;ZDHHC24;ZDHHC22
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.31004147351235917,-0.7844734668840925,0.7403508771929824,0.9904140295755852,1.0,3/12,12.68%,CNOT1;NOCT;CNOT6L
prerank,kinase activator activity (GO:0019209),0.31913590250758667,0.7829064944891436,0.7706310679611651,0.9294789039299112,1.0,8/30,26.76%,FGF13;STRADA;MADD;WNK1;DUSP19;RPTOR;DAXX;WNT11
prerank,single-stranded DNA helicase activity (GO:0017116),0.3479923499671944,0.7818039744489956,0.7444005270092227,0.9290081549287699,1.0,2/19,7.65%,HELB;MCM2
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.28568360956352135,-0.7800736055481216,0.7603305785123967,0.9892753597217648,1.0,11/15,41.90%,P2RY14;GPR34;P2RY1;P2RX7;P2RX3;P2RX5;GPR171;P2RX1;GPR87;P2RY13;P2RX6
prerank,PDZ domain binding (GO:0030165),0.28527347745993825,0.7759999174451764,0.8199566160520607,0.9347568425848574,1.0,9/61,9.69%,CIT;CRIM1;DOCK4;SLC26A6;ERC1;KIDINS220;FZD7;DLG4;NSF
prerank,protein tyrosine kinase binding (GO:1990782),0.28247591275744954,0.775741868302244,0.8351177730192719,0.933077837209794,1.0,12/71,13.88%,GAS6;DOCK4;PRR7;SHC1;PITPNM1;ACVR1;NOX4;CBL;ANGPT4;KHDRBS1;PTPN2;SQSTM1
prerank,microtubule motor activity (GO:0003777),-0.20862979290183303,-0.7733681339038204,0.9405940594059405,0.9912394706332649,1.0,20/51,22.23%,STARD9;DYNC1I1;KIF3C;KIF18A;KIFC3;KIF26A;KIFC2;KIF1A;KIF11;KIF5B;KIF1C;KIF15;KIF21B;DNAH3;KIF26B;KIF27;KIF18B;KIF4A;KIF22;KIF14
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.24909619687139617,-0.7730668616808857,0.7936507936507936,0.9834223197447057,1.0,5/24,9.87%,OSBPL8;PLEKHA5;CERT1;SESTD1;LANCL2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.2987481865687047,-0.7718714165625796,0.782608695652174,0.9769304548498878,1.0,4/12,12.70%,GABRB1;GABRB2;GABRB3;GABRA5
prerank,beta-tubulin binding (GO:0048487),0.30817516101014747,0.77091864353671,0.7915151515151515,0.9378015440689802,1.0,4/31,10.03%,FGF13;BCAS3;SMC3;SPAST
prerank,tau-protein kinase activity (GO:0050321),0.3361500738438978,0.7705549258312576,0.7685534591194969,0.936289470850398,1.0,7/20,28.72%,MARK1;MARK4;CDK5;TAOK1;ROCK1;TAOK2;TTBK2
prerank,cardiolipin binding (GO:1901612),0.3820957125902232,0.7702148074743074,0.7402402402402403,0.9346967434086046,1.0,4/10,30.13%,GSDME;UQCC3;STOML2;PLEKHN1
prerank,RNA stem-loop binding (GO:0035613),-0.30466033721036473,-0.7677763284555387,0.7663230240549829,0.9757462888612773,1.0,3/12,9.55%,MYH10;DDX3X;ZC3H12A
prerank,glycerophospholipid flippase activity (GO:0140333),-0.2953820047067185,-0.7650987275245944,0.7731958762886598,0.9719324771183516,1.0,3/11,9.82%,ATP10A;ATP8A2;ABCA4
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3045043787289561,0.7635777079960373,0.8026315789473685,0.9414512817343071,1.0,6/34,17.21%,ERI3;REXO2;DIS3L2;EXOSC4;CNOT8;DIS3
prerank,NAD+ binding (GO:0070403),0.36129373922640523,0.7608734078544689,0.764456981664316,0.9428423156656397,1.0,3/12,15.74%,SIRT5;SIRT2;CRYL1
prerank,protein heterodimerization activity (GO:0046982),0.25976961802814974,0.76033847718419,0.9190283400809717,0.9414338383272205,1.0,37/178,20.09%,EXT1;KCNB1;ATP1B1;P4HB;SNX2;CD3E;ATF4;ADCY8;BHLHE40;IRAK3;SMC3;SNX1;CHUK;RCC1;BCL2L2;IRAK1;NEUROD2;AOC3;MICU2;TENM1;YWHAE;PAFAH1B2;HEXA;NOLC1;NPAS1;ADD1;MEF2A;MICU1;ERBB2;HIP1;EXT2;SAE1;KATNA1;PAFAH1B3;TCF3;MLXIPL;ATF6
prerank,nucleotide diphosphatase activity (GO:0004551),-0.27833892930302506,-0.7602879933069809,0.7915057915057915,0.9709126046445228,1.0,5/14,18.92%,ENPP1;NUDT4;CILP;NUDT12;CILP2
prerank,neuropeptide receptor binding (GO:0071855),0.35577911481401675,0.7599636456156648,0.766896551724138,0.939928085874244,1.0,2/14,12.34%,SHANK1;AGRP
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.34700680194729305,0.7590997394207881,0.7635135135135135,0.9389821492806527,1.0,2/15,8.24%,PLA2G4A;SH3PXD2B
prerank,P-type ion transporter activity (GO:0015662),-0.289187036317736,-0.7586727503319606,0.7657342657342657,0.9653955677920966,1.0,2/12,8.61%,ATP2B1;ATP2A3
prerank,tubulin binding (GO:0015631),0.254686036377966,0.7558287144254369,0.9628514056224899,0.9411287109991673,1.0,68/295,23.07%,MAP7D3;FGF13;MAP1B;CFAP157;STMND1;KIF13A;TBCE;TTLL2;MID1;RAE1;BCAS3;TUBGCP3;DNM2;BLOC1S2;ALMS1;GPAA1;SYBU;NDRG1;BEX4;SMC3;TPGS1;AGBL5;MACO1;SPAST;EML3;CKAP5;MTUS1;CCDC66;RAB11FIP5;GIT1;MID2;RCC2;CHP1;TRAPPC14;EZR;MAPRE3;NDEL1;REEP3;MARK4;RMDN1;HDAC6;TBCD;VBP1;POLB;DIP2B;MAST2;KIF20B;KATNA1;BIRC5;CDK5;KIF6;CCDC61;DLGAP5;KIF1B;APPL1;DCTN1;LRRK2;CLIP2;STMN2;KIF21A;RITA1;SBDS;CRIPT;SETD2;CDK5RAP2;CAPN6;RABGAP1;PEX14
prerank,mRNA 3'-UTR binding (GO:0003730),0.27367335916316593,0.7553296024358668,0.8551502145922747,0.9398008476499942,1.0,28/79,29.31%,DDX5;YBX3;PABPC1;PUM1;CRYZ;HNRNPA2B1;ILF3;PCBP4;DAZAP1;AUH;RBM4;HNRNPC;EXOSC4;SECISBP2;CIRBP;FXR2;RNF20;PABPC4;HNRNPU;RBM24;TP53;ZFP36L1;RPL41;FXR1;CCT5;LARP1;KHSRP;PUM2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.37652391149903985,0.7541080881360375,0.7635327635327636,0.939331610922485,1.0,3/10,22.63%,FAAP20;IDE;DNAJC2
prerank,calcium activated cation channel activity (GO:0005227),0.3322923688057045,0.7537142366183741,0.7741514360313316,0.9377941517032836,1.0,4/17,16.88%,KCNN1;TRPM4;PKD2L1;KCNN4
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.282966353284286,-0.7529508125897394,0.7879858657243817,0.9658911505197869,1.0,3/12,10.64%,CDK6;CDK19;CDK8
prerank,phospholipase C activity (GO:0004629),0.31359857846175304,0.7508049252206642,0.8121890547263682,0.9393463073271785,1.0,2/25,3.12%,PLCE1;EDNRA
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.352211749431632,0.750539993295771,0.7696476964769647,0.9376802890022138,1.0,4/13,15.63%,PIK3C2B;PIP4K2B;PIK3CB;PIP5K1A
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.3669932003626504,0.7495165598156865,0.7894736842105263,0.9370349901333518,1.0,1/10,5.11%,GABRA3
prerank,steroid hydroxylase activity (GO:0008395),-0.26089777163027333,-0.7471837041167999,0.7862595419847328,0.9662005086242879,1.0,2/16,5.40%,CYP7B1;CYP27A1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.3548324378893457,0.7445465998330858,0.7667121418826739,0.9412288446408451,1.0,2/12,15.08%,SLC25A25;SLC35B3
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.3468355835055459,0.7443151140723464,0.7825484764542936,0.9395714357963924,1.0,4/15,17.61%,LPCAT1;GPAT4;PNPLA3;AGPAT5
prerank,GABA-A receptor activity (GO:0004890),-0.25991376156135954,-0.7415479442367521,0.8215767634854771,0.9668589026179538,1.0,4/18,12.70%,GABRB1;GABRB2;GABRB3;GABRA5
prerank,microtubule binding (GO:0008017),0.25157590537710645,0.7405851625814851,0.9446680080482898,0.9420985502315146,1.0,51/222,23.07%,MAP7D3;FGF13;MAP1B;CFAP157;KIF13A;MID1;RAE1;CLIP4;TUBGCP3;DNM2;ALMS1;SYBU;NDRG1;TPGS1;STIM1;MACO1;SPAST;EML3;CKAP5;MTUS1;CCDC66;MID2;RCC2;CHP1;EZR;MAPRE3;NDEL1;REEP3;MARK4;RMDN1;HDAC6;POLB;MAST2;KIF20B;KATNA1;BIRC5;CDK5;KIF6;CCDC61;DLGAP5;KIF1B;DCTN1;LRRK2;CLIP2;KIF21A;SBDS;CRIPT;CDK5RAP2;CAPN6;CAMSAP3;PEX14
prerank,exonuclease activity (GO:0004527),0.28746066420759475,0.7400258487176283,0.8443181818181819,0.9408101046467974,1.0,9/46,16.14%,REV3L;REXO2;RAD1;WRN;REXO1;RAD50;DCLRE1B;EXOSC4;AEN
prerank,alanine transmembrane transporter activity (GO:0022858),0.3599429516531652,0.7384430013144291,0.7960893854748603,0.9407557954578689,1.0,4/12,23.72%,SLC38A3;SLC1A4;SLC3A2;SLC36A1
prerank,exopeptidase activity (GO:0008238),-0.19868054684224729,-0.7330838401165346,0.9565217391304348,0.970834504946711,1.0,7/50,8.60%,DPP4;DPP10;CPM;ENPEP;TRHDE;ACE;DPP6
prerank,glucose transmembrane transporter activity (GO:0005355),0.32907889630633935,0.7327486758683265,0.7886944818304172,0.9454857222675789,1.0,3/17,17.24%,SLC5A2;SLC2A10;SLC2A2
prerank,calcium:sodium antiporter activity (GO:0005432),0.36786616511977027,0.7325744548541129,0.8074179743223966,0.9437406797405063,1.0,1/10,1.41%,SLC24A3
prerank,retinoic acid receptor binding (GO:0042974),0.32454334161810144,0.7300712649028767,0.795071335927367,0.9447427281864631,1.0,5/17,17.91%,NRIP1;NSD1;MED25;VDR;HMGA1
prerank,histone acetyltransferase binding (GO:0035035),0.30879074618231783,0.7288856996619625,0.825974025974026,0.9440785566263711,1.0,7/21,24.86%,BCAS3;MEF2A;SIRT2;CITED2;KANSL1;GLI3;TP53
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.33788203804927985,0.7268590751630395,0.8254847645429363,0.9445357450301953,1.0,2/14,11.46%,NOX4;AIFM1
prerank,mRNA 5'-UTR binding (GO:0048027),-0.2327966900910134,-0.7262151076082263,0.86,0.972259750532112,1.0,5/24,10.34%,RPS14;MYH10;DDX3X;RPS7;RPL26
prerank,protein phosphatase activator activity (GO:0072542),0.34006154442423464,0.7247577430158,0.8081805359661495,0.9448998795069714,1.0,3/13,16.30%,CALM2;PPP2R5C;CALM3
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2879407252399403,0.722651840726358,0.8355184743742551,0.9452827334933588,1.0,4/33,12.75%,RNF144A;DCUN1D5;RNF14;DCUN1D2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.30055653035902313,0.7197163352127958,0.82125,0.9466688043855619,1.0,6/25,19.57%,PLEKHA4;GAB2;DAPP1;HIP1;AKT1;MAPKAP1
prerank,protein phosphatase 2A binding (GO:0051721),0.30208611022956516,0.7144049903967162,0.8269720101781171,0.9506285066983112,1.0,3/23,7.51%,GRIN3A;ADCY8;STRN4
prerank,ribosomal small subunit binding (GO:0043024),-0.2547596196102749,-0.7126283356387855,0.8727272727272727,0.9817715088266324,1.0,2/17,5.21%,CPEB2;DDX3X
prerank,pentosyltransferase activity (GO:0016763),0.2840680298032295,0.7122793169450309,0.8554913294797688,0.9509510807755226,1.0,7/36,15.94%,PARP3;SIRT5;QPRT;UPP2;TNKS2;SIRT2;PARP1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.33955436889965085,0.7077432109929773,0.8319444444444445,0.9540416520631473,1.0,5/11,27.71%,PPEF2;TCF3;DUSP19;STK38;MAP3K11
prerank,hormone activity (GO:0005179),0.26961372954201934,0.7070304100649171,0.8701007838745801,0.9528690603054771,1.0,5/54,12.95%,INSL6;EDN3;VIP;AGRP;INHBA
prerank,G protein-coupled receptor activity (GO:0004930),0.236636989824691,0.7024886635851426,0.9757820383451059,0.9557514440969608,1.0,9/239,2.78%,CMKLR1;PDGFRL;FSHR;GPR27;GALR1;NPR3;GNRHR;DRD1;ADGRL2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.25106271509805833,-0.7016678788986827,0.875,0.9870943551995689,1.0,9/16,28.91%,CD38;MACROD2;SARM1;NEIL1;NEIL3;RPS3;OARD1;NEIL2;MACROD1
prerank,syntaxin-1 binding (GO:0017075),0.29825402346367574,0.6987772737371807,0.8498074454428755,0.9576574774263483,1.0,4/22,12.90%,UNC13B;PRRT2;NSF;STXBP5
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.31877198645643173,0.6954159776260493,0.8349514563106796,0.9591500260201071,1.0,6/14,22.75%,ALDH1L2;MTHFD1;MTHFR;NOXRED1;CRYM;PYCR1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.24338678661989774,-0.6933748437725941,0.8611111111111112,0.9883802425407213,1.0,1/16,1.64%,PIR
prerank,fatty acid synthase activity (GO:0004312),0.3494169260166538,0.6931037948443661,0.8195266272189349,0.9595229363770428,1.0,4/10,26.48%,ELOVL5;CBR4;MCAT;ELOVL1
prerank,bHLH transcription factor binding (GO:0043425),0.29794776859116334,0.6879429692581213,0.8642765685019206,0.962891654211373,1.0,5/19,19.28%,TWIST1;BHLHE40;MAP3K10;CREBBP;TCF3
prerank,protein phosphatase inhibitor activity (GO:0004864),0.2873571928197891,0.6846162763131802,0.8739290085679314,0.9643686160195355,1.0,10/26,28.38%,PPP1R9B;PPP1R8;CABIN1;ARPP19;SAG;MGAT5;BOD1L1;LMTK2;PPME1;PABIR1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.2821628313947437,0.6824142146284589,0.8661887694145759,0.96460252355505,1.0,6/26,22.30%,CHPF2;B3GNT7;B3GNT9;B3GNT6;B4GALNT3;B3GNT2
prerank,translation elongation factor activity (GO:0003746),0.31174383136682904,0.6820681916671346,0.8434903047091413,0.9630120807039738,1.0,5/14,23.97%,EEF1B2;TUFM;EEFSEC;GTPBP2;EIF5A2
prerank,hexosaminidase activity (GO:0015929),-0.2639408994379092,-0.6782424235704847,0.8916083916083916,0.9958263024557112,1.0,3/12,15.93%,CEMIP;CEMIP2;HYAL2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.26359654188604076,0.6763315285328988,0.9101654846335697,0.9666770224479623,1.0,7/42,17.86%,CCNL2;CCNL1;CCNT2;CCNE2;CCNG2;HEXIM1;CKS1B
prerank,neuropeptide receptor activity (GO:0008188),0.27913035931254065,0.6760692430521242,0.8759213759213759,0.964973073165996,1.0,1/29,1.85%,GALR1
prerank,ion channel inhibitor activity (GO:0008200),0.2653643331089079,0.6751887429157076,0.8829151732377539,0.9638885664201131,1.0,3/35,4.94%,NEDD4;CAMK2D;CALM2
prerank,ATP hydrolysis activity (GO:0140603),0.26104518851538466,0.6743822585434712,0.9105691056910569,0.9626579546914913,1.0,10/41,23.84%,CHD1L;VCP;CHD3;MYO1E;ABCB6;VWA8;KIF20B;CLU;ABCD1;ABCB10
prerank,adenylyltransferase activity (GO:0070566),0.28959863034197264,0.6741686754821846,0.8727959697732998,0.9609896686459626,1.0,9/21,32.67%,TENT4B;ABL1;NMNAT3;NMNAT2;TENT2;SELENOO;PAPOLG;NMNAT1;COASY
prerank,amyloid-beta binding (GO:0001540),0.24325519775474455,0.673469549637539,0.9416135881104034,0.9597599423548044,1.0,10/79,11.21%,LRP1;EPHB2;APBB3;LRPAP1;TGFB2;IAPP;FZD5;CST3;BACE1;COL25A1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.33244730403830813,0.670440191252968,0.850974930362117,0.9606672690896605,1.0,4/10,23.72%,OTUD5;YOD1;DESI2;CYLD
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.32478451437403383,0.6697348570904637,0.8609865470852018,0.959386826024,1.0,8/11,34.03%,PIGF;PTDSS1;PTDSS2;PIGN;SGMS2;GNPTAB;PIGO;SAMD8
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.2901095677323692,0.6671768991420509,0.8705583756345178,0.9596646205986673,1.0,5/20,17.61%,LPCAT1;GPAT4;PNPLA3;PLA2G15;AGPAT5
prerank,proton transmembrane transporter activity (GO:0015078),0.26345615519241183,0.6650127971863289,0.8976190476190476,0.9596980879296818,1.0,5/39,13.65%,SLC4A11;SLC9A1;CLCN4;NNT;ATP6V1B2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2726825827297706,0.6607108320857676,0.8928571428571429,0.9615945013209642,1.0,8/28,30.67%,AGO2;RPP40;ELAC2;RPP14;ENDOV;RPP21;POP5;PRORP
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.3111581631888416,0.6601395170075288,0.8643578643578643,0.9601992020048808,1.0,8/12,35.06%,HDAC1;TBP;FOS;TAF1;H3-3A;RELA;RUVBL2;POU2F1
prerank,FMN binding (GO:0010181),-0.2558843406600189,-0.6541123557609547,0.8703071672354948,1.0,1.0,5/11,27.39%,NOS3;NOS1;PNPO;NOS2;NDOR1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.29458408480340714,0.653142713045147,0.8939597315436242,0.9642865528975717,1.0,3/18,9.20%,ANXA2;PAK4;ANXA1
prerank,methyl-CpG binding (GO:0008327),-0.20780583705305566,-0.652500423343289,0.9471153846153846,1.0,1.0,5/22,15.09%,MBD2;CXXC4;TET1;ERH;CXXC5
prerank,acetylcholine receptor activity (GO:0015464),0.28014090704712125,0.6489687394581483,0.8972691807542262,0.9657645306589645,1.0,2/22,8.65%,CHRNB2;CHRNA5
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.32296441435907575,0.6441881451616129,0.8955223880597015,0.9678714298312792,1.0,1/10,5.96%,NOX4
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.19465570474193783,-0.643422485081032,0.9633507853403142,1.0,1.0,9/28,25.32%,STAT1;BABAM2;EDA;TRAP1;MYD88;TRAF1;TRAF2;FEM1B;FADD
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.23858471927352465,0.6409465789171586,0.9375,0.9686441205244595,1.0,7/60,8.98%,PPP1CC;PPP1R3C;PHLPP2;CDC14A;PPM1H;PGAM5;PPM1M
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.3081409145566998,0.637254374757664,0.8868458274398868,0.9696347097561261,1.0,4/12,24.85%,CASP1;BAD;BCL2L13;RPS27L
prerank,MAP kinase activity (GO:0004707),0.29695951418027206,0.6356437391336414,0.9046979865771813,0.9690439932231797,1.0,3/14,11.74%,MAPK15;MAPK8;MAPK12
prerank,GABA receptor activity (GO:0016917),-0.2126788480964136,-0.6328914828344875,0.9380530973451328,1.0,1.0,4/21,12.70%,GABRB1;GABRB2;GABRB3;GABRA5
prerank,MHC class I protein binding (GO:0042288),-0.2319668529097872,-0.6324281164135211,0.9372549019607843,0.9972784148242119,1.0,13/13,76.83%,ATP5F1B;TAP1;CD8B;ABCB9;ATP5F1A;TUBB;PILRA;CD8A;TAPBP;TAP2;LILRB1;TUBB4B;DERL1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.30898015217962427,0.6322840169716635,0.8840782122905028,0.9698497801728083,1.0,3/11,22.27%,HNRNPA2B1;RAD50;HNRNPA1
prerank,MAP kinase kinase activity (GO:0004708),-0.2279472780565769,-0.626919031570443,0.9475806451612904,0.9938300255226935,1.0,2/15,6.04%,MAP2K6;PAK3
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.2622438075975582,0.6233897403785646,0.9229828850855746,0.9744200229998854,1.0,5/25,15.94%,PARP3;SIRT5;TNKS2;SIRT2;PARP1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.2720785942177679,0.6230033794376901,0.91005291005291,0.9728050143471105,1.0,2/21,8.65%,CHRNB2;CHRNA5
prerank,thioesterase binding (GO:0031996),-0.2411455896204835,-0.6152822617076045,0.9228070175438596,0.9945280422818206,1.0,4/11,23.05%,ADRA2A;CDC42;TRAF1;TRAF2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.2716114979322019,0.6142427932209754,0.9176788124156545,0.9769540992509487,1.0,9/17,38.73%,AKR1C1;BDH2;SRD5A3;MECR;DECR2;TM7SF2;BLVRA;TECR;DECR1
prerank,chloride channel regulator activity (GO:0017081),0.278373734458397,0.6103888319690273,0.9161028416779432,0.9775540862581494,1.0,6/14,31.85%,WNK1;STX1A;SGK3;VTI1B;SGK1;STX7
prerank,microtubule plus-end binding (GO:0051010),0.2564709292001193,0.5996433400126335,0.9356499356499357,0.9825856686255621,1.0,5/20,20.72%,CLIP4;STIM1;MAPRE3;DCTN1;CLIP2
prerank,mitogen-activated protein kinase binding (GO:0051019),0.2455587405642478,0.5983468138820756,0.9546568627450981,0.981516833145089,1.0,4/29,10.41%,NBR1;CDK5RAP3;NFATC1;ABL1
prerank,peptidase activator activity (GO:0016504),0.2521908523480477,0.5960413691052731,0.9288486416558862,0.9810472412852316,1.0,4/22,16.12%,VCP;PCOLCE;TANK;PSMD14
prerank,ribosomal large subunit binding (GO:0043023),0.28292112592943164,0.5959631434496198,0.9183381088825215,0.9792363059535322,1.0,4/11,24.71%,LTN1;EIF6;CPSF6;RBM3
prerank,chloride channel inhibitor activity (GO:0019869),-0.23888557293480583,-0.5871570746466198,0.9485530546623794,1.0,1.0,3/10,14.56%,WNK2;WNK4;CFTR
prerank,C-C chemokine binding (GO:0019957),-0.18439302318271422,-0.583448243616647,0.9605911330049262,0.9981554611147272,1.0,5/22,20.71%,CCR9;CX3CR1;ZFP36;CCR5;CCR2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.2915101716787215,0.5832497203858434,0.9313304721030042,0.9846833100308833,1.0,7/10,40.77%,CASP1;CASP2;CASP6;CASP7;CASP12;CASP8;CFLAR
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.2855042333762522,0.5742658057742731,0.9365303244005642,0.9874801231396539,1.0,3/10,25.74%,FAAP20;IDE;DAXX
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.2795471052473183,0.5739583796156835,0.9405940594059405,0.9857434530663695,1.0,2/11,22.51%,SLC25A47;SLC22A3
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.1620142297094699,-0.5711200879217785,1.0,0.9900145173893209,1.0,33/34,72.76%,NDUFC2;NDUFA13;NDUFB2;NDUFB7;NDUFS1;NDUFA8;NDUFS6;NDUFA4;NDUFA2;NDUFA12;NDUFC1;NDUFB4;NDUFV1;NDUFS5;NDUFB8;NDUFS4;NDUFA5;NDUFA3;NDUFS2;NDUFB5;NDUFS8;NDUFS3;NDUFB10;NDUFB3;NDUFA10;NDUFA9;NDUFV3;NDUFA6;NDUFV2;NDUFB9;NDUFA7;NDUFA1;NDUFB6
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.1620142297094699,-0.5711200879217785,1.0,0.9900145173893209,1.0,33/34,72.76%,NDUFC2;NDUFA13;NDUFB2;NDUFB7;NDUFS1;NDUFA8;NDUFS6;NDUFA4;NDUFA2;NDUFA12;NDUFC1;NDUFB4;NDUFV1;NDUFS5;NDUFB8;NDUFS4;NDUFA5;NDUFA3;NDUFS2;NDUFB5;NDUFS8;NDUFS3;NDUFB10;NDUFB3;NDUFA10;NDUFA9;NDUFV3;NDUFA6;NDUFV2;NDUFB9;NDUFA7;NDUFA1;NDUFB6
prerank,phosphate ion binding (GO:0042301),-0.2270909793234218,-0.5636254040209983,0.9556213017751479,0.986087304910487,1.0,2/10,14.71%,PDE2A;ADSS1
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.208110992529349,-0.5624848768264097,0.9696969696969697,0.9797364207407336,1.0,13/13,79.21%,DNA2;DNASE1L1;EXO1;FEN1;GEN1;DNASE1;DNASE1L3;DICER1;ZGRF1;FAN1;DNASE1L2;SLX4;ENDOV
prerank,voltage-gated anion channel activity (GO:0008308),0.25358020888662874,0.5544470745623065,0.9634146341463414,0.9928641078389902,1.0,2/15,11.03%,CLCN4;VDAC2
prerank,microtubule minus-end binding (GO:0051011),0.25579612173684696,0.5481448044730066,0.9512855209742895,0.9935590469138119,1.0,1/13,5.21%,TUBGCP3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.26176603002294896,0.5342743603569361,0.9516837481698389,0.9968057512014762,1.0,1/11,8.54%,DDAH1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.24101551444363478,0.5151825715503013,0.9693593314763231,1.0,1.0,3/13,24.61%,GABRA3;GLRB;GABRE
prerank,RNA methyltransferase activity (GO:0008173),0.2225090705267393,0.510753272663474,0.9811083123425692,1.0,1.0,6/19,34.43%,TYW3;FBL;METTL8;MEPCE;TGS1;MRM2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.19399257144594978,-0.49206186177263145,0.9894736842105263,0.9921376779942342,1.0,6/11,26.85%,NEIL1;NEIL3;RPS3;HMGA2;NEIL2;APEX1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.22575672655517875,0.48415508283726455,0.9862068965517241,1.0,1.0,4/14,24.85%,CASP1;BAD;BCL2L13;RPS27L
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.1983476846118098,0.47862700431289923,0.995079950799508,1.0,1.0,10/28,28.07%,SBK2;AKT1;MAP2K3;LRRK2;MAP2K7;PRKACA;RPS6KB1;RPS6KA2;SGK1;MAP2K4
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.21684007407737144,0.4438195748814173,0.9859550561797753,1.0,1.0,7/11,40.77%,CASP1;CASP2;CASP6;CASP7;CASP12;CASP8;CFLAR
prerank,C-C chemokine receptor activity (GO:0016493),0.1743579203782979,0.40949711415663925,1.0,1.0,1.0,4/21,26.31%,ACKR4;CXCR4;ACKR3;CCRL2
prerank,5'-3' exonuclease activity (GO:0008409),0.18983215996376474,0.40600380392678737,0.9959239130434783,1.0,1.0,7/14,37.18%,XRN1;DCLRE1B;DXO;CPSF3;FAN1;MRE11;EXOG
prerank,neuropeptide binding (GO:0042923),0.1784501390809477,0.3992931071420521,0.9986824769433466,1.0,1.0,4/18,32.29%,MC4R;NMUR1;GPR37;SSTR2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.19500225024158657,0.3941287390586665,0.9970104633781763,1.0,1.0,2/10,23.75%,HEXIM1;KAT2B
prerank,death receptor binding (GO:0005123),0.17603628803491222,0.38818914408622457,1.0,1.0,1.0,3/15,26.09%,MADD;BID;RIPK1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.16312824803412823,0.3372730259651278,1.0,1.0,1.0,4/10,36.70%,DCLRE1B;POLD1;MGME1;TATDN1
prerank,MHC protein binding (GO:0042287),0.13642034605075387,0.3107403021187186,1.0,0.9999566502178326,1.0,5/20,34.66%,LAG3;DERL1;TUBB4B;LILRB1;TAP2
